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Yellowtail Kingfish (Seriola lalandi) (YTK) are carnivorous marine finfishes that are 206 
commercially farmed in Australia. YTK present the greatest opportunity for expansion of the 207 
Australian aquaculture industry, but improved diet formulations and feed conversion ratios are 208 
essential for production gains and economic upscaling. 209 
Lipids constitute a major cost component of aquafeeds but lipid composition has not 210 
been optimised for YTK. The purpose of this research was to increase understanding of how 211 
YTK utilise dietary lipids, and to improve feed conversion efficiency and product quality for 212 
human consumers. Fish oil (FO) as a dietary lipid source is central to this research as YTK 213 
require dietary omega 3 (n-3) long chain polyunsaturated fatty acids (LC PUFA) from FO for 214 
healthy development and growth, but FO is limited and less economically sustainable than 215 
other types of oil/lipid. 216 
The first study presented in this thesis sought to benchmark the fatty acid composition 217 
of wild YTK compared to aquacultured YTK. Tissue total lipid content was on average 4-times 218 
higher in aquacultured than wild YTK, with significantly higher concentrations of total 219 
saturated, omega 9, omega 7 and omega 6 fatty acids in tissues, but n-3 LC PUFA 220 
concentrations were not significantly different in the white muscle of wild and aquacultured 221 
YTK.  222 
The second and third studies were carried out with YTK grown in tanks using aquafeeds 223 
with varying lipid formulations. Generally, the fatty acid composition of aquacultured fish is 224 
reflective of the composition of aquafeeds, however this was not always the case for YTK in 225 
the following experiments. The key findings were that YTK have the capacity to spare in full 226 
Docosahaexonoic Acid (DHA) in white muscle at the expense of oleic acid (18:1n-9) when 227 
dietary levels of n-3 LC PUFA were <1.6 g 100 g-1 feed and that the digestibility of saturated 228 
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fatty acids decreased with increasing chain length. Both of these findings could be used to 229 
manipulate dietary formulations and improve utilisation of n-3 LC PUFA.  230 
The fourth study investigated the potential for finishing diets to be utilised to modify 231 
the tissue fatty acid composition of YTK prior to harvest. Results showed significant changes 232 
in white muscle n-3 LC PUFA over 33 days at warm water temperatures, however further 233 
research was recommended to optimise the duration of finishing periods under a range of 234 
conditions. It was also recommended that the n-3 LC PUFA content of YTK feeds be closely 235 
monitored with strict lower limits set to ensure optimal product quality. 236 
The fifth and final study validated a method for the quantification of bioactive free fatty 237 
acid and oxylipin levels in YTK blood plasma. The approach was then used to determine the 238 
effects of dietary levels of n-3 LC PUFA on plasma free fatty acids and oxylipin bioactives. 239 
This method provides a new tool for aquaculture nutritionists to assess the impact of changes 240 
to YTK aquafeed formulations. 241 
In summary, this thesis has provided insight into the factors that affect fatty acid 242 
utilisation in YTK which have the potential to positively influence future aquafeed 243 
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Chapter 1 – General introduction and literature review 277 
1.1. Background and purpose  278 
This research was undertaken as part of the national Kingfish for Profit (K4P) project, 279 
which was funded by industry partners and the Australian Department of Agriculture and Water 280 
Resources under the rural research and development (R&D) for profit programme. The aim of 281 
the K4P project was to develop more cost-effective Yellowtail Kingfish (Seriola lalandi) 282 
(YTK) feeds and feeding strategies, drive immediate production gains for YTK aquaculture, 283 
and build a YTK aquaculture R&D network to strengthen industry adoption of research 284 
outcomes. 285 
Yellowtail Kingfish farming presents the greatest opportunity to expand the aquaculture 286 
industry in Australia. Industry leaders in YTK farming, Clean Seas Seafood Ltd. (based in 287 
South Australia), are in the processes of expanding their production volume with the addition 288 
of a fourth production site in Whyalla, in regional South Australia. Meanwhile, Huon 289 
Aquaculture have recently invested in YTK farming as part of the K4P project, with trial YTK 290 
sea-cage farming in Port Stephens, New South Wales and the acquisition of new lease sites in 291 
regional Western Australia. The production of YTK in Australia is predicted to increase by 292 
34,000 tonnes in the next decade, at a value of $440 million, which will require an additional 293 
68,000 tonnes of aquafeeds (Stone et al., 2019a). To enable the expansion of the YTK 294 
aquaculture industry the K4P project had 3 key objectives: 1) to improve diet formulations and 295 
the economic sustainability of feeds, 2) to improve feeding strategies to increase the 296 
profitability of commercial farming operations, and 3) to improve the nutritional health to boost 297 
production profitability (Stone et al., 2019a). The body of work presented in this thesis assisted 298 
in achieving these objectives by focusing on the utilisation of dietary lipids by large (> 2kg) 299 
YTK. In relation to the first and third objectives, an in-depth understanding of the range of 300 
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interactions that dietary lipids and their fatty acids have within the body of farmed YTK will 301 
aid in the development of more functional and sustainable diets and has the potential to bolster 302 
the nutritional health of farmed YTK.  303 
Formulating diets with a lipid composition that can be utilised with the greatest 304 
efficiency will be pivotal in reducing the cost of aquaculture feeds (aquafeeds). Dietary lipids 305 
constitute a major cost component of aquafeeds, yet their composition and the potential for 306 
their manipulation have not been fully explored. Previous research efforts have predominantly 307 
focused on YTK nutritional demands during larval, fingerling and small grow-out stages; 308 
during these stages optimal nutrition is paramount as it is a key factor affecting survival and 309 
minimising rates of deformities (Kolkovski and Sakakura, 2004; Abbink et al., 2012). In 310 
contrast, the efficiency of dietary lipid utilisation in large, grow-out stage YTK has received 311 
less attention, regardless of the extensive quantity of aquafeed required to grow YTK through 312 
this production stage. For decades, the scientific community and aquaculture practitioners have 313 
been aware that aquacultured fish achieve optimal growth, maintain superior health and attain 314 
superior product quality when sustained on feeds rich in fish oil (FO), compared to feeds 315 
supplemented with alternative oils. However, the growth of aquaculture worldwide has resulted 316 
in the industry using greater quantities of FO in aquafeeds which is economically 317 
unsustainable.  318 
The use of FO in aquafeeds is hereafter reviewed, with specific focus on: 1) the 319 
replacement of FO in aquafeeds, 2) species-specific dietary omega 3 (n-3) long chain 320 
polyunsaturated fatty acid (LC PUFA) requirements, and 3) methods for modifying the n-3 LC 321 
PUFA concentrations of aquacultured species prior to harvest to benefit human consumers. 322 
Furthermore, the state of knowledge specifically concerning dietary FO and n-3 LC PUFA 323 
utilisation by YTK will be evaluated.  324 
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1.2. Fish oil use in aquaculture 325 
In 1990 global aquaculture production was at 13 million tonnes per year, increasing by 326 
75 million tonnes to 88 million tonnes per year in 2016 (FAO, 2016). On the other hand, total 327 
global wild capture fisheries production only increased by 6.23 million tonnes per year during 328 
the same period, indicating that aquaculture is fulfilling a substantial and increasing proportion 329 
of global demand for seafood (FAO, 2016 - Figure 1.1). Problematically for the aquaculture 330 
industry, the harvests from wild capture fisheries that supply fish meal and FO for aquafeeds 331 
have remained relatively static over the same period, meaning that the supply of key ingredients 332 
for aquafeeds are becoming limiting. Specifically, the global quantity of FO has peaked at 333 
approximately one million tonnes per year (Finco et al., 2016) and a large percentage of this is 334 
consumed by the aquaculture industry. In the future, as aquaculture production continues to 335 
increase, there will be a need to reduce the quantity of FO used per unit of aquafeed. 336 
Over the last 20 years a vast amount of research has focused on quantifying the effect 337 
of aquaculture on global supplies of FO, reducing the inclusion levels of FO and finding 338 
suitable replacements for FO in commercial aquaculture feeds that satisfy the cultured species 339 
requirements for n-3 LC PUFA, including Eicosapentaenoic Acid (EPA), Docosapentaenoic 340 
Acid (DPA) and Docosahexaenoic Acid (DHA). With dwindling wild fisheries stocks the cost 341 
of FO has increased dramatically in the past 20 years (from approximately $600USD to 342 
$1,450USD per tonne between 1995 and 2015; FAO, 2016). This has caused a flow-on increase 343 
to the cost of aquafeeds and the overall cost of production for commercial aquaculture.  344 
The use of marine resources in the aquaculture industry has been reviewed numerous 345 
times over the past 20 years. Most recently Turchini et al. (2019) reviewed the use of marine 346 
resources with the perspective of realigning key issues and contemplating future directions. 347 
That review outlined the necessity for understanding the way that raw ingredients complement 348 
each other and collectively fulfil the nutrient requirements of the target species, rather than 349 
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focusing on replacing unsustainable or costly ingredients with alternatives. Prior to this Tocher 350 
(2015) reviewed the use of n-3 LC PUFA sourced from FO in the aquaculture industry. That 351 
review outlined the key changes in nutritional aquaculture research over the previous 20 years 352 
and the ways in which n-3 LC PUFA requirements can be defined. Specifically, that they can 353 
be set by either: 1) meeting the minimum essential fatty acid (EFA) requirements of the target 354 
species, 2) determining the level that results in maximal growth and health of the target species, 355 
or 3) at a level which results in a similar product quality profile to the wild counterpart of the 356 
cultured species. In that review it was concluded that the aquaculture industry needs to find 357 
suitable new sources of n-3 LC PUFA and, indeed, set a challenge for the aquaculture industry 358 
to become a net producer of n-3 LC PUFA via de novo synthesis of n-3 LC PUFA.  359 
Additionally, a number of other reviews have previously addressed similar issues 360 
(Trushenski et al., 2006, Miller et al., 2008, Turchini et al., 2009). The general consensus within 361 
these reviews was that the aquaculture industry has expanded with such exponential growth 362 
that the resources that it relies on are no longer capable of supporting it, specifically the demand 363 
for FO. Furthermore, it is widely agreed that the majority of aquacultured species are limited 364 
by their essential demand for n-3 LC PUFA, from FO, to maintain proper biological function 365 
and as such the only option for sustaining the continual growth of the industry is to find 366 
alternate dietary sources of these n-3 LC PUFA. 367 
From the perspective of minimising negative interactions with the environment, mainly 368 
overexploiting natural resources such as FO, Naylor et al. (2000) and Naylor et al. (2009) have 369 
provided reviews addressing the effects of aquaculture on world fish supplies and highlighted 370 
the issue of finite resources in aquafeeds. These reviews assessed the challenges which the 371 
aquaculture industry would face into the future. The authors discussed the strides which had 372 
been made by the aquaculture industry and also the limitations that it would face. A particular 373 
challenge is that human consumers desire aquaculture products that are produced in an 374 
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environmentally friendly manner, but still require the same nutritional benefits in terms of n-3 375 
LC PUFA content when compared to wild caught fish products. This means that the 376 
aquaculture industry is limited by its reliance on wild fisheries as a source of FO and 377 
specifically n-3 LC PUFA. The inclusion rate of FO in aquafeeds is low, indeed the quantity 378 
of FO in salmon diets has decreased from 30% to 10%. However, the immense quantity of 379 
aquafeed required worldwide means that the aquaculture industry is consuming most of the 380 
global supply of FO and consequently that in the future the aquaculture industry will be 381 
responsible for either conserving or depleting wild fisheries.  382 
The authors of these reviews stated a clear way forward: 1) utilising n-3 LC PUFA from 383 
terrestrial sources such as genetically modified canola or 2) commercially developing single 384 
cell organisms, such as algae, to provide n-3 LC PUFA. However, both of these options are 385 
currently limited, the former by consumer acceptance of genetically modified organisms and 386 
the latter by the high cost of production. As the aquaculture industry and the human population 387 
continue to expand, the requirement for nutritionally beneficial seafood will increase and it is 388 
likely that these challenges will be overcome as consumer opinions change and production 389 
techniques improve.  390 
Encouragingly since theses reviews have been published it is apparent that the 391 
aquaculture industry has made positive strides in managing FO use. With the sustainable use 392 
of by-product lipid sources, terrestrial lipid sources and reducing the overall FO inclusion in 393 
aquafeeds the predicted negative impacts of worldwide aquaculture have not been realised. 394 
It is clear that the future success of the aquaculture industry will be determined by its 395 
ability to overcome its reliance on FO as a raw ingredient and to carefully manage all of the 396 
resources that it relies on. Importantly, as an industry there is a clear path forward with a 397 
number of viable alternatives to the unsustainable use of FO and as a sector it is obvious that 398 
collaboration and ongoing research is essential to future success.  399 
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1.3. Replacement of dietary FO in aquafeeds 400 
A vast quantity of research has endeavoured to increase our understanding of how FO 401 
replacement in aquafeeds affects the cultured animals consuming such feeds. The topic of FO 402 
replacement has been reviewed by Turchini et al. (2010) and Turchini et al. (2009). Once again, 403 
the key issues identified within these reviews were: potentially restricted expansion of the 404 
aquaculture industry due to reliance on wild fisheries for FO, altered product quality of farmed 405 
fish due to dietary FO replacement and the requirement for the industry to find new sources of 406 
dietary lipids and n-3 LC PUFA. These authors state that future replacements for dietary FO in 407 
aquafeeds need to be competitively priced, readily available and have minimal concentrations 408 
of linoleic acid (18:2n-6). This last point, concerning linoleic acid, is not considered with the 409 
same weighting elsewhere but is important in relation to fish and human nutrition. Omega 6 410 
fatty acids have pro-inflammatory downstream bioactive metabolites (free fatty acids and 411 
oxylipins) and for fish and humans the ratio of dietary n-3 to omega 6 fatty acid has implication 412 
for nutrient metabolism and bioconversion. Furthermore, omega 6 fatty acids are already 413 
abundant in the human diet, main due to the consumption of terrestrial plant oils and as such 414 
their minimization in seafood products is preferable.   415 
Fish oil replacement has also been discussed in depth by Glencross et al. (2007), 416 
Nasopoulou and Zabetakis (2012) and Oliva-Teles (2012), who address issues such as 417 
ingredient quality, animal nutrition and health, and the benefits of plant derived oils. The key 418 
point of difference of the Glencross et al. (2007) review was the necessity for refined 419 
experimental designs which are capable of addressing specific diet composition queries. This 420 
is vital because of the interactive nature of dietary ingredients and the fact that it is often 421 
difficult to discern the source of impacts if experimental diets are not formulated correctly. The 422 
Nasopoulou and Zabetakis (2012) review differed from others because it solely focused on 423 
plant originated oil as a replacement for FO in aquafeeds. Furthermore, those authors discussed 424 
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the implication of growing terrestrial oil crops for aquafeeds in the context of climate change 425 
and an increasing shortage of freshwater for agriculture. Lastly, Oliva-Teles (2012) discussed 426 
the reduced immunity of farmed fish when dietary FO was reduced, noting that reduced disease 427 
resistance could be driven by changes to the ratio of dietary fatty acids and also by essential 428 
fatty acids not being supplied in adequate quantities. These three reviews demonstrate that FO 429 
replacement is a multifactorial problem and that each factor needs to be carefully considered.  430 
Dietary FO is currently replaced in aquafeeds by four groups of alternative oils: 431 
terrestrial derived animal oils and tallows, terrestrial vegetable and plant derived oils, oils 432 
derived from marine algae and oils derived from terrestrial crops that have been genetically 433 
modified to produce n-3 LC PUFA. Generally, terrestrial animal derived oils and tallows, 434 
primarily poultry oil (PO) but also beef tallow, have been used most broadly and successfully 435 
as a FO replacement in aquafeeds.  436 
1.3.1. Terrestrial derived animal oils and tallows 437 
Poultry oil has been shown to be a viable partial or total FO replacement in the 438 
aquafeeds for Yellowtail Kingfish (100% replacement) (Bowyer et al., 2012a), European Sea 439 
Bass (Dicentrarchus labrax) (75% replacement) (Monteiro et al., 2018) and Barramundi (Lates 440 
calcarifer) (100% replacement) (Ahmad et al., 2013, Salini et al., 2015) without affecting 441 
growth or feed conversion efficiency, however the fatty acid profile the fish is consistently 442 
reflective of the dietary fatty acid profile. Beef tallow has successfully replaced FO in the feeds 443 
for Atlantic Salmon (Salmo salar) (Emery et al., 2016) and Rainbow Trout (Oncorhynchus 444 
mykiss) (Gause and Trushenski, 2013) without affecting growth or feed conversion efficiency. 445 
However, beef tallow as a FO replacement has been shown to be detrimental in Silvery Black 446 
Porgy (Sparidentex hasta), which exhibited reduced growth and feed conversion efficiency 447 
(Mozanzadeh et al., 2016) and in Cobia, where growth was unaffected but feed conversion 448 
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efficiency was inferior (Woitel et al., 2014a, Woitel et al., 2014b). As with the majority of FO 449 
replacements the major bottleneck for terrestrial derived animal oils and tallows is the 450 
modification to the fatty acid profile of the fish, generally resulting in tissues that are high in 451 
saturated fatty acids (SFA), monounsaturated fatty acids (MUFA) and omega 6 fatty acids and 452 
low in n-3 LC PUFA. Comparatively, the fatty acid profile of wild-caught seafood is generally 453 
abundant in n-3 LC PUFA and scarce in omega 6 fatty acids (Yearsley et al., 1998). Reduced 454 
n-3 LC PUFA concentrations in fish flesh resulting from dietary oil replacement can be 455 
mitigated with a partial replacement strategies (including a small amount of FO in the diet), 456 
but the high levels of SFA, MUFA and omega 6 fatty acids can be difficult to reduce in fish 457 
flesh. Omega 6 fatty acids are already in great abundance in non-fish protein sources in the 458 
western diet (Givens and Gibbs, 2006; Zambiazi et al., 2007) and they should be limited in the 459 
diet. Reducing their content in fish products would likely be beneficial to the human consumer.  460 
The general consensus from recent research into terrestrial derived animal oils and 461 
tallows as a FO replacement are that these alternative oils are capable of producing comparable 462 
growth and feed efficacy in fish as when they are reared on FO diets. The cost reduction 463 
associated with alternative oils currently make these sources viable for commercial aquafeeds. 464 
While a substantial portion of FO can be replaced with these alternative oils, some dietary FO 465 
is still generally required to assure n-3 LC PUFA requirements of the species are met and n-3 466 
LC PUFA inclusion is the flesh is adequate for human consumers. Terrestrial animal-derived 467 
oils and tallows only provide the part of the solution to replacing FO in aquafeeds and in the 468 
future they will need to be used in conjunction with the efficient use of FO and finishing diets 469 
to improve fatty acid composition and provide human consumers with the superior nutritional 470 
quality found in wild caught fish or in cultured fish reared on FO rich diets. 471 
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1.3.2. Terrestrial derived plant oils 472 
The most consistently utilised terrestrial derived plant oil is arguably canola oil (CO). 473 
Canola oil has been used to successfully replace FO in Red Hybrid Tilapia (Oreochromis sp.) 474 
(100% replacement) (Teoh and Ng, 2016), Atlantic Salmon (80% replacement) (Liland et al., 475 
2013) and Rainbow Trout (75% replacement) (Turchini et al., 2013) aquafeeds without 476 
negatively affecting growth or feed conversion efficiency. However, in YTK high dietary CO 477 
at an inclusion above 50% affected growth and feed conversion efficiency and also 478 
downregulated trypsin and lipase enzyme activities, which could impact nutrient digestibility 479 
(Bowyer et al., 2012b). Conversely, in Red Hybrid Tilapia, dietary CO has a positive effect, 480 
upregulating n-3 LC PUFA biosynthetic pathways resulting in greater quantities of n-3 LC 481 
PUFA in the flesh, compared to diets where FO was replaced with sunflower oil (Teoh and Ng, 482 
2016). This was attributed to the increased quantities of precursor 18:3n-3 alpha-linoleic acid 483 
in the CO diet, compared to the sunflower oil diet, that were able to be readily bio-converted 484 
in to n-3 LC PUFA by Nile Red Tilapia. When comparing the two species it is evident that vast 485 
differences exist in the capacity of different species to bio-convert precursor fatty acids into n-486 
3 LC PUFA and as such while CO might be a viable alternative lipid source for some species 487 
of farmed fish it will not be suitable for all.   488 
A range of other terrestrial derived plant oils have been successfully trialled recently in 489 
feeds for a range of aquacultured species. In Barramundi, rice bran oil can 100% replace FO 490 
(Glencross et al., 2016), in Atlantic Salmon olive oil can replace 80% FO (Liland et al., 2013), 491 
in Greater Amberjack (Seriola dumerili) palm oil can 50% replace FO and linseed oil can 100% 492 
replace FO (Monge‐Ortiz et al., 2018), in Cobia (Rachycentron canadum) soybean oil can 493 
replace 67% FO (Trushenski et al., 2011), in Murray Cod (Maccullochella peelii peelii) FO 494 
can be replaced with palm oil, olive oil, sunflower oil or linseed oil (Turchini et al., 2011), in 495 
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Rainbow Trout FO can be 75% replaced with sunflower oil or soybean oil (Turchini et al., 496 
2013), and in all cases growth and feed conversion efficiency were unaffected by FO 497 
replacement. However, other effects were observed in European Sea Bass, where replacing 498 
dietary FO with terrestrial derived plant oils resulted in changes to the anterior and posterior 499 
gut morphology and microbiota (Torrecillas et al., 2017). In Murray Cod fed terrestrial derived 500 
plant oils, the abundant MUFA and SFA were catabolised at the expense of n-3 LC PUFA, 501 
creating a n-3 LC PUFA sparing effect (Turchini et al., 2011). The sparing of n-3 LC PUFA 502 
refers to a mechanism that is responsible for the n-3 LC PUFA concentration in various tissue 503 
regions being preserved while other fatty acids are utilised for energy and metabolic processes 504 
(Trushenski et al., 2011). When n-3 LC PUFA is not being spared in fish it generally appears 505 
that all fatty acids are utilised for energy and metabolic processes without prejudice. The 506 
sparing of n-3 LC PUFA generally occurs in fish when dietary levels of n-3 LC PUFA are low, 507 
however it remains to be elucidated how fish are able to discriminate between these fatty acids 508 
to achieve these processes. Lastly in Rainbow Trout, FO replacement with terrestrial derived 509 
plant oils caused fish to actively bio-convert EPA to DHA (Turchini et al., 2013). These authors 510 
did however note that this bio-conversion also occurred in their FO control group, they 511 
thereafter indicated that the ratio of EPA to DHA of 1.8 was likely not ideal. They concluded 512 
that close attention needed to be paid to the ratio of individual n-3 LC PUFA in aquafeeds for 513 
Rainbow Trout to minimise the metabolic effort required for such processes. This last study 514 
brings attention to the need to closely monitor all factors that can be affected by modifications 515 
to aquafeeds formulations and manage them such that results of feed trials are not limited by 516 
inadequate nutrient supply. 517 
Using terrestrial derived plant oils as a replacement for FO has similar associated 518 
problems to terrestrial derived animal oils with alterations to the flesh fatty acid profile. 519 
However, these plant derived alternative oils do appear to trigger some beneficial biological 520 
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reactions with regards to n-3 LC PUFA sparing and bio-conversion of precursor fatty acids into 521 
n-3 LC PUFA by some species. However, given that this sparing was at the expense of MUFA 522 
and SFA, it is likely that the same reactions could be triggered with the inclusion of terrestrial 523 
derived animal oil replacements. It appears to be necessary to consider the capacity of each 524 
individual species to spare and bio-convert n-3 LC PUFA when fed different alternative dietary 525 
lipids in order to maximise the utilisation of aquafeeds.  526 
1.3.3. Marine algal products 527 
Recently marine algal products have become more widely available for experimental 528 
use in aquafeeds. Algal products have the added benefit of being a naturally rich source of 529 
important n-3 LC PUFA and are in fact the source of LC PUFA in all marine fish. The marine 530 
algae Tisochrysis lutea and Tetraselmis suecica have been successfully used to substitute for 531 
FO in the feeds for European Sea Bass (Cardinaletti et al., 2018). Similarly, Aurantiochytrium 532 
sp. has been utilised in the feeds for Totoaba (Totoaba macdonaldi) to counteract the reduction 533 
in n-3 LC PUFA deposition resulting from replacing dietary FO with PO and beef tallow (Mata-534 
Sotres et al., 2018). Arthrospira sp. and Schizochytium limacinum have also shown potential 535 
as algal products capable of replacing dietary FO in aquafeeds for Red Drum (Sciaenops 536 
ocellatus) (Perez-Velazquez et al., 2018). 537 
The primary bottleneck for the use of marine algal oils in large-scale aquaculture 538 
operations is high cost and limited availability. The potential for marine algal products to 539 
replace dietary FO in aquafeeds has only recently been realised. As with the development of 540 
any new product the process of refining and upscaling production can be complex. However, 541 
over time, as production techniques improve and costs decrease, it is expected that marine algal 542 
products will become more available and affordable, and as such will be used more readily in 543 
commercial aquafeeds. 544 
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1.3.4. Oils derived from terrestrial transgenic crops  545 
Lastly, transgenics provides an interesting opportunity to modify terrestrial crops to 546 
produce a new source of n-3 LC PUFA and fill the gap between supply and demand of these 547 
critically important fatty acids. Recently, the Commonwealth Scientific and Industrial 548 
Research Organisation (CSIRO) successfully bioengineered a strain of canola which is capable 549 
of producing n-3 LC PUFA (CSIRO, 2019). This was achieved by introducing a set of eight 550 
genes from marine algal sources into canola DNA to extend its fatty acid biosynthetic pathway 551 
and allow it to produce n-3 LC PUFA. The fatty acids profile of the oil from these canola crops 552 
are exceptionally abundant in DHA and have an ideal n-3 to omega 6 ratio. Similar strides have 553 
been made in producing transgenic flaxseed oil (Linum usitatissimum) crops capable of 554 
producing n-3 LC PUFA (Lu and Kang, 2008). 555 
Recently, Napier et al. (2015), Sayanova and Napier (2011) and Robert (2006) have 556 
reviewed the capacity for oils derived from terrestrial transgenic crops to meet the growing 557 
demand for n-3 LC PUFA, both as a direct source for humans and also for aquaculture. These 558 
authors consistently note the same challenges that must be overcome if terrestrial transgenic 559 
oil seed crops are going to alleviate the pressure on wild fisheries as a source of n-3 LC PUFA. 560 
Firstly, they identify the need to obtain regulatory approval to grow these crops and then utilise 561 
their products in aquafeeds. Secondly, there is a need to obtain a thorough understanding of the 562 
agronomy of these crops to ensure their efficient production. Thirdly, it will be important to 563 
understand the capacity of farmed fish to utilise n-3 LC PUFA from this new source and any 564 
secondary factors that may present as a result of FO being replaced with oils derived from 565 
terrestrial transgenic crops, for example, changes to gut microbiota or morphology, which 566 
could have flow on effects for fish health. And lastly, there is the challenge of consumer 567 
acceptance. The general public will likely require a thorough understanding of the benefits of 568 
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oils derived from terrestrial transgenic crops in order to accept their incorporation in food 569 
products.  570 
Utilising oils derived from terrestrial transgenic crops will not be as challenging as 571 
utilising marine algal products in relation to high cost or availability, but other challenges may 572 
be difficult to overcome. As previously mention the production of terrestrial transgenic crops 573 
is currently limited by regulatory restrictions, but approval for production appears to be 574 
imminent in Australia and the United States of America (Napier et al., 2019). The recent 575 
primary research utilising oils from transgenic terrestrial crops has focussed on the use of 576 
transgenic Camelina sativa in the feeds of Atlantic Salmon (Betancor et al., 2015a, Betancor 577 
et al., 2015b) and Gilthead Sea Bream (Sparus aurata) (Betancor et al., 2016). In both species, 578 
genetically modified oils from terrestrial transgenic crops, high in n-3 LC PUFA, where shown 579 
to be suitable replacements for dietary FO. Therefore, the likely final challenge will be 580 
overcoming negative consumer preconceptions about genetically modified products and 581 
educate them on the need for such products in the expanding aquaculture industry. 582 
1.3.5. Fish oil replacement in YTK feeds 583 
As previously mentioned, dietary FO can be replaced for juvenile YTK 100% by PO or 584 
50% by CO, as long as the minimum n-3 LC PUFA requirement is met. Furthermore, Bowyer 585 
et al. (2012a) and Meigel et al. (2010) found that temperature influenced the digestibility of 586 
dietary fatty acids in juvenile YTK. In large YTK, FO is also replaced in significant 587 
proportions, often by PO, after the n-3 LC PUFA specification has been fulfilled with an 588 
adequate inclusion of FO, but further research is required to fully understand the range of 589 
effects that PO as a dietary lipid source has on YTK. 590 
In YTK the use of PO as a dietary lipid source appears to have negligible effects on 591 
growth or feed conversion efficiency, however, there is an impact on the resulting product 592 
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quality. As observed with other species, the fatty acid profile of YTK is reflective of the dietary 593 
fatty acid profile. When PO replaces dietary FO, this results in higher quantities of SFA, MUFA 594 
and omega 6 fatty acids compared to the quantities observed in wild YTK or YTK reared on 595 
high FO, more ‘natural’ diets. Canola oil is not widely used as a FO replacement in the diets 596 
of large YTK given its inferior results in terms of growth and feed conversion efficiency in 597 
juvenile YTK.  598 
Marine algal products and oils derived from terrestrial transgenic crops that are high in 599 
n-3 LC PUFA have not yet been trialled for YTK, however, once these lipid sources become 600 
more widely available and affordable it will be worthwhile investigating their suitability for 601 
this species.  602 
1.4. Dietary n-3 LC PUFA requirements 603 
To sustainably manage FO as a resource it will continue to be important to understand 604 
species-specific n-3 LC PUFA requirements and how they can change with age, environmental 605 
parameters and/or disease status. Defining these requirements for commercially important 606 
aquaculture species will allow the minimal quantity of FO to be used to attain maximal growth 607 
and feed efficacy without being wasteful. 608 
Specific dietary n-3 LC PUFA requirements have been established for juvenile 609 
Japanese Yellowtail (Seriola quinqueradiata) (3.9 g 100 g-1 feed (Ishihara and Saito, 1996)), 610 
adult Japanese Yellowtail (2.0 g 100 g-1 feed (Deshimaru et al., 1982)), juvenile Meagre 611 
(Argyrosomus regius) (2.0 g 100 g-1 feed (Carvalho et al., 2018)), Grouper (Epinephelus 612 
coioides) (1.83 g 100 g-1 feed (Chen et al., 2017)), and Atlantic Salmon (> 2.0 g 100 g-1 feed - 613 
ref 17). In terms of net production of n-3 LC PUFA, Nile Tilapia and Eurasian Perch (Perca 614 
fluviatilis), have been shown to be efficient bio-converters of linoleic acid (LOA) to n-3 LC 615 
PUFA (Henrotte et al., 2011, Chen et al., 2018), while Grouper and Barramundi have been 616 
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shown to be inefficient converters to n-3 LC PUFA. In Barramundi excess inclusion of alpha 617 
linoleic acid (ALA) may inhibit DHA synthesis.  618 
Recently, in Atlantic Salmon and Rainbow Trout the addition of dietary micronutrients 619 
and coenzymes has been observed to improve n-3 LC PUFA biosynthetic pathways (Lewis et 620 
al., 2013, Giri et al., 2016). The timing of feeding has also been investigated in relation to the 621 
efficiency of n-3 LC PUFA deposition in Rainbow Trout (Brown et al., 2010), Gilthead Sea 622 
Bream and European Sea Bass (Eroldoğan et al., 2018). In all cases feeding in the afternoon 623 
had a positive effect on fatty acid deposition, suggesting that circadian patterns can be exploited 624 
to improve feeding efficiency.  625 
Lastly, some studies have sought to understand whether all individual n-3 LC PUFA 626 
are required for cultured fish. Research in this area had been limited due to the limited 627 
availability of purified forms of EPA, DPA, DHA and Arachidonic Acid (ARA). In California 628 
Yellowtail (Seriola dorsalis), it appears that only DHA and ARA are required for optimal 629 
growth and health and when they can be supplemented into the diet at adequate quantities, 630 
100% FO can be replaced in the diet (Rombenso et al., 2016). Similarly, in juvenile Cobia, 631 
dietary DHA was required while EPA was largely expendable (Trushenski et al., 2012). 632 
As mentioned above, species-specific n-3 LC PUFA requirements are likely to change 633 
based on a number of factors (age, sexual maturity, environmental parameters and/or disease 634 
status) but are also likely to be influenced by changes to other dietary components and feeding 635 
strategies. The complex nature of n-3 LC PUFA species-specific requirements has likely 636 
limited progress in this area. The lack of defined requirements for all commercially important 637 
species is indicative that further research is required in this area.  638 
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1.4.1. Dietary n-3 LC PUFA requirements for YTK 639 
The dietary n-3 LC PUFA requirement for YTK had previously been conservatively 640 
estimated based on the requirement reported for the closely related Japanese Yellowtail at 2.0 641 
g 100 g-1 feed (Deshimaru et al., 1982; Stone and Bellgrove, 2013). Based on results from the 642 
recently completed K4P project this requirement has since been revised to 2.12 – 2.26 g 100 g-643 
1 feed for sub-adult Yellowtail Kingfish (Stone et al., 2019b). This requirement was established 644 
based on the optimal growth and feed conversion of large sub-adult YTK (> 2 kg) during an 645 
84-day experiment conducted at warm water temperatures. This requirement will be discussed 646 
further in Chapter 3.  647 
1.5. Modifications to n-3 LC PUFA concentrations of aquacultured species prior 648 
to harvest to benefit human consumers 649 
Phase feeding and finishing/harvest diets have been utilised in the aquaculture industry 650 
for a number of years. While they are not a long-term solution to minimising the use of FO in 651 
aquafeeds, they are a means of reducing the quantity of FO required to produce a product that 652 
is as nutritionally beneficial to the human consumer as a fish reared on high FO diets throughout 653 
the production cycle. The basic premise of phase feeding and finishing/harvest diets is that 654 
farmed fish can be reared during the majority of the production cycle on a cheaper and more 655 
sustainable low FO diet, then in the weeks/months prior to harvest the diet is substituted for 656 
high FO diet. The high FO diet is abundant in n-3 LC PUFA and improves the fatty acid profile 657 
of the fish relative to a particular benchmark (generally the fatty acid profile of fish reared 658 
throughout production on the equivalent of the high FO diet or the fatty acid profile of a wild 659 
caught fish of the same species).  660 
The use of finishing diets has been investigated for Rainbow Trout (Thanuthong et al., 661 
2011, Stone et al., 2011a, Stone et al., 2011b, Thanuthong et al., 2012) Atlantic Salmon (Bell 662 
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et al., 2003, Codabaccus et al., 2012), Gilthead Sea Bream (Benedito-Palos et al., 2009), Turbot 663 
(Psetta maxima) (Regost et al., 2003), Senegalese Sole (Solea senegalensis) (Reis et al., 2014), 664 
Jade Perch (Scortum barcoo) (Van Hoestenberghe et al., 2013) and Red Hybrid Tilapia (Ng et 665 
al., 2013). In all cases a finishing diet rich in FO resulted in a significant increase in tissue n-3 666 
LC PUFA concentration. However, there were slight differences in the experimental designs 667 
utilised, with finishing periods varying from 2 weeks (Van Hoestenberghe et al., 2013) up to 668 
20 weeks (Bell et al., 2003) and in some cases a food deprivation period was implemented prior 669 
to the finishing period (Codabaccus et al., 2012, Thanuthong et al., 2012). Generally, shorter 670 
finishing periods did not restore the fatty acid profile to the same degree as longer finishing 671 
periods and were not able to fully restore the fatty acid profile compared to a control treatment 672 
fed dietary FO throughout the growth period. Van Hoestenberghe et al. (2013) achieved a 25% 673 
recovery of n-3 LC PUFA in 2 weeks, while in Bell et al. (2003) achieved approximately 80% 674 
recovery in 20 weeks. Also, from a fatty acid perspective, omega 6 (n-6) fatty acids remained 675 
consistently higher in fish reared on non-FO diets and then switched to finishing diets, 676 
compared to those reared throughout the growth period on FO control diets. The high n-6 fatty 677 
acid concentrations in these fish is problematic, because n-6 fatty acids are abundant in the 678 
western diet and their consumption should be limited in humans (Simopoulos, 2002), and as 679 
such their excess quantity in aquacultured fish is not a desirable trait. 680 
In more recent studies, a finishing period was preceded by a food deprivation period, 681 
which aimed to reduce flesh fat content to improve n-3 LC PUFA restoration. In Codabaccus 682 
et al. (2012) food deprivation prior to the finishing period improved the efficiency of n-3 LC 683 
PUFA restoration in the flesh of Atlantic Salmon. However, Thanuthong et al. (2012) found 684 
that this strategy resulted in only minor improvements in tissue n-3 LC PUFA content and a 685 
loss of weight gain due to the 2 weeks of food deprivation. The shorter food deprivation period 686 
utilised by Codabaccus et al. (2012) had reduced negative implications for weight gain but in 687 
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parallel likely reduced total lipid loss during this time and would have implications for the 688 
degree of n-3 LC PUFA restoration that was possible. Furthermore, in both studies, food 689 
deprivation did not result in significantly different contents of n-3 LC PUFA in the flesh 690 
compared to a standard finishing diet fed without prior food deprivation. These results indicate 691 
that the same level of recovery could be achieved in a shorter period of time when the food 692 
deprivation method was employed, specifically, 1 or 2 weeks of food deprivation followed by 693 
4 or 6 weeks respectively of feeding of the finishing diet, compared to a standard 5 or 8 weeks 694 
of continual feeding of a finishing diet result in the same muscle content of n-3 LC PUFA. This 695 
is promising as a smaller quantity of high FO feed is required to produce a fish with the same 696 
nutritional benefits (n-3 LC PUFA), meaning that producers can reduce FO use and aquafeed 697 
costs, and improve environmental sustainability. Conversely, withholding feed has substantial 698 
associated risk, such as reduced health status of fish and reduced product quality if finishing 699 
periods are not successful. The practicality of such strategies would need to be carefully 700 
considered and extensively research before implementation.  701 
1.5.1. Modification of n-3 LC PUFA concentration in YTK prior to harvest 702 
Finishing diets have not yet been assessed for YTK, but they do present an opportunity 703 
to alter the fatty acid profile of YTK in a positive manner prior to harvest. A short period of 704 
feeding of a high FO diet prior to harvest, with or without a period of food deprivation, could 705 
assist in providing human consumers with a product that is higher in n-3 LC PUFA than that 706 
which is available with current commercial YTK aquaculture practices. This is investigated 707 
further in Chapter 5. 708 
1.6. Thesis objectives and aims 709 
The primary objective of this research was to expand on the current state of knowledge 710 
of lipid utilisation by YTK, with a specific focus on optimising dietary lipids for YTK during 711 
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the grow-out stage of production (when fish were > 2kg). Implications for fish health, human 712 
consumers, commercial YTK producers and economic and environmental sustainability were 713 
considered throughout each stage of investigation.  714 
To understand the baseline or normal lipid and fatty acid composition of YTK this 715 
research compared the composition of aquacultured and wild YTK. And although the sample 716 
size of wild fish was small (n = 6) and the average fish weight was two times greater (6.7 kg) 717 
than that of the YTK tested in the current tank-based trial, differences existed between the two 718 
groups likely due to differences between their respective diets. Understanding the effects of 719 
compounded aquafeeds and commercial feeding practices on the lipid and fatty acid 720 
composition of aquacultured YTK compared to ‘natural’ diets and feeding behaviours of wild 721 
YTK has provided a key starting point for improving biological functioning and product quality 722 
of aquacultured YTK, while also improving the profitability and sustainability of YTK 723 
production. Thereafter, methods to manipulate and improve the utilisation of n-3 LC PUFA in 724 
aquacultured YTK were investigated. The aim of these experiments was to investigate how 725 
dietary n-3 LC PUFA, the critical group of fatty acids provided by the inclusion of FO in YTK 726 
aquafeeds, could be reduced without negatively impacting fish health or fatty acid digestibility 727 
and could be manipulated during the final stages of production to benefit human consumers. 728 
Lastly, this research aimed to validate a new method to quantify the downstream bioactive 729 
products of dietary fatty acids and investigate the effect of changes to dietary fatty acid 730 
composition on their relative abundance. This line of investigation has provided a new tool for 731 
aquaculture nutrition studies and has the potential to increase our understanding of dietary fatty 732 
acids are utilised once within the bodies of YTK.  733 
  734 
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1.8. Figure 992 
 993 
Figure 1.1:  Global capture fisheries and aquaculture production from 1990 and estimated 994 
through to 2030 (Source: FAO, 2016 – Figure 34). 995 
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Abstract  1025 
Consumers often set benchmarks for the product quality of aquacultured fish based on 1026 
a comparison to wild fish, and arguably one of the most important product quality attributes 1027 
for fish is its omega 3 (n-3) long chain (LC) polyunsaturated fatty acid (PUFA) content, due to 1028 
its benefits for human health. In the present study, we investigated the differences in total lipids 1029 
and fatty acid content between wild and aquacultured Yellowtail Kingfish (Seriola lalandi) 1030 
(YTK) from South Australia, where most farmed Australian YTK is grown. Tissue samples 1031 
(white muscle, red muscle, liver and visceral adipose) were taken from tank-reared 1032 
aquacultured (n = 9; average weight = 3.79 kg) and wild YTK (n = 6; average weight = 6.77 1033 
kg). Tissue total lipid content of the aquacultured YTK was on average 4-times higher 1034 
compared to the wild YTK (e.g. 6.8% vs 1.5% for white muscle). There was a significantly 1035 
higher content of total saturated, omega 9, omega 7, omega 6 and omega 3 fatty acids (P < 1036 
0.001) in the white muscle and liver of the aquacultured fish, however, the total n-3 LC PUFA 1037 
content of the aquacultured fish was not significantly different to the wild fish (P > 0.05). In 1038 
red muscle and adipose tissue, the total n-3 LC PUFA was significantly lower in aquacultured 1039 
YTK. There were also significant differences in the relative abundances of each of the 1040 
individual n-3 LC PUFAs (DHA > EPA > DPA) in the tissues of the aquacultured and wild 1041 
YTK. Importantly, for consumers to obtain their recommended daily intake of 500 mg of n-3 1042 
LC PUFA a 72 g portion of white muscle from either the aquacultured or wild YTK would be 1043 
sufficient. Commercial feed manufacturers and YTK producers can utilise this information to 1044 




Yellowtail Kingfish, wild, aquaculture, omega 3 (n-3) long chain (LC) polyunsaturated fatty 1047 
acids (PUFA) and product quality. 1048 
 1049 
Highlights 1050 
1. The fatty acid composition of the white muscle, red muscle, liver and adipose tissue 1051 
of wild and aquacultured South Australian YTK was determined.  1052 
2. The quantity of n-3 LC PUFA in the white muscle of the wild and aquacultured South 1053 
Australian YTK did not differ significantly. 1054 
3. A 72 g portion of white muscle from either the aquacultured or wild YTK would be 1055 
sufficient for human consumers to obtain their recommended daily intake of 500 mg 1056 
of n-3 LC PUFA. 1057 
4. Fat content was significantly higher in aquacultured than wild South Australian YTK.   1058 
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2.1. Introduction 1059 
Commercial farming of Yellowtail Kingfish (Seriola lalandi) (YTK) is expanding in 1060 
Australia, with lease areas now allocated in South Australia and Western Australia, and 1061 
production outputs expected to increase substantially in the coming years (Norwood, 2017). 1062 
From a product quality perspective, it is desirable that aquacultured YTK are nutritionally at 1063 
least as beneficial to consumers as their wild caught counterparts, given that consumers could 1064 
reasonably set a benchmark expectation for the nutritional quality of aquacultured fish based 1065 
on equivalency with the wild fish (Yearsley et al., 1998). This can be challenging for 1066 
aquaculturists to achieve as they try to minimise the costs of production, improve the 1067 
sustainable use of marine ingredients (fish oil) in the fish diets, maximise growth rates, and 1068 
carefully manage fish health and product quality. Furthermore, since regular consumption of 1069 
fish products is recommended to meet human daily intake requirements for omega 3 (n-3) long 1070 
chain (LC) polyunsaturated fatty acids (PUFA) (e.g. The International Society for the Study of 1071 
Fatty Acids and Lipids (ISSFAL) recommends a daily intake of 500 mg n-3 LC PUFA per day 1072 
(ISSFAL, 2004)) consumers and producers want to know the serving size of the aquacultured 1073 
fish product that contributes toward this target.  1074 
Formulated aquaculture diets require a certain amount of fish oil (FO) as it provides 1075 
essential n-3 LC PUFA for growth and development, energy for metabolism and also adds to 1076 
the palatability of the diet (Sargent et al., 1999, Miller et al., 2008). However, FO and likewise 1077 
fish meal (FM) are limited resources and high global demand has made them some of the most 1078 
expensive macro-ingredients in aquaculture feeds (Naylor et al., 2000, Naylor et al., 2009, 1079 
Tacon and Metian, 2008). Moving forward, there is a need to ensure global supply of marine 1080 
fish for human food. The measure of sustainability most commonly used in the aquaculture 1081 
industry is the fish-in fish-out ratio, which equates the quantity of fish and fish products (FO 1082 
and FM) required to produce the same quantity of aquacultured fish (Terpstra, 2015). For these 1083 
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reasons, considerable effort has been made to reduce the FO and FM content of aquaculture 1084 
diets by replacing a portion of it with more sustainable and cheaper protein sources and 1085 
terrestrial lipids such as poultry meal, poultry oil, canola oil, soybean oil, corn oil and to a 1086 
lesser extent, meat tallows (Turchini et al., 2009, Naylor et al., 2009). These terrestrial lipid 1087 
sources have a different fatty acid profile to wild FO, with higher omega 6 (n-6) PUFA, 1088 
monounsaturated (omega 9, n-9) and/or saturated fatty acids, depending on the type of oil 1089 
(Burton et al., 2004). Importantly, the saying “you are what you eat” is largely true for fish in 1090 
regard to lipids and substitution of FO with terrestrial oils is known to affect the fatty acid 1091 
composition of the aquacultured fish (Turchini et al., 2009). 1092 
For this reason, differences in the fatty acid composition of aquacultured and wild YTK 1093 
are likely to exist. Recently O'Neill et al. (2015) studied the fatty acid composition of 1094 
aquacultured and wild YTK from the southern region of Africa, concluding that there was no 1095 
significant difference in n-3 fatty acid content between them, although, aquacultured fish had 1096 
significantly higher quantities of n-6 PUFA and thus a higher ratio of n-6 to n-3 fatty acids. 1097 
Similar differences are likely to exist between Australian aquacultured and wild YTK. 1098 
In Australia, while there has been substantial research effort to define parasite 1099 
interactions between wild and aquacultured YTK (Hutson, 2007), differentiating between wild 1100 
and aquacultured YTK with natural element signatures and otolith analyses (Gillanders and 1101 
Joyce, 2005) and to define the fatty acid composition of aquacultured YTK (Bowyer et al., 1102 
2012, Stone et al., 2016, Australian Seafood CRC, 2018, Chapter 3; Stone et al., 2019), there 1103 
is currently little available information on the fatty acid composition of wild YTK (Yearsley et 1104 
al., 1998). The aim of the current study, based on limited spatial and temporal sampling, was 1105 
to obtain a preliminary understanding of the fatty acid composition of wild and aquacultured 1106 
YTK from South Australian stocks.  1107 
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2.2. Methods and Materials  1108 
2.2.1. Sample collection  1109 
A total of 6 wild YTK, 3 females and 3 males, with an average weight of 6.77  1.37 1110 
kg (mean  SE, range: 2.85 - 12.40 kg), were collected off the south west coast of the Eyre 1111 
Peninsula in South Australia in February 2018. Fish were captured utilizing standard 1112 
recreational fishing practices including lures and baited hooks. Once on-board the fishing 1113 
vessel, each fish was stunned, bled and tissue samples collected including: white muscle, red 1114 
muscle, liver and adipose. White muscle was collected from the dorsal fillet adjacent to the 1115 
dorsal fin, red muscle was collected from along the lateral line posterior to the pectoral fin, the 1116 
whole liver was collected, and visceral fat was collected from around the visceral mass. 1117 
Samples were frozen and stored at -20 °C until analysis. Additionally, for each fish length and 1118 
weights (including total, visceral mass, visceral fat, stomach, gonad and liver) were recorded, 1119 
stomach contents and gonads were collected, and reproductive stage was scored. 1120 
Aquacultured YTK were collected as part of a tank-based feed trial that investigated 1121 
the optimum dietary inclusion levels of n-3 LC PUFA 100 g-1 on the growth of large sub-adult 1122 
YTK in May 2016 (Stone et al., 2019). The optimum growth rate resulted from using a 1123 
commercial diet containing 2.14 g n-3 LC PUFA 100 g-1 using 5% FO and 15% poultry oil 1124 
coated onto a pellet that contained 7% lipid (from fishmeal and other ingredients) (20% fish 1125 
meal; 40% crude protein, 27% crude lipid and a gross energy level of approximately 21 MJ kg-1126 
1;Stone et al., 2019). Given that this feed composition was recommended to commercial YTK 1127 
feed producers, this data set was selected to be utilized to represent the aquacultured YTK for 1128 
comparisons. Thus, matching tissue samples from 9 YTK, with an average weight of 3.79  1129 
0.01 kg (mean  SE, range: 3.59 - 4.34 kg), that had been reared on a commercial diet 1130 
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containing 2.14 g n-3 LC PUFA 100 g-1 feed for 12-weeks were collected, frozen and stored at 1131 
-20 °C until analysis.  1132 
2.2.2. Total lipid analysis 1133 
Tissue total crude lipid (as a percentage of wet weight) was estimated utilizing the 1134 
gravimetric approach (Folch et al., 1957). Briefly, samples were homogenised in 0.9% saline 1135 
in a 10 mL glass centrifuge tube, thereafter lipids were extracted into a 4:1 chloroform: 1136 
isopropanol solution and then centrifuged at 3000 RPM for 10 minutes. The chloroform layer 1137 
was removed, placed into a pre-weighed vial and then evaporated using nitrogen gas leaving 1138 
only the lipid component behind; the vial was then reweighed. 1139 
2.2.3. Fatty acid analysis 1140 
Fatty acid profiling was conducted for all samples. The lipid component (extracted 1141 
during total lipid analysis) was transmethylated with 1 % H2SO4 in MeOH at 70 °C for 3 hours, 1142 
then cooled to room temperature, after which fatty acid methyl esters (FAME) were extracted 1143 
in to 2 mL of heptane. The heptane was transferred to a gas chromatography (GC) vial with 1144 
approximately 30 mg of anhydrous sodium sulphate, sealed and stored at -20 °C until analysis 1145 
by GC. Samples were processed on a Hewlett-Packard 6890 GC (Hewlett-Packard, CA, USA) 1146 
with a flame ionization detector, a split injector and a BPX-70 capillary column (internal 1147 
diameter of 50 m × 0.32 mm) with a 0.25 µm film thickness (SGE, Victoria, Australia). Gas 1148 
chromatography operating conditions were as described previously (Tu et al., 2010) and peaks 1149 
were identified with GLC 463 external standard (Nu-Chek Prep Inc., MN, USA). Data output 1150 




2.2.4. Calculations 1153 
Condition index was calculated using the following equation: 1154 
- Condition index = (fish weight (kg) / fork length (m3)) / 10 1155 
Hepatosomatic index was calculated using the following equation: 1156 
- Hepatosomatic index (HSI, %) = (liver weight (g) / fish weight (g)) × 100 1157 
Visceral somatic index was calculated using the following equation: 1158 
- Visceral somatic index (VSI, %) = (wet visceral weight (g) / fish weight (g)) × 100 1159 
2.2.5. Statistics 1160 
Statistical analysis was performed using IBM SPSS (version 24). Homogeneity of 1161 
variance was assessed using Levene’s test, whilst normality was assessed with Kolmogorov-1162 
Smirnov test. Differences were analysed using a one-way ANOVA where fish source 1163 
(aquacultured or wild) was a factor and data were separated by tissue region. An alpha level of 1164 
0.05 was used for all statistical tests. Results are presented as means ± standard error (SE).  1165 
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2.3. Results 1166 
2.3.1. General observations 1167 
All aquacultured YTK readily accepted their feed and appeared to be in good health at 1168 
the time of sample collection. All wild fish collected appeared healthy, minimal external 1169 
parasite infection was observed, and no internal signs of compromised health were present. 1170 
Although the sample size of wild YTK was small and the size range was large, minimal 1171 
differences total lipid or fatty acid composition were observed between fish, creating increased 1172 
confidence despite experimental limitations. Furthermore, wild YTK had little visceral fat, 1173 
could be described as lean and had a condition index of 1.16 ± 0.03 compared to a condition 1174 
index of 1.73 ± 0.04 for aquacultured YTK (Table 2.1). The adipose tissue collected from wild 1175 
YTK was membranous and scarce, whereas visceral fat was abundant in aquacultured YTK.  1176 
2.3.2. Tissue total lipid content 1177 
Total lipid content of all tissues examined was more than 4 times higher for 1178 
aquacultured YTK than for their wild counterparts (Tables 2.2 – 2.5). Notably, aquacultured 1179 
YTK had 6.8% lipid in the white muscle compared to 1.5% in the wild YTK (P <0.001). In the 1180 
liver, there was 32.9% lipid in aquacultured YTK compared to 6.4% in wild YTK (P <0.001).   1181 
2.3.2.1. Fatty acid composition of white muscle 1182 
With the exception of total n-3 fatty acids, all totals for major groups of fatty acids were 1183 
substantially more abundant in the aquacultured YTK. In the aquacultured YTK total n-6 fatty 1184 
acids were 13.5 times higher, total omega 7 (n-7) fatty acids were 8.1 times higher, total n-9 1185 
fatty acids were 12.5 times higher and total saturated fatty acids were 3.6 times higher, than in 1186 
wild fish (Figure 2.1; all P < 0.001). All individual fatty acids, except DHA, were significantly 1187 
more abundant in the aquacultured group (Table 2.2). On the other hand, there was no 1188 
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significant difference in the quantity of n-3 LC PUFA in the white muscle between groups, 1189 
overall average 705 mg 100 g-1 muscle (one-factor ANOVA; P = 0.182; Table 2.2). However, 1190 
there was significantly higher levels of DHA in the wild YTK, with 575 mg 100 g-1 muscle 1191 
compared to 422 mg 100 g-1 muscle in the aquacultured YTK (one-factor ANOVA; P < 0.001; 1192 
Table 2.2). In contrast, the quantities of EPA and DPA were significantly higher in the white 1193 
muscle of the aquacultured YTK, with 78 mg EPA and 32 mg DPA 100 g-1 tissue in wild fish, 1194 
compared to 227 mg EPA and 76 mg DPA 100 g-1 muscle in aquacultured fish.  1195 
The n-3: n-6 ratio in the white muscle was significantly different between groups (one-1196 
factor ANOVA; P < 0.001). In wild YTK for every unit of n-3 present there was 0.1 unit of n-1197 
6, while in aquacultured YTK this increased to 0.9 units of n-6 (Table 2.2).  1198 
2.3.2.2. Fatty acid composition of red muscle 1199 
Total n-6, n-7, saturated fatty acids and individual fatty acids were significantly more 1200 
abundant in the aquacultured group (Tables 2.3). Aquacultured YTK had a significantly higher 1201 
content of n-3 LC PUFA in their red muscle compared to their wild counterparts, with 3179 1202 
mg and 2871 mg 100 g-1 muscle respectively (one-factor ANOVA; P < 0.001; Table 2.3). 1203 
Similar to the white muscle, DHA was significantly more abundant in red muscle of wild YTK 1204 
(one-factor ANOVA; P < 0.001) and EPA and DPA were both significantly more abundant in 1205 
the aquacultured YTK (one-factor ANOVA; P < 0.001 for both). The n-3: n-6 ratio in the red 1206 
muscle was significantly different between groups (one-factor ANOVA; P < 0.001, Table 2.3) 1207 
and consistent with observations made in the white muscle. 1208 
2.3.2.3. Fatty acid composition of liver 1209 
All major groups of fatty acids and individual fatty acids were present in significantly 1210 
greater quantities in the aquacultured YTK group (Table 2.4), with the exception of total n-3 1211 
51 
 
fatty acids, DHA and tetracosenoic acid (24:1n-9), which were not significantly different 1212 
between groups.  1213 
There were significantly higher quantities of DHA (one-factor ANOVA; P < 0.001) in 1214 
the liver of the wild YTK but significantly higher levels of EPA and DPA in the aquacultured 1215 
YTK (one-factor ANOVA; P < 0.001 for both), which resulted in total n-3 LC PUFA levels 1216 
that were not significantly different between groups (Table 2.4).  1217 
Differences in the n-3: n-6 ratio were more exacerbated in the liver compared to the 1218 
muscles, for every 1 unit of n-3 there was 1.6 units of n-6 in the aquacultured YTK, while in 1219 
the wild YTK for every 1 unit of n-3 there was 0.1 units of n-6 (Table 2.4). 1220 
2.3.2.4. Fatty acid composition of adipose tissue 1221 
With the exception of total n-3 fatty acids, all totals for major groups of fatty acids, 1222 
total n-6, n-7, n-9 saturated fatty acids, were all substantially more abundant in the adipose 1223 
tissue of aquacultured YTK (Table 2.5). In aquacultured YTK, total n-3 fatty acids, DHA and 1224 
n-3 LC PUFA were significantly less abundant compared to the wild YTK (one-factor 1225 
ANOVA; P < 0.001 on all accounts; Table 2.5). On the other hand, all other individual fatty 1226 
acids were present in significantly higher quantities in the aquacultured YTK than in the wild 1227 
YTK, with the exception of tetracosanoic acid (24:0) and tetracosenoic acid (24:1n-9) which 1228 
did not differ significantly between groups (Table 2.5).  1229 
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2.4. Discussion 1230 
The data presented here describe the full fatty acid profile of wild South Australian 1231 
YTK and provide a comparison to aquacultured South Australian YTK. Summary data for key 1232 
fatty acids in wild Australian YTK flesh were previously described by Yearsley et al. (1998). 1233 
Total lipid content, arachidonic acid and EPA values reported by Yearsley et al. (1998) and the 1234 
current study were similar, however DHA values were substantially higher in wild fish in the 1235 
current study. The higher DHA content could be explained by differences in numerous factors 1236 
between the two studies; environmental (water temperature, capture location, feed source, etc.), 1237 
physical (age, sexual maturity, etc.) or sample location (whole body verses fillet). Without 1238 
further information regarding these factors from the Yearsley et al. (1998) study the reason for 1239 
the difference in DHA content of wild YTK could not be discerned.  1240 
The most recent comparable study that investigated the differences between wild and 1241 
farmed YTK was from African stocks (O'Neill et al., 2015). Data reported by O'Neill et al. 1242 
(2015) were for the whole fillet, skin and bones removed and fish were collected in March 1243 
2009 for both wild and sea-cage farmed fish. The key findings from the O'Neill et al. (2015) 1244 
study and the current study were similar; in the fillet (O'Neill et al., 2015) and in the white 1245 
muscle (current study) total n-3 LC PUFA was not significantly different between wild and 1246 
aquacultured YTK, DHA was significantly higher in the wild YTK, but EPA and n-6 PUFA 1247 
were significantly higher in the aquacultured YTK.  1248 
O'Neill et al. (2015) didn’t find any significant difference in total fat content of the fillet 1249 
between aquacultured and wild YTK (3.72% vs 4.29% respectively). Interestingly, the 1250 
commercial diet utilized by O'Neill et al. (2015) had a dietary lipid level of 15% compared to 1251 
27% in the current study, and this would have resulted in a lower total lipid and gross energy 1252 
value in the farmed South African diet and perhaps this was why the fillet lipid level was less 1253 
than in Australian farmed fish. In contrast, in the current study the fat content in all tissues 1254 
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collected from the aquacultured YTK were significantly higher than their wild counterparts. 1255 
This difference was attributed to aquacultured YTK being raised in intensive culture conditions 1256 
with feeding to visual satiation occurring daily designed to maximise growth rate (Stone et al., 1257 
2016). Furthermore, commercial YTK feed in Australia typically consists of 6.8% moisture, 1258 
45.1% crude protein, 24% crude lipid, 15.2% carbohydrates and 19.1 MJ gross energy kg-1 1259 
(Stone et al., 2016), which provides a substantially higher content of lipid than the aquacultured 1260 
YTK feed from the O'Neill et al. (2015) study. In comparison, wild YTK need to hunt and 1261 
capture mostly live prey items (such as fish and squid) and are likely to consume a substantially 1262 
smaller portion of food on a daily basis and expend a lot more energy to obtain their food. A 1263 
standard prey item for wild YTK is the South Australian sardine (Sardinops sagax; a plentiful 1264 
baitfish species in South Australian waters) and its composition has been reported as 72.1% 1265 
moisture, 18.9% crude protein, 4.1% crude lipid, 0.4% carbohydrates and only 4.73 MJ gross 1266 
energy kg-1 (Stone et al., 2016).  Therefore, the quantity and nutrient density of foods, as well 1267 
as differences in energy expenditure to capture that food, are likely driving the differences 1268 
observed in the quantitative aspect of lipid deposition in all tissues in the present study. 1269 
Furthermore, the qualitative fatty acids composition of aquacultured YTK was 1270 
substantially different to their wild counterparts. There were significantly higher content of non 1271 
n-3 LC PUFA fatty acids, particularly n-6, n-9 and saturated fatty acids, in aquacultured 1272 
compared to wild YTK, which could be considered an undesirable quality to human consumers. 1273 
The Food and Agriculture Organization of the United Nations (FAO) recommends limiting 1274 
dietary intake of saturated and n-6 PUFA due to associated negative health outcomes (FAO, 1275 
2010). In the current study, on average, saturated and n-6 PUFA are 3.6 and 12.9 times more 1276 
abundant in aquacultured YTK than in their wild counterparts, due to their high concentrations 1277 
in aquafeeds. When consuming aquacultured YTK this translates to an additional intake of 1.2 1278 
g or 0.7 g 100 g-1 white muscle of saturated and n-6 fatty acids respectively. Saturated fatty 1279 
54 
 
acids are abundant in animal products, such as meat or dairy (Givens and Gibbs, 2006), while 1280 
n-6 fatty acids are abundant in plant-based oils, such as canola or sunflower oil (Zambiazi et 1281 
al., 2007), all of which are generally consumed in greater quantities in the western diet than 1282 
fish products. Since saturated and n-6 fatty acids should be limited in the diet and are already 1283 
highly abundant in other food products, reducing their content in fish products would likely be 1284 
beneficial to the human consumer. However, when comparing both aquacultured and wild 1285 
YTK to other commonly consumed protein sources, such as beef, chicken or pork, the fatty 1286 
acid profile of YTK (both aquacultured and wild) appears to be superior in relation to n-6 1287 
PUFA and saturated fatty acids being less abundant (Table 2.6). 1288 
In relation to n-3 LC PUFA, which was not significantly different between the wild and 1289 
aquacultured YTK, human consumers would require a 72 g portion of white muscle from either 1290 
aquacultured or wild YTK to obtain their recommended daily intake of 500 mg of n-3 LC 1291 
PUFA. However, this was the case when aquacultured YTK were fed a level of n-3 LC PUFA 1292 
that maximised fish growth, whereas white muscle n-3 LC PUFA concentration of 1293 
aquacultured YTK could be further increased with a period feeding a high n-3 LC PUFA 1294 
finishing diet prior to harvesting (see Chapter 5), making the n-3 LC PUFA concentration 1295 
higher than the wild YTK.  1296 
For individual n-3 LC PUFA, DHA was significantly higher in all tissues measured in 1297 
the wild YTK. For human consumers DHA is highly nutritionally beneficial, playing an 1298 
important role in brain and vision development during infancy and in minimizing risk of 1299 
cardiovascular issues and reducing inflammation in adults (FAO, 2010). Marine fish are 1300 
recognized for being an excellent source of DHA (Ackman, 2008) and are often strongly 1301 
marketed on this basis, however these results suggest that aquacultured YTK aren’t reaching 1302 
the benchmark of wild YTK in concern to this key fatty acid. Given that n-3 LC PUFA are 1303 
digested with equal efficacy (see Chapter 4), it is likely that dietary content of individual n-3 1304 
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LC PUFA was responsible for this difference. In wild marine fish, such as the sardines that 1305 
wild YTK consumer, DHA approximately twice as abundant as EPA and this dietary pattern 1306 
then gets reflected in the YTK body tissues. Comparatively, in the diets of aquacultured YTK 1307 
(see Chapter 3 diets), DHA is only approximately 1.5 times more abundant than EPA, similarly, 1308 
this dietary pattern then gets reflected in the YTK body tissues and likely accounts for this 1309 
difference in DHA observed between aquacultured and wild YTK. Human daily intake 1310 
requirements for DHA are not currently available, only n-3 LC PUFA requirements are 1311 
available, as the individual benefits of consuming EPA and DPA are not fully understood. Until 1312 
recently, purified forms of these fatty acids have not been available in sufficient quantities to 1313 
undertake such studies and this has been a limiting factor for research (Kris-Etherton et al., 1314 
2009). Once the individual benefits of these n-3 LC PUFA are elucidated, it may be possible 1315 
to more specifically modify their content and proportion in seafood products. However, given 1316 
the current state of knowledge it is important to note that in terms of n-3 LC PUFA these wild 1317 
and aquacultured YTK are not significantly different, regardless of the proportional differences 1318 
in EPA, DHA and DPA.  1319 
The product characteristics of aquacultured and wild YTK, in terms of sensory 1320 
attributes, are also likely to be driven by differences in the tissue lipid content. The difference 1321 
in crude fat content between aquacultured and wild YTK would likely be discernible when 1322 
consuming white and red muscle both as sashimi and when cooked. Sensory evaluation panels 1323 
would need to be conducted to assess whether higher fat content is considered to be a positive 1324 
or negative attribute, however the preference would likely differ among consumer groups. The 1325 
significantly higher fat content of aquacultured YTK also results in an increased caloric intake 1326 
for the human consumer. Specifically, consuming a 100 g portion of white muscle from 1327 
aquacultured or wild YTK would result in an intake of either 1.5 g or 6.8 g of fat, respectively; 1328 
this means that consuming aquacultured YTK results in an additional 48 kilocalories per 100 1329 
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g serve. When considering the 2500 and 2000 kilocalories per day recommendations for adult 1330 
men and women respectively, this could impact consumer selection. However, when 1331 
considered in the context of other foods, such as processed meats, which are substantially 1332 
higher in fat it would be likely that this difference would be trivial. 1333 
High fat content in aquafeeds has previously been observed to have some negative 1334 
implications for YTK and aquaculturists. Firstly, feeds with high lipid contents more readily 1335 
degrade before they are able to be consumed by the fish (during transport and storage, etc.), 1336 
resulting in fish being fed oxidized or rancid lipids (Goddard, 2012). This has mostly been 1337 
overcome by including antioxidants in aquafeeds (Hertrampf and Piedad-Pascual, 2012), 1338 
however, it is an ongoing issue that requires careful management. Secondly, from the 1339 
perspective of both aquaculturists and human consumers, high lipid feeds are wasteful in terms 1340 
of lipid and specifically n-3 LC PUFA being incorporated in to the less commonly consumed 1341 
portions (liver and adipose) of the fish. During summer months YTK growth rates substantially 1342 
increase and feed rates increase in parallel to meet increased metabolic demand (Bowyer et al., 1343 
2012). However, not all of the nutrients are utilized for growth or energy and as such adipose 1344 
tissue is accumulated in the body, often this adipose tissue is utilised for energy in winter 1345 
months were reduced water temperature coincides with reduced feed intake. Importantly, 1346 
aquacultured YTK do not appear to preferentially distribute different fatty acids among 1347 
functionally different tissues (Chapter 3), meaning that fat storage/ non-edible tissues, such as 1348 
visceral adipose, have the same amount of n-3 LC PUFA per gram of fat as the white muscle, 1349 
which appears to be very wasteful, unless the processing of by-products can help to reclaim 1350 
these nutrients.  1351 
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2.5. Conclusions 1352 
This study has provided important information on the fatty acid profile of wild 1353 
Australian YTK that can be used to inform seafood consumers and the commercial YTK 1354 
aquaculture industry. Aquacultured YTK had higher crude fat levels in their tissues relative to 1355 
wild fish (e.g. 6.8% vs 1.5% for white muscle, respectively) and proportionally higher levels 1356 
of n-3 LC PUFA. However, when n-3 LC PUFA is calculated as mg 100 g-1 white muscle, the 1357 
average content was 705 mg 100 g-1, and not significantly different between wild and 1358 
aquacultured YTK. Therefore, for consumers to obtain their recommended daily intake of 500 1359 
mg of n-3 LC PUFA a 72 g (recommended serving size of 100g) portion of white muscle from 1360 
either aquacultured or wild YTK would be sufficient. 1361 
  1362 
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2.8. Tables and figures 1465 
Table 2.1: Mean length (cm), weight (kg), condition index, hepatosomatic index (HSI) (%) 1466 
and visceral somatic index (VSI) (%) wild (n = 6) and aquacultured (n = 9) Yellowtail Kingfish 1467 
(Seriola lalandi) from South Australia (mean ± standard error). 1468 
 Length (cm) Weight (kg) CI HSI (%) VSI (%) 
Wild  81.9 ± 6.27 6.77 ± 1.37 1.16 ± 0.03 1.23 ± 0.14 6.39 ± 0.30 
Aquacultured 60.6 ± 0.58 3.79 ± 0.08 1.73 ± 0.04 1.30 ± 0.05 6.27 ± 0.23 
  1469 
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Table 2.2: Total lipid content (%), fatty acid composition (mg 100 g-1 tissue) and ratio of omega 1470 
3 (n-3) to omega 6 (n-6) fatty acids of white muscle of wild (n = 6) and aquacultured (n = 9) 1471 
Yellowtail Kingfish (Seriola lalandi) from South Australia (mean ± standard error). 1472 
 Wild Aquacultured P = 
Lipid content (%) 1.5 ± 0.3 6.8 ± 0.6 < 0.001 
t18:1n-9 (Palmitelaidic acid) 1.4 ± 0.1 15.8 ± 0.4 < 0.001 
t18:1n-7 (Elaidic acid) 0.0 ± 0.0 21.7 ± 2.5 < 0.001 
14:0 (Myristic acid) 29.9 ± 4.0 148.2 ± 8.0 < 0.001 
15:0 (Pentadecanoic acid) 9.4 ± 0.7 17.7 ± 0.7 < 0.001 
16:0 (Palmitic acid) 300.9 ± 4.0 1119.3 ± 7.9 < 0.001 
17:0 (Margaric acid) 12.2 ± 0.3 26.1 ± 0.5 < 0.001 
18:0 (Stearic acid) 110.1 ± 0.1 355.3 ± 3.2 < 0.001 
20:0 (Arachidic acid) 2.4 ± 0.1 10.2 ± 0.4 < 0.001 
22:0 (Docosanoic acid) 0.6 ± 0.2 4.5 ± 0.2 < 0.001 
24:0 (Tetracosanoic acid) 0.3 ± 0.1 2.5 ± 0.1 < 0.001 
18:3n-3 (Alpha Linolenic acid- ALA) 8.2 ± 1.0 106.7 ± 1.6 < 0.001 
20:5n-3 (Eicosapentaenoic acid- EPA) 78.4 ± 3.3 227.4 ± 18.1 < 0.001 
22:5n-3 (Docosapentaenoic acid- DPA)   31.5 ± 1.5 76.3 ± 3.5 < 0.001 
22:6n-3 (Docosahexaenoic acid- DHA) 575.2 ± 28.6 421.7 ± 24.6 < 0.001 
18:2n-6 (Linoleic acid- LOA) 20.2 ± 1.2 14.2 < 0.001 
18:3n-6 (Gamma Linolenic acid) 1.7 ± 0.2 9.1 ± 0.2 < 0.001 
20:2n-6 (Eicosadienoic acid) 4.6 ± 0.2 11.8 ± 0.1 < 0.001 
20:3n-6 (Dihomo-gamma-linoleic acid) 1.8 ± 0.1 10.0 ± 0.1 < 0.001 
20:4n-6 (Arachidonic acid) 26 ± 2.2 51.0 ± 1.7 < 0.001 
22:4n-6 (Docosatetraenoic acid) 3.0 ± 0.3 8.3 ± 0.2 < 0.001 
16:1n-7 (Palmitoleic acid) 37.4 ± 5.5 400.5 ± 5.1 < 0.001 
18:1n-7 (Octadecenoic acid) 35.8 ± 2.1 190 ± 1.1 < 0.001 
18:1n-9 (Oleic acid- OLA) 179.1 ± 17.8 2369.1 ± 50.0 < 0.001 
20:1n-9 (Eicosenoic acid) 8.5 ± 0.8 56.3 ± 1.4 < 0.001 
22:1n-9 (Docosenoic acid) 0.9 ± 0.1 6.4 ± 0.3 < 0.001 
24:1n-9 (Tetracosenoic acid) 6.3 ± 0.5 10.5 ± 0.4 < 0.001 
Total trans 1.5 ± 0.1 45.7 ± 2.5 < 0.001 
Total saturated  466.5 ± 4.0 1684.4 ± 15.1 < 0.001 
Total Omega 3 693.3 ± 24.4 832.2 ± 43.2 < 0.001 
Total Omega 6 57.3 ± 1.9 771.4 ± 12.8 < 0.001 
Total Omega 7 73.2 ± 7.4 590.5 ± 6.0 < 0.001 
Total Omega 9 194.9 ± 19.2 2442.3 ± 48.5 < 0.001 
n-3 LC PUFA 685.1 ± 25.4 725.4 ± 16.2 0.182 
n-3 FA: n-6 FA 0.1 ± 0.0 0.9 ± 0.0 < 0.001 
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Table 2.3: Total lipid content (%), fatty acid composition (mg 100 g-1 tissue) and ratio of 1474 
omega 3 (n-3) to omega 6 (n-6) fatty acids of red muscle of wild (n = 6) and aquacultured (n = 1475 
9) Yellowtail Kingfish (Seriola lalandi) from South Australia (mean ± standard error). 1476 
 Wild Aquacultured P = 
Lipid content (%) 6.8 ± 0.8 29.3 ± 1.2 < 0.001 
t18:1n-9 (Palmitelaidic acid) 8.3 ± 0.2 79.8 ± 3.8 < 0.001 
t18:1n-7 (Elaidic acid) 0.0 ± 0.0 86.4 ± 4.8 < 0.001 
14:0 (Myristic acid) 193.3 ± 9.0 612.8 ± 25.2 < 0.001 
15:0 (Pentadecanoic acid) 53.5 ± 1.1 80.1 ± 2.4 < 0.001 
16:0 (Palmitic acid) 1196.6 ± 9.4 4947.2 ± 30.5 < 0.001 
17:0 (Margaric acid) 67.5 ± 1.9 138.8 ± 6.9 < 0.001 
18:0 (Stearic acid) 528 ± 19.1 1647.1 ± 21.5 < 0.001 
20:0 (Arachidic acid) 15.8 ± 1.0 51.2 ± 6.9 < 0.001 
22:0 (Docosanoic acid) 5.2 ± 0.6 25.1 ± 0.8 < 0.001 
24:0 (Tetracosanoic acid) 0.0 ± 0.0 16.2 ± 0.7 < 0.001 
18:3n-3 (Alpha Linolenic acid- ALA) 50.7 ± 2.3 399.5 ± 10.9 < 0.001 
20:5n-3 (Eicosapentaenoic acid- EPA) 378.7 ± 12.1 882.5 ± 60.5 < 0.001 
22:5n-3 (Docosapentaenoic acid- DPA)  171.8 ± 2.2 410.0 ± 19.7 < 0.001 
22:6n-3 (Docosahexaenoic acid- DHA) 2320.0 ± 46.1 1886.6 ± 122.4 < 0.001 
18:2n-6 (Linoleic acid- LOA) 119.5 ± 2.2 2870.3 ± 58.4 < 0.001 
18:3n-6 (Gamma Linolenic acid) 13.1 ± 0.4 77.8 ± 7.1 < 0.001 
20:2n-6 (Eicosadienoic acid) 27.3 ± 1.0 56.2 ± 1.7 < 0.001 
20:3n-6 (Dihomo-gamma-linoleic acid) 9.0 ± 0.2 42.3 ± 0.5 < 0.001 
20:4n-6 (Arachidonic acid) 98.8 ± 5.1 204.6 ± 4.6 < 0.001 
22:4n-6 (Docosatetraenoic acid) 14.8 ± 1.0 39.5 ± 0.9 < 0.001 
16:1n-7 (Palmitoleic acid) 219.0 ± 19.4 1614.0 ± 24.2 < 0.001 
18:1n-7 (Octadecenoic acid) 200.9 ± 3.8 872.9 ± 11.3 < 0.001 
18:1n-9 (Oleic acid- OLA) 1006.3 ± 28.7 11434.3 ± 206.0 < 0.001 
20:1n-9 (Eicosenoic acid) 54.4 ± 2.8 220.2 ± 2.9 < 0.001 
22:1n-9 (Docosenoic acid) 6.4 ± 0.8 32.8 ± 0.8 < 0.001 
24:1n-9 (Tetracosenoic acid) 41.9 ± 2.7 61.9 ± 2.3 < 0.001 
Total trans 9.6 ± 0.3 265.3 ± 19.6 < 0.001 
Total saturated  2064.6 ± 16.2 7521.2 ± 59.4 < 0.001 
Total Omega 3 2921.2 ± 45.9 3578.5 ± 192.3 < 0.001 
Total Omega 6 282.5 ± 7.4 3290.7 ± 55.7 < 0.001 
Total Omega 7 419.9 ± 20.6 2486.9 ± 28.7 < 0.001 
Total Omega 9 1108.9 ± 28.3 11749.2 ± 202.3 < 0.001 
n-3 LC PUFA 2870.5 ± 46.6 3179.0 ± 39.1 < 0.001 
n-3 FA: n -6 FA 0.1 ± 0.0 0.9 ± 0.0 < 0.001 
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Table 2.4: Total lipid content (%), fatty acid composition (mg 100 g-1 tissue) and ratio of 1478 
omega 3 (n-3) to omega 6 (n-6) fatty acids of liver tissue of wild (n = 6) and aquacultured (n = 1479 
9) Yellowtail Kingfish (Seriola lalandi) from South Australia (mean ± standard error). 1480 
 Wild Aquacultured P = 
Lipid content (%) 6.4 ± 0.3 32.9 ± 1.7 < 0.001 
t18:1n-9 (Palmitelaidic acid) 7.7 ± 0.5 81.5 ± 1.9 < 0.001 
t18:1n-7 (Elaidic acid) 0.0 ± 0.0 97.5 ± 4.0 < 0.001 
14:0 (Myristic acid) 60.3 ± 2.1 434.3 ± 27.1 < 0.001 
15:0 (Pentadecanoic acid) 22.8 ± 2.5 68.6 ± 4.6 < 0.001 
16:0 (Palmitic acid) 1426.5 ± 57.8 5077.5 ± 76.8 < 0.001 
17:0 (Margaric acid) 43.7 ± 6.2 136.3 ± 5.6 < 0.001 
18:0 (Stearic acid) 483.9 ± 23.7 1833.9 ± 26.8 < 0.001 
20:0 (Arachidic acid) 9.1 ± 1.9 21.4 ± 0.8 < 0.001 
22:0 (Docosanoic acid) 0.0 ± 0.0 7.9 ± 0.5 < 0.001 
24:0 (Tetracosanoic acid) 0.0 ± 0.0 7.6 ± 0.6 < 0.001 
18:3n-3 (Alpha Linolenic acid- ALA) 21.4 ± 2.3 465.4 ± 12.6 < 0.001 
20:5n-3 (Eicosapentaenoic acid- EPA) 264.1 ± 31.7 615.6 ± 98.6 < 0.001 
22:5n-3 (Docosapentaenoic acid- DPA)  153.8 ± 17.9 501.378.2 < 0.001 
22:6n-3 (Docosahexaenoic acid- DHA) 1788.2 ± 184.3 952.4 ± 139.1 < 0.001 
18:2n-6 (Linoleic acid- LOA) 61.7 ± 6.1 3592.9 ± 79.3 < 0.001 
18:3n-6 (Gamma Linolenic acid) 8.6 ± 0.7 50.9 ± 3.4 < 0.001 
20:2n-6 (Eicosadienoic acid) 16.9 ± 1.7 145.0 ± 8.3 < 0.001 
20:3n-6 (Dihomo-gamma-linoleic acid) 3.9 ± 1.3 72.8 ± 3.1 < 0.001 
20:4n-6 (Arachidonic acid) 141.9 ± 11.8 219.0 ± 16.4 < 0.001 
22:4n-6 (Docosatetraenoic acid) 13.6 ± 1.2 40.9 ± 2.9 < 0.001 
16:1n-7 (Palmitoleic acid) 211.3 ± 43.3 1536.9 ± 43.1 < 0.001 
18:1n-7 (Octadecenoic acid) 211.6 ± 14.8 1520.1 ± 34.0 < 0.001 
18:1n-9 (Oleic acid- OLA) 1378.1 ± 168.9 14164.3 ± 395.8 < 0.001 
20:1n-9 (Eicosenoic acid) 45.6 ± 5.8 354.4 ± 20.3 < 0.001 
22:1n-9 (Docosenoic acid) 0.0 ± 0.0 19.3 ± 1.3 < 0.001 
24:1n-9 (Tetracosenoic acid) 0.0 ± 0.0 24.0 ± 1.4 0.659 
Total trans 7.7 ± 0.5 210.8 ± 5.4 < 0.001 
Total saturated  2046.3 ± 44.8 7643.1 ± 98.0 < 0.001 
Total Omega 3 2227.4 ± 231.8 2534.7 ± 312.9 0.139 
Total Omega 6 246.6 ± 20.3 4121.5 ± 66.4 < 0.001 
Total Omega 7 422.8 ± 56.6 3057.0 ± 49.7 < 0.001 
Total Omega 9 1445.8 ± 175.1 14561.9 ± 410.1 < 0.001 
n-3 LC PUFA 2206.0 ± 229.6 2069.3 ± 43.6 0.488 
n-3 FA: n -6 FA 0.1 ± 0.0 1.6 ± 0.0 < 0.001 
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Table 2.5: Total lipid content (%), fatty acid composition (mg 100 g-1 tissue) and ratio of 1482 
omega 3 (n-3) to omega 6 (n-6) fatty acids of adipose tissue of wild (n = 6) and aquacultured 1483 
(n = 9) Yellowtail Kingfish (Seriola lalandi) from South Australia (mean ± standard error). 1484 
 Wild Aquacultured P = 
Lipid content (%) 27.9 ± 7.8 92.4 ± 1.8 < 0.001 
t18:1n-9 (Palmitelaidic acid) 36.1 ± 0.9 273.7 ± 12.7 < 0.001 
t18:1n-7 (Elaidic acid) 0.0 ± 0.0 0.0 ± 0.0 < 0.001 
14:0 (Myristic acid) 989.7 ± 51.9 2565.0 ± 108.9 < 0.001 
15:0 (Pentadecanoic acid) 263.7 ± 7.5 282.4 ± 9.6 0.043 
16:0 (Palmitic acid) 5459.4 ± 95.0 15688.1 ± 127.0 < 0.001 
17:0 (Margaric acid) 282.3 ± 10.4 413.6 ± 12.3 < 0.001 
18:0 (Stearic acid) 1904.9 ± 73.5 5180.2 ± 42.0 < 0.001 
20:0 (Arachidic acid) 72.9 ± 3.6 163.4 ± 4.6 < 0.001 
22:0 (Docosanoic acid) 16.3 ± 5.4 84.6 ± 13.2 < 0.001 
24:0 (Tetracosanoic acid) 0.0 ± 0.0 4.8 ± 0.0 0.435 
18:3n-3 (Alpha Linolenic acid- ALA) 260.3 ± 8.5 1579.0 ± 24.5 < 0.001 
20:5n-3 (Eicosapentaenoic acid- EPA) 1887.6 ± 50.1 3385.3 ± 223.0 < 0.001 
22:5n-3 (Docosapentaenoic acid- DPA)  665.4 ± 24.1 1003.2 ± 37.2 < 0.001 
22:6n-3 (Docosahexaenoic acid- DHA) 8173.3 ± 179.4 3740.4 ± 226.8 < 0.001 
18:2n-6 (Linoleic acid- LOA) 539.6 ± 10.9 10329.8 ± 147.0 < 0.001 
18:3n-6 (Gamma Linolenic acid) 52.6 ± 3.2 170.9 ± 6.5 < 0.001 
20:2n-6 (Eicosadienoic acid) 117.1 ± 8.2 167.0 ± 5.1 < 0.001 
20:3n-6 (Dihomo-gamma-linoleic acid) 41.1 ± 0.8 145.2 ± 4.9 < 0.001 
20:4n-6 (Arachidonic acid) 361.0 ± 15.4 552.2 ± 20.5 < 0.001 
22:4n-6 (Docosatetraenoic acid) 52.7 ± 2.5 106.6 ± 3.4 < 0.001 
16:1n-7 (Palmitoleic acid) 1058.1 ± 78.2 6166.4 ± 70.9 < 0.001 
18:1n-7 (Octadecenoic acid) 823.2 ± 19.1 3058.7 ± 59.1 < 0.001 
18:1n-9 (Oleic acid- OLA) 4367.2 ± 102.9 34404.0 ± 621.9 < 0.001 
20:1n-9 (Eicosenoic acid) 226.2 ± 12.3 1092.3 ± 25.7 < 0.001 
22:1n-9 (Docosenoic acid) 0.0 ± 0.0 136.0 ± 6.2 < 0.001 
24:1n-9 (Tetracosenoic acid) 169.3 ± 7.6 153.9 ± 5.2 0.075 
Total trans 40.4 ± 1.8 410.6 ± 34.6 0.001 
Total saturated  143.1 24712.7 ± 248.4 < 0.001 
Total Omega 3 10986.6 ± 203.0 9707.8 ± 474.1 < 0.001 
Total Omega 6 1164.1 ± 24.0 11471.6 ± 132.8 < 0.001 
Total Omega 7 1881.3 ± 91.4 9225.1 ± 94.4 < 0.001 
Total Omega 9 4762.8 ± 107.3 35786.2 ± 606.2 < 0.001 
n-3 LC PUFA 10726.3 ± 201.5 8128.8 ± 127.5 < 0.001 
n-3 FA: n -6 FA 0.1 ± 0.0 1.2 ± 0.0 < 0.001 
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Table 2.6: Fatty acid composition (g 100 g-1 tissue) of wild and aquacultured Yellowtail Kingfish (Seriola lalandi) (YTK) white muscle, 1486 
compared to commonly consumed portions of beef, chicken, lamb and pork. 1487 
 












Lipid content  1.50 6.80 5.20 1.60 4.30 1.80 
Total Saturates 0.47 1.68 2.13 0.53 1.41 0.68 
Total n-3 0.69 0.83 0.16 0.04 0.12 0.03 
Total n-6 0.06 0.77 0.43 0.28 0.42 0.27 
Total n-7 0.07 0.59 0.17 0.05 0.07 0.07 
Total n-9 0.19 2.44 1.99 0.66 1.90 0.73 
n-3 LC PUFA 0.69 0.73 0.10 0.02 0.06 0.02 
n-3: n-6 0.09 0.93 2.65 7.21 3.46 9.87 
n-3: n-9 0.28 2.94 12.35 17.08 15.82 27.13 
*Beef, chicken, lamb and pork values sourced from Nuttab 2010 (FSANZ, 2011). 1488 






Figure 2.1: Comparison of major fatty acid groups; total trans, saturates, omega 3 (n-3) omega 1493 
3 long chain polyunsaturated fatty acids (n-3 LC PUFA), omega 6 (n-6), omega 7 (n-7) and 1494 
omega 9 (n-9) (mg 100g-1 white muscle), from wild (n = 6) and aquacultured (n = 9) Yellowtail 1495 
Kingfish (Seriola lalandi) (mean ± standard error). Levels of significance defined as: *** P < 1496 
0.001; NS = non-significant. 1497 
  1498 
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2.9. Statement to link Chapter 2 and Chapters 3 and 4  1499 
After examining the differences in the fatty acid composition between wild and 1500 
aquacultured YTK (fed an optimal dietary concentration of n-3 LC PUFA) in Chapter 2, it 1501 
became apparent that the fatty acid profile of the flesh from aquacultured YTK was 1502 
quantitatively and qualitatively different to that of wild YTK. These differences were mainly 1503 
attributed to quantitative and qualitative differences in the fatty acid composition of the diets 1504 
of the two groups. Knowing that dietary fatty acid composition was so influential for flesh fatty 1505 
acid composition, further investigation into a number of different commercially relevant YTK 1506 
diets was warranted. As such, diets with graded inclusions of n-3 LC PUFA were formulated 1507 
to cover a range from deficient to excess of the expected requirement of YTK. The effect of 1508 
these diets on fatty acid utilisation and the composition of YTK are addressed in Chapters 3 1509 
and 4.   1510 
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Abstract  1542 
Yellowtail Kingfish (Seriola lalandi) (YTK) require dietary omega 3 (n-3) long chain 1543 
polyunsaturated fatty acids (LC PUFA) for healthy development and growth. Dietary n-3 LC 1544 
PUFA are typically provided by incorporating fish oil into aquafeeds, but because of cost and 1545 
sustainability issues, attempts to reduce the use of fish oil has led to partial replacement with 1546 
cheaper terrestrial plant and animal oils. However, interactions between dietary fatty acids 1547 
(especially omega 6) have been observed to influence the incorporation of n-3 LC PUFA in 1548 
YTK muscle tissues. This may have consequences for the nutritional value of fish to the 1549 
consumer. In the present study, we investigated the effects of reducing dietary n-3 LC PUFA 1550 
on white and red muscle fatty acid composition of harvest size sub-adult YTK. This was 1551 
achieved by partially replacing dietary fish oil with poultry oil, which is particularly high in 1552 
omega 9 (n-9) fatty acids. Eight diets were formulated to cover a range from deficient to 1553 
excessive levels of n-3 LC PUFA (0.8 to 3.0 g n-3 LC PUFA 100 g-1 feed). Diets were fed to 1554 
large YTK (3.77 ± 0.04 kg; mean final weight ± SE; n = 480) to apparent satiation daily for 12 1555 
weeks. At the conclusion of the trial, white and red muscle samples were collected for fatty 1556 
acid analysis. The fatty acid composition of the red muscle lipids correlated with the dietary 1557 
fatty acid profile, with the proportions of n-3 LC PUFA decreasing and n-9 fatty acids 1558 
increasing with dietary fish oil replacement. However, in the white muscle there was an 1559 
apparent trade-off between n-9 (primarily oleic acid; OLA; 18:1n-9) and n-3 LC PUFA 1560 
(primarily docosahexaenoic acid; DHA; 22:6n-3) when dietary fish oil inclusion was low and 1561 
n-3 LC PUFA was supplied at less than 1.6 g 100 g-1 feed, below this level white muscle DHA 1562 
content was maintained at the expense of OLA. This result is positive for the consumer because 1563 
the n-3 LC PUFA content of the fillet is maintained at a higher level than would otherwise be 1564 
the case when fish are fed diets containing low n-3 LC PUFA. However, it also demonstrates 1565 
that OLA may not be neutral in regard to DHA deposition in YTK white muscle. Further 1566 
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research to investigate this relationship will enhance our understanding of fatty acid 1567 
metabolism in YTK and may be beneficial to aid in development of sustainable production 1568 




Yellowtail Kingfish; aquaculture; omega 3 (n-3) long chain (LC) polyunsaturated fatty acids 1571 
(PUFA); Oleic acid (18:1n-9); product quality. 1572 
 1573 
Highlights 1574 
1. An interaction between DHA and OLA in the white muscle of Yellowtail Kingfish was 1575 
observed when dietary n-3 LC PUFA was supplied at concentrations below 1.6 g 100 1576 
g-1 feed.  1577 
2. The fatty acid composition of the red muscle correlated with the dietary fatty acid 1578 
profile, with the proportions of n-3 LC PUFA decreasing and n-9 fatty acids increasing 1579 
with gradual dietary fish oil replacement 1580 
3. Recommendations were made for OLA to be considered in dietary formulations as it 1581 
plays a role in DHA deposition in Yellowtail Kingfish.   1582 
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3.1. Introduction: 1583 
Carnivorous marine finfish, such as Yellowtail Kingfish (Seriola lalandi) (YTK) have 1584 
an essential dietary requirement for omega 3 (n-3) long chain polyunsaturated fatty acids (LC 1585 
PUFA) (NRC, 2011, Stone et al., 2019). These n-3 LC PUFA, including eicosapentaenoic acid 1586 
(EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA), are necessary for 1587 
healthy cellular metabolism and maintaining cell membrane structure and integrity in fish 1588 
(Sargent et al., 1999a, Miller et al., 2008) and also play a vital role in human nutrition (McCann 1589 
and Ames, 2005, Eilander et al., 2007). In commercial aquaculture, dietary n-3 LC PUFA are 1590 
primarily supplied by dietary inclusions of fish oil (FO) (NRC, 2011). However, the increasing 1591 
use of wild fisheries-sourced FO is unsustainable, and future growth and success of the 1592 
aquaculture industry depends on the successful replacement or reduction of wild fisheries 1593 
sourced FO in commercial diets.  1594 
Numerous studies have investigated the implications of reducing or replacing dietary 1595 
FO with poultry oil (PO) and canola oil in aquaculture diets (reviewed in Miller et al., 2008 1596 
and Tocher, 2015). Importantly, in YTK dietary FO has been 100% replaced by poultry oil 1597 
(PO) or 50% replaced by canola oil without reducing growth, so long as the minimum n-3 LC 1598 
PUFA requirements were met (Bowyer et al., 2012a). The major advantage of FO replacement 1599 
with terrestrially sourced animal or plant oil is that these sources are perceived to be more 1600 
sustainable, reliably available and relatively inexpensive (Miller et al., 2008). However, the 1601 
key challenge for FO replacement with terrestrial-sourced oils is their lack of n-3 LC PUFA 1602 
and the high concentrations of omega 6 (n-6), omega 9 (n-9) and/ or saturated fatty acids, which 1603 
skews the fatty acid composition of the aquacultured fish and thus diminishes the nutritional 1604 
benefits for the human consumer (Turchini et al., 2009).  1605 
Understanding the mechanisms that affect fatty acid deposition and thus the final fatty 1606 
acid profile of harvested fish is an important part of responsibly utilising FO. Interactions 1607 
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between dietary fatty acids, particularly relating to n-3 LC PUFA, have been observed in 1608 
terrestrial animals, including piglets and rats (Leece and Allman, 1996, Blank et al., 2002) and 1609 
in humans (Schmitz and Ecker, 2008, Gibson et al., 2011). In these cases, high dietary inclusion 1610 
of n-6 linoleic acid (LOA) inhibited the incorporation of n-3 LC PUFA into tissues and 1611 
consequently diets low in n-6 fatty acids are recommended to increase n-3 LC PUFA tissue 1612 
concentrations. Furthermore, but less commonly reported, there are interactions between 1613 
dietary n-3 and n-9 fatty acids, with abundant dietary concentrations of n-9 fatty acids, 1614 
primarily oleic acid (18:1n-9; OLA), having an impact on the rate at which n-3 alpha linolenic 1615 
acid (ALA) and n-3 LC PUFA were deposited in chicken and mouse tissues (Picklo et al., 2017, 1616 
Elkin et al., 2018). In commercial aquaculture feeds FO is routinely partially replaced with PO. 1617 
However, PO has a substantially higher content of n-6 and n-9 fatty acids than FO and the 1618 
relationship between these fatty acids and the utilisation of n-3 LC PUFA in fish is unknown.  1619 
The dietary requirements for n-3 LC PUFA to achieve optimal growth for small and 1620 
harvest size sub adult YTK have been established (Bowyer et al., 2013; Stone et al., 2019), 1621 
however the effects of reducing dietary n-3 LC PUFA on fatty acid deposition in the tissues 1622 
have not been fully investigated. Therefore, the aim of the current study was to investigate the 1623 
effect of reducing n-3 LC PUFA (from FO) with a concomitant increase in the concentration 1624 
of n-6 and n-9 (from PO) in the diets of large sub-adult YTK during the grow-out phase of 1625 
production on white and red muscle tissue fatty acid composition as these are the tissues eaten 1626 
by consumers.   1627 
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3.2. Methods and Materials  1628 
3.2.1. Experimental location and animals  1629 
Animal ethics approval for this work was granted by the University of Adelaide animal 1630 
ethics committee (Approval number: S-2016-127). The experiment was conducted at the South 1631 
Australian Research and Development Institute (SARDI) South Australian Aquatic Science 1632 
Centre (SAASC) (West Beach, South Australia, Australia). Yellowtail Kingfish were supplied 1633 
by Clean Seas Seafood Ltd. (Port Lincoln, South Australia, Australia). Prior to the experiment, 1634 
fish were housed in 18 × 5000 L tanks supplied with partial flow-through/recirculating (100% 1635 
system water exchange day-1), sand filtered, UV treated, aerated sea water at ambient 1636 
temperature and held for ~3.5 months. During this period fish were fed a 9 mm commercial 1637 
diet (Ridley Pelagica diet; crude protein 46%; crude lipid 24%; gross energy 19.30 MJ kg-1; 1638 
Narangba, Queensland, Australia) to apparent satiation once daily. 1639 
3.2.2. Experimental diets 1640 
The diet kernels, FO and PO used in the experimental diets were supplied by Skretting 1641 
Australia. The diet formulations were based on Skretting Australia’s YTK diet (20% fish meal; 1642 
40% crude protein, 30% crude lipid and a gross energy level of approximately 21 MJ kg-1) 1643 
(Stone et al., 2019). The diet kernels contained a base level of 10% crude lipid and were then 1644 
top coated with an additional 17% lipid (graded blends of FO and PO; total crude lipid level 1645 
27%) at Aquafeeds Australia (Mount Barker, South Australia). The main effect of substituting 1646 
FO with PO was a decrease in n-3 LC PUFA with an increase in n-9 fatty acids (mostly OLA). 1647 
Eight experimental diets were formulated with n-3 LC PUFA levels ranging from 0.8 to 3.0 g 1648 
100 g-1 of feed (Table 3.1). Diets were coded according to dietary n-3 LC PUFA inclusion (e.g. 1649 
DIET0.8 has 0.8 g of n-3 LC PUFA 100 g-1 of feed and DIET3.0 has 3.0 g of n-3 LC PUFA 1650 
100 g-1 of feed). 1651 
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3.2.3. Experimental housing and animal care 1652 
At the start of the 12-week feed trial, YTK were anaesthetised in 5000 L tanks (total 1653 
water volume 2500 L) using AQUI-S® (AQUI-S® New Zealand Ltd., Lower Hutt, New 1654 
Zealand) at a concentration of 14 mg L−1 of seawater. Fish were randomly distributed into 24 1655 
× 5000 L recirculating aquaculture tanks (20 fish per tank) and randomly assigned one of the 1656 
8 experimental diets (3 replicate tanks diet-1). Initial weight of fish was 2.67 kg. Fish were fed 1657 
their experimental diet once daily to apparent satiation and intake was recorded as grams 1658 
consumed per tank per day. Apparent satiation was defined as the point at which ~90% of the 1659 
population had ceased feeding. Water quality parameters were measured daily and maintained 1660 
within the accepted optimal levels for YTK (Bowyer et al., 2014). Temperature (ºC) was 1661 
measured with a thermometer. Dissolved oxygen (mg L-1 and percentage saturation) was 1662 
measured using a dissolved oxygen meter (OxyGuard International A/S, Birkerød, Denmark). 1663 
The pH was measured using a multi-parameter meter (Oakton pHtestr 20; Oakton Instruments, 1664 
Vernon Hills, IL, USA). Ammonia (ppm) was measured using an Aquarium Pharmaceuticals 1665 
ammonia test kit (Mars Fishcare, North America). Salinity (g L-1) was measured weekly using 1666 
a portable salinity refractometer (model RF20, Extech Instruments, Nashua, NH, USA). 1667 
3.2.4. Sample collection 1668 
After 12 weeks the fish were anaesthetised, removed from their tank, measured and 1669 
weighed. Three randomly selected fish from each tank were humanely euthanised by 1670 
percussive stunning, and the white and red muscle was sampled. White muscle was collected 1671 
from the dorsal fillet adjacent to the dorsal fin and red muscle was collected from along the 1672 
lateral line posterior to the pectoral fin. Tissue samples were immediately frozen by immersion 1673 
in dry ice and thereafter stored at -20 ºC prior to analysis. 1674 
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3.2.5. Total lipid analysis 1675 
Tissue total crude lipid (as a percentage of wet weight) was estimated for white and red 1676 
muscle samples utilizing the gravimetric approach (Folch et al., 1957). Briefly, samples were 1677 
homogenised in 0.9% saline in a 10 mL glass centrifuge tube, thereafter lipids were extracted 1678 
into a 4:1 chloroform: isopropanol solution and then centrifuged at 3000 RPM for 10 minutes. 1679 
The chloroform layer was removed, placed into a pre-weighed vial and then evaporated using 1680 
nitrogen gas leaving only the lipid component behind. 1681 
3.2.6. Fatty acid analysis 1682 
Fatty acid profiling was conducted for white and red muscle samples. The lipid 1683 
component (extracted during total lipid analysis) was transmethylated with 1% H2SO4 in 1684 
MeOH at 70 °C for 3 hours, then cooled to room temperature, after which fatty acid methyl 1685 
esters (FAMES) were extracted into 2 mL of heptane. The heptane was transferred to a gas 1686 
chromatography (GC) vial with 30 mg of anhydrous sodium sulphate, sealed and stored at -20 1687 
°C until analysis by GC. Samples were processed on a Hewlett-Packard 6890 GC (Hewlett-1688 
Packard, CA, USA) with a flame ionization detector, a split injector and a BPX-70 capillary 1689 
column (50 m × 0.32 mm) with a 0.25 µm film thickness (SGE, Victoria, Australia). Gas 1690 
chromatography operating conditions were as described previously (Tu et al., 2010) and peaks 1691 
were identified with GLC 463 external standard (Nu-Chek Prep Inc., MN, USA). Data output 1692 
was processed with Agilent ChemStation (version Rev: B.01.03) (Agilent Technologies, CA, 1693 
USA). 1694 
3.2.7. Statistics 1695 
Statistical analysis was performed using IBM SPSS (version 24). Homogeneity of 1696 
variance was assessed using Levene’s test, whilst normality was assessed with the 1697 
80 
 
Kolmogorov-Smirnov test. Where data met prior requirements, differences were analysed 1698 
using a one-way ANOVA where diet was a factor. Where significant differences were detected, 1699 
post-hoc comparisons were made via Tukey’s tests. An alpha level of 0.05 was used for all 1700 
statistical tests. Results are presented as means ± standard error (SE) unless otherwise stated.   1701 
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3.3. Results  1702 
3.3.1. General observations 1703 
The mean water temperature during the experimental period was 19.7 ± 0.03 °C (range: 1704 
15.5 – 24.5 °C). Experimental diets were readily accepted by YTK with no rejection of feed 1705 
observed. Overall YTK survival for the duration of the experiment was 98.5%. Fish behaviour 1706 
and gross pathology (data not shown) were typical of healthy fish suggesting there were no 1707 
negative impacts of dietary treatments (Stone et al., 2019). The mean final weight of YTK was 1708 
3.77 ± 0.04 kg (n = 480) and there were significant differences in specific growth rate (SGR) 1709 
and feed conversion ratio (FCR) between groups. Maximal SGR was achieved in the DIET2.4 1710 
group and an optimal FCR was achieved in the DIET2.1 group (Table 3.2 extracted form Stone 1711 
et al., 2019). 1712 
3.3.2. Total lipid and fatty acid profiles 1713 
Total lipid content was not significantly influenced by experimental diet; average total 1714 
lipid concentration was 6.4% and 29.0% for white muscle and red muscle, respectively (one-1715 
factor ANOVA; P > 0.05 for both; Table 3.3).  1716 
3.3.2.1. Fatty acid composition of white muscle 1717 
The fatty acid composition of the white muscle was significantly affected by dietary 1718 
treatments (Table 3.4). Notably, there was a 44.4% increase in white muscle n-3 LC PUFA 1719 
between DIET0.8 and DIET3.0 (one-factor ANOVA; P < 0.001; Table 3.3). However, this 1720 
increase primarily occurred between DIET1.6 and DIET3.0, or above a n-3 LC PUFA dietary 1721 
concentration of 1.6 g 100 g-1 feed (one-factor ANOVA; P < 0.001); below this threshold the 1722 
white muscle n-3 LC PUFA remained consistent at an average of 0.6 g 100 g-1 tissue (between 1723 
DIET0.8 and DIET1.6) (Figure 3.1). This pattern was primarily driven by DHA; the 1724 
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concentration of DHA in white muscle reached a minimum of 0.35 g 100 g-1 with DIET1.6 and 1725 
then did not significantly change as dietary n-3 LC PUFA concentration continued to decrease 1726 
(one-factor ANOVA; P < 0.001, Table 3.4). Total n-6 fatty acid concentration consistently and 1727 
significantly decreased from DIET0.8 to DIET3.0 (one-factor ANOVA; P < 0.001; Figure 3.1). 1728 
Total n-9 fatty acids in the white muscle followed the same but opposite pattern to n-3 LC 1729 
PUFA with decreasing concentrations between DIET1.8 and DIET3.0 and remained constant 1730 
between DIET0.8 and DIET1.6 (one-factor ANOVA; P < 0.001; Figure 3.1). This was 1731 
primarily driven by OLA, increased with increasing dietary inclusion to a maximum of 2.5 g 1732 
100 g-1 tissue in the DIET1.3 group, thereafter no significant changes were observed between 1733 
DIET1.3 and DIET0.8 (one-factor ANOVA; P < 0.001, Table 3.4).  1734 
3.3.2.2. Fatty acid composition of red muscle 1735 
The fatty acid composition of the red muscle was significantly affected by dietary 1736 
treatments in a similar way to the white muscle. A 56% increase in red muscle n-3 LC PUFA 1737 
resulted from the 291% increase in dietary n-3 LC PUFA (one-factor ANOVA; P < 0.001; 1738 
Table 3.3). Red muscle n-3 LC PUFA concentrations increased consistently and significantly 1739 
between DIET0.8 and DIET3.0 (one-factor ANOVA; P < 0.001; Figure 3.2). Similarly, total 1740 
n-6 fatty acid concentration consistently and significantly decreased from DIET0.8 to DIET3.0 1741 
(one-factor ANOVA; P < 0.001; Figure 3.2). In contrast to what was observed in the white 1742 
muscle, the red muscle DHA concentration continually and significantly decreased from 1743 
treatment DIET3.0 to DIET0.8 (one-factor ANOVA; P < 0.001; Table 3.5), while OLA 1744 
concentrations increased from treatment DIET3.0 to DIET1.6 with no further significant 1745 
change from DIET1.6 to DIET0.8 (one-factor ANOVA; P < 0.001, Figure 3.2).  1746 
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3.4. Discussion 1747 
As expected, the fatty acid composition of the muscle tissues was affected by the fishes’ 1748 
dietary fatty acid intake, but there were some surprising results. Importantly, the results indicate 1749 
a novel interaction between n-9 fatty acids (particularly OLA) and n-3 LC PUFA (particularly 1750 
DHA) in white muscle of YTK. When n-3 LC PUFA was supplied at an inclusion above 1.6 g 1751 
100 g-1 feed, white muscle concentrations of DHA and OLA were reflective of dietary 1752 
concentrations. However, when dietary n-3 LC PUFA was supplied in quantities less than 1.6 1753 
g 100 g-1 feed, white muscle DHA and OLA concentrations remained fixed in spite of dietary 1754 
concentrations of DHA decreasing and OLA increasing (Figure 3.3). While competitive 1755 
interactions for metabolism and incorporation between n-6 and n-3 fatty acids have been well 1756 
documented in a range of finfish species (Sargent et al., 1999a, Sargent et al., 1999b, Glencross, 1757 
2009), interactions between n-9 fatty acids and n-3 LC PUFA have not previously been 1758 
documented in YTK. These results could suggest that YTK differ from other finfish species, 1759 
as an interaction between n-6 fatty acids and n-3 LC PUFA was absent in this study while an 1760 
interaction between n-9 fatty acids and n-3 LC PUFA was observed. However, the interaction 1761 
of n-9 instead of n-6 fatty acids with n-3 LC PUFA could also have been driven by the relative 1762 
abundance of these fatty acid groups in the diet, with n-9 fatty acids being 4 times more 1763 
abundant than n-6 fatty acids. The implications of the relative magnitude of n-9 fatty acids to 1764 
n-3 LC PUFA has not been evaluated in fish feeds before, so this hypothesis remains to be 1765 
tested. 1766 
In the current study the relationship between OLA and DHA in the YTK white muscle 1767 
may suggest preferential absorption, incorporation, conversion and/ or sparing of DHA at the 1768 
expense of OLA. These findings are supported by a recent study demonstrating that dietary 1769 
OLA is not neutral in regard to the process by which ALA is absorbed, metabolized and 1770 
deposited in the egg yolks of Hy-Line W-36 laying hens (Elkin et al., 2018). While there was 1771 
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no obvious competition between ALA and OLA for metabolic enzymes, Elkin et al. (2018) 1772 
suggested that the triacylglycerol structure of the dietary oils, particularly the higher quantity 1773 
of OLA (85 mol%), compared to ALA (63 mol%) in the sn-2 position of dietary triglycerides, 1774 
which was expected to be more conserved during absorption, was likely to be the mechanism 1775 
by which OLA outcompeted ALA for absorption and therefore incorporation into tissues. 1776 
While Elkin et al. (2018) attributed their differences to a potential higher rate of absorption of 1777 
OLA than ALA, this explanation does not fit with the data presented for YTK in the current 1778 
study. Analysis of faecal material from experimental animals (Refer to Chapter 5) indicated a 1779 
mean of 96.1 ± 0.1% and 96.6 ± 0.2% (mean ± SE) absorption of OLA and DHA respectively, 1780 
which did not differ significantly among treatments.  1781 
Another recent study by Picklo et al. (2017), observed that high OLA diets reduced 1782 
tissue content of ALA in mice. Those authors suggested that competitive inhibition of ALA 1783 
uptake into cells by OLA was a possible cause for reduced ALA content in tissues. A plausible 1784 
explanation for the relationship between DHA and OLA in YTK in the current study is 1785 
competition for incorporation and more specifically selective incorporation of DHA when 1786 
dietary concentrations are low at the expense of OLA. Reduction of dietary OLA could thus 1787 
potentially reduce competition for incorporation between DHA and OLA, resulting in 1788 
increased accumulation of n-3 LC PUFA in YTK muscle. Therefore, further investigation of 1789 
the impacts of high OLA diets for other fish species is recommended as a means of better 1790 
understanding the mechanisms affecting the utilization dietary n-3 LC PUFA. 1791 
The maintenance of white muscle DHA at low dietary inclusion rates could also have 1792 
been driven by conversion of EPA or DPA to DHA. Conversion of ALA to n-3 LC PUFA is 1793 
known to be limited in marine fish (Tocher, 2003, Strobel et al., 2012) and it is likely that the 1794 
conversion of EPA and DPA to DHA is also limited. Generally, n-3 LC PUFA are accumulated 1795 
up the food chain after being produced by phytoplankton, rather than being converted or 1796 
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interconverted in higher order consumers such as YTK. In the current study, the ratio of EPA: 1797 
DPA: DHA in the muscle was reflective of the dietary ratios of these fatty acids, indicating that 1798 
the interconversion of n-3 LC PUFA was either not necessary or not occurring even at the 1799 
lowest dietary inclusion rate. Furthermore, the de novo biosynthesis of longer chain fatty acids 1800 
such as the conversion from EPA to DHA is known to be supressed by excess intake of n-6 1801 
fatty acids and n-3 LC PUFA in fish, due to excess competition for the Δ6 desaturase enzyme 1802 
system (Sargent et al., 1993, Glencross, 2009). Therefore, it is unlikely that interconversion of 1803 
n-3 LC PUFA was responsible for conservation of white muscle DHA concentrations. 1804 
In the current study the sparing of DHA was observed at dietary inclusion of less than 1805 
1.6 g n-3 LC PUFA 100 g-1 feed. The recommended dietary inclusion of n-3 LC PUFA for 1806 
optimal growth of large YTK has been defined as between 2.1 and 2.3 g 100 g-1 feed (Stone et 1807 
al., 2019) so with an adequate dietary inclusion sparing of DHA should not be observed. 1808 
However, developing an understanding of the mechanisms by which DHA can be spared in 1809 
YTK could have positive repercussions for maximizing dietary n-3 LC PUFA utilization. 1810 
Sparing, selective accumulation and selective retention of DHA, has been reported in a range 1811 
of marine fish including YTK (Ishihara and Saito, 1996, Saito et al., 1996, Bowyer et al., 2012b, 1812 
Codabaccus et al., 2012, Rombenso et al., 2015) and high utilization of O;A has previously 1813 
been observed in YTK, which was attributed to the ease with which O;A was catabolized by β 1814 
oxidation (Bowyer et al., 2012b). Similarly, the interaction observed between DHA and O;A 1815 
in the current study could be attributed to conservation of DHA by selectively increasing the 1816 
rate at which O;A is utilized for energy.  If DHA can be spared at the expense of O;A, supplying 1817 
dietary O;A at an adequate concentration may ensure the maintenance of muscle DHA 1818 
concentrations. However, if there is a persistently low dietary concentration of DHA 1819 
throughout a period of rapid growth, it is likely that DHA concentrations in muscle tissue would 1820 
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decrease. This would have negative implications for fish growth and health and nutritional 1821 
value for human consumers.  1822 
Interestingly, large increases in the dietary n-3 LC PUFA content (3.9-fold increase) 1823 
between DIET0.8 and DIET3.0 did not result in equally or even comparatively large increases 1824 
in n-3 LC PUFA content in the white muscle (1.4-fold increase) or the red muscle (1.6-fold 1825 
increase). While these results could suggest inefficiency in n-3 LC PUFA accumulation by 1826 
YTK, it is more likely that the magnitude of change was limited by the quantity of growth 1827 
(approximately 50% increase in body weight) achieved during the 12-week experimental 1828 
period. Tissue compositional changes are achieved more rapidly during the accumulation of 1829 
new tissue rather than the turnover of existing tissue lipids. This has been described in a 1830 
previous study which proposed a dilution model for fatty acid compositional changes, over 1831 
time, when dietary lipid composition is altered (Jobling, 2003). In the current study, the relative 1832 
change in fatty acid profile would likely be more reflective of the dietary composition if the 1833 
weight gain achieved during the experimental period was greater. 1834 
The difference in n-3 LC PUFA accumulation between tissue regions could be 1835 
attributed to differences in the functional role of each region. The fatty acid profile of the red 1836 
muscle was influenced to a greater degree by experimental diet than the white muscle (Table 1837 
3.3). In YTK the red muscle is primarily responsible for routine swimming activity and requires 1838 
a large energy reserve which can be readily utilized (Tsukamoto, 1984). Therefore, utilization 1839 
of tissue lipids for energy in combination with growth and incorporation of new tissue lipids 1840 
likely accelerated tissue compositional changes. Comparatively, the vast majority of lipid in 1841 
the white muscle is in the form of phospholipids, which form the structural components of cells 1842 
and are not readily utilized for energy (Tsukamoto, 1984). Therefore, compositional changes 1843 
to the white muscle fatty acid profile would be more limited and occurring primarily in 1844 
response to the accumulation of new tissue. From a grow-out perspective, the difference in the 1845 
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rate of change of tissue fatty acid composition should be considered in relation to finishing 1846 
diets for improved product quality during the final stages of growth before harvest, with a 1847 
particular focus on the limited changes possible in the white muscle as this is the main tissue 1848 
eaten by consumers. 1849 
Concentrations of n-3 LC PUFA in the white muscle ranged from 0.6 (DIET0.8) to 0.9 1850 
(DIET3.0) g 100 g-1 tissue. Importantly, in relation to seafood consumption, fish from all of 1851 
the treatment groups had the potential to meet the recommended daily intake requirements of 1852 
n-3 LC PUFA for human consumers. In Australia, the Nation Health and Medical Research 1853 
Council (NHMRC) recommends a dietary intake target of n-3 LC PUFA of 0.43 g per day for 1854 
adult females and 0.61 g per day for adult males (NHMRC, 2006), while the International 1855 
Society for the Study of Fatty Acids and Lipids (ISSFAL) recommends a daily intake of 0.50 1856 
g per day of n-3 LC PUFA (ISSFAL, 2004). Therefore, a 100 g serving of YTK white muscle 1857 
from any of these treatment groups would exceed the 0.50 g n-3 LC PUFA per day requirement, 1858 
by 19% (DIET0.8) to 72% (DIET3.0) (Table 3.3). When YTK is served as sashimi or as a skin-1859 
on portion of fillet, a portion of the red muscle is also consumed. This would contribute 1860 
additional n-3 LC PUFA toward the daily recommended intake (e.g. only 13 g or 20 g of red 1861 
muscle from DIET3.0 or DIET0.8 respectively, would satisfy the 0.50 g n-3 LC PUFA per day 1862 
requirement).  1863 
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3.5. Conclusions 1864 
This study has revealed an interaction between DHA and OLA when dietary n-3 LC 1865 
PUFA concentrations are significantly reduced (below 1.6 g 100 g-1 feed). These results suggest 1866 
that OLA plays a role in regard to DHA deposition in YTK white muscle and should be 1867 
considered when formulating commercial diets. Two possible explanations for this interaction 1868 
are proposed: 1) competition between DHA and OLA for incorporation into lipid molecules, 1869 
and 2) selective conservation of DHA at the expense of OLA. These explanations would result 1870 
in conflicting recommendations for future diet formulations for YTK. Further research is 1871 
required to elucidate the mechanisms driving this interaction and should focus on the effects 1872 
of increasing or decreasing dietary OLA on DHA deposition in YTK white muscle.  1873 
Given that a 100 g serving of YTK white muscle from any of the treatment groups 1874 
would exceed the recommended daily intake requirements for n-3 LC PUFA it is suggested 1875 
that the primary factors to consider when setting n-3 LC PUFA requirements for YTK should 1876 
be cost and availability of dietary fats, maximizing growth rate, minimizing feed conversion 1877 
ratio and maintaining optimal health of the fish. However, further research should additionally 1878 
focus on optimizing the incorporation and conservation of n-3 LC PUFA in YTK muscle such 1879 
that consumers can reap maximum nutritional benefits.  1880 
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3.8. Tables and figures  1994 
Table 3.1: Total dietary lipid content (%) and fatty acid composition (mg 100 g-1 feed) of eight 1995 
experimental diets  1996 
Item (as fed) DIET0.8 DIET1.0 DIET1.3 DIET1.6 DIET1.8 DIET2.1 DIET2.4 DIET3.0 
Lipid content (%) 26.2 26 26.9 26.6 27.1 26.9 26.8 27.1 
Analysed fatty acids (mg 100 g-1)         
t18:1n-9 (Palmitelaidic acid) 83 76 74 73 74 73 72 72 
t18:1n-7 (Elaidic acid) 140 131 127 121 121 119 115 108 
14:0 (Myristic acid) 420 480 540 620 660 730 760 900 
15:0 (Pentadecanoic acid) 53 59 66 69 74 77 77 89 
16:0 (Palmitic acid) 5930 5880 5890 5860 5780 5760 5570 5550 
17:0 (Margaric acid) 89 90 93 95 98 100 100 110 
18:0 (Stearic acid) 1870 1860 1840 1810 1790 1770 1690 1670 
20:0 (Arachidic acid) 36 44 48 44 47 51 49 53 
22:0 (Docosanoic acid) 25 23 24 26 28 30 31 31 
24:0 (Tetracosanoic acid) 13 14 14 15 15 16 16 18 
18:3n-3 (Alpha Linolenic acid- ALA) 550 540 530 520 490 490 460 430 
20:5n-3 (Eicosapentaenoic acid- EPA) 270 400 530 680 790 930 1060 1350 
22:5n-3 (Docosapentaenoic acid- DPA) 63 72 83 100 110 130 140 160 
22:6n-3 (Docosahexaenoic acid- DHA) 420 540 680 830 930 1080 1190 1440 
18:2n-6 (Linoleic acid- LOA) 3150 3040 2960 2900 2730 2650 2500 2300 
18:3n-6 (Gamma Linolenic acid) 31 30 35 36 37 41 38 43 
20:2n-6 (Eicosadienoic acid) 28 28 30 30 31 32 33 36 
20:3n-6 (Dihomo-gamma-linoleic acid) 24 27 25 28 28 35 33 33 
20:4n-6 (Arachidonic acid) 110 110 120 140 140 50 160 170 
22:4n-6 (Docosatetraenoic acid) 16 17 18 19 19 20 21 23 
16:1n-7 (Palmitoleic acid) 1450 1440 1490 1540 1530 1560 1570 1610 
18:1n-7 (Octadecenoic acid) 640 640 650 660 650 660 650 670 
18:1n-9 (Oleic acid- OLA) 11050 10580 10310 10080 9530 9290 8700 8020 
20:1n-9 (Eicosenoic acid) 130 140 150 140 150 150 156 160 
22:1n-9 (Docosenoic acid) 11 12 14 16 18 20 22 26 
24:1n-9 (Tetracosenoic acid) 20 24 24 32 35 41 37 48 
Total trans 223 207 201 194 196 192 187 180 
Total saturated  8436 8450 8515 8539 8492 8534 8293 8421 
Total Omega 3 1303 1552 1823 2130 2320 2630 2850 3380 
Total Omega 6 3359 3252 3187 3153 2985 2829 2785 2605 
Total Omega 7 2090 2080 2140 2200 2180 2220 2220 2280 
Total Omega 9 11211 10756 10498 10268 9733 9501 8915 8254 
n-3 LC PUFA 753 1012 1293 1610 1830 2140 2390 2950 
n-3 FA: n -6 FA 2.58 2.10 1.75 1.48 1.29 1.08 0.98 0.77 
n-3 FA: n -9 FA 8.60 6.93 5.76 4.82 4.20 3.61 3.13 2.44 
  1997 
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Table 3.2. Growth performance, feed utilisation, proximate composition and nutrient retention Yellowtail Kingfish (Seriola lalandi) from fish fed 1998 
eight experimental diets for 12 weeks extracted from Stone et al. (2019). (D0.75 = Diet0.8, D1.01= Diet 1.0, D1.29 = Diet1.3, D1.61 = Diet 1.6, 1999 




Table 3.3: Total lipid content (%), fatty acid composition totals (mg 100 g-1 tissue) and ratio of omega 3 (n-3) to omega 6 (n-6) and omega 9 (n-2002 
9) fatty acids of white and red muscle of Yellowtail Kingfish (Seriola lalandi) from fish fed eight experimental diets for 12 weeks (values presented 2003 
as mean ± standard error, n = 3, different subscripts denote significant differences between treatments; P < 0.05). 2004 
  DIET0.8 DIET1.0 DIET1.3 DIET1.6 DIET1.8 DIET2.1 DIET2.4 DIET3.0 P = 
White muscle          
Lipid content 5.3 ± 0.6 6.0 ± 1.1 6.0 ± 0.5  6.9 ± 1.0  6.7 ± 0.8  6.8 ± 0.6  6.8 ± 0.7  6.7 ± 0.6 0.798 
Total trans 49.3 ± 1.2 44.5 ± 3.1 46.7 ± 2.0  43.6 ± 0.8  45.1 ± 2.1  45.7 ± 2.5  49.9 ± 0.5  43.9 ± 2.7 0.204 
Total saturated  1629.5 ± 16.7 a 1642.4 ± 19.3 ab 1644.0 ± 15.5 ab 1641.5 ± 12.9 ab 1676.0 ± 9.8 bc 1684.4 ± 15.1 bc 1707.8 ± 10.6 c 1719.1 ± 14.4 c < 0.001 
Total Omega 3 704.1 ± 28.4 a 714.9 ± 33.5 ab 707.4 ± 33.3 ab 721.4 ± 22.8 ab 793.8 ± 21.9 bc 832.2 ± 43.2 cd 874.9 ± 42.1 d 961.4 ± 31.3 e < 0.001 
Total Omega 6 841.8 ± 10.2 a 822.4 ± 7.3 ab 814.0 ± 13.4 b 804.7 ± 10.3 b 783.1 ± 11.4 c 771.4 ± 12.8 cd 757.3 ± 12.3 de 740.2 ± 15.3 e < 0.001 
Total Omega 7 567.9 ± 6.3 ab 562.2 ± 7.1 a 572.7 ± 8.4 ab 590.2 ± 5.3 bc 583.8 ± 8.3 abc 590.5 ± 6.0 bc 592.8 ± 9.2 bc 607.4 ± 8.2 c < 0.001 
Total Omega 9 2575.6 ± 35.8 a 2579.9 ± 39.5 a 2584.3 ± 37.7 a 2566.8 ± 29.9 ab 2484.7 ± 25.6 bc 2442.3 ± 48.5 cd 2383.0 ± 47.6 d 2288.4 ± 35.3 e < 0.001 
n-3 LC PUFA 595 ± 24.1 a 604.4 ± 23.9 ab 596.1 ± 19.2 a 608.4 ± 11.7 ab 684.9 ± 18.0 bc 725.4 ± 16.2 cd 771.2 ± 23.1 d 859.3 ± 12.3 e < 0.001 
n-3 FA: n -6 FA 1.2 ± 0.1 a 1.2 ± 0.0 a 1.2 ± 0.0 a 1.1 ± 0.0 a 1.0 ± 0.0 b 0.9 ± 0.0 b 0.9 ± 0.0 bc 0.8 ± 0.0 c < 0.001 
n-3 FA: n -9 FA 3.7 ± 0.2 a 3.6 ± 0.1 a 3.7 ± 0.1 a 3.6 ± 0.1 ab 3.1 ± 0.1 bc 2.9 ± 0.1 c 2.7 ± 0.1 cd 2.4 ± 0.0 d < 0.001 
Red muscle                  
Lipid content  27.8 ± 2.4 29.0 ± 1.9 28.8 ± 2.2  28.8 ± 1.7  33.4 ± 1.9  29.3 ± 1.2  28.0 ± 1.8  26.7 ± 1.3 0.340 
Total trans 338.8 ± 27.9 a 315.2 ± 10.9 ab 318.3 ± 12.2 ab 281.6 ± 26.1 ab 246.0 ± 27.0 a 265.3 ± 19.6 ab 287.0 ± 20.8 ab 247.9 ± 15.1 b 0.008 
Total saturated  7285.3 ± 74.7 a 7327.1 ± 59.0 ab 7366.3 ± 64.5 abc 7343.4 ± 64.9 ab 7483.6 ± 39.8 abcd 7521.2 ± 59.4 bcd 7558.9 ± 50.1 cd 7617.9 ± 59.1 d < 0.001 
Total Omega 3 2895.7 ± 112.9 a 2991.8 ± 113.8 ab 3136.9 ± 139.2 b 3186.2 ± 69.6 bc 3419.4 ± 114.7 cd 3578.5 ± 192.3 de 3748.2 ± 197.3 e 4218.0 ± 184.2 f < 0.001 
Total Omega 6 3624.4 ± 57.4 a 3530.2 ± 32.6 ab 3469.6 ± 71.5 bc 3413.2 ± 46.8 cd 3315.2 ± 48.2 de 3290.7 ± 55.7 e 3246.0 ± 59.6 ef 3154.6 ± 66.3 f < 0.001 
Total Omega 7 2404 ± 9.7 ab 2430.9 ± 27.1 abc 2379.8 ± 24.2 a 2436.5 ± 28.9 abc 2487.6 ± 27.5 bcd 2486.9 ± 28.7 bcd 2518.7 ± 28.4 cd 2559.3 ± 32.1 d < 0.001 
Total Omega 9 12359.2 ± 127.1 a 12307.0 ± 132.0 a 12232.6 ± 147.3 a 12241.7 ± 89.4 a 11946.5 ± 106.3 b 11749.2 ± 202.3 bc 11525.9 ± 180.4 c 11086.6 ± 190.4 d < 0.001 
n-3 LC PUFA 2465.1 ± 57.3 a 2547.5 ± 29.4 ab 2712.8 ± 44.0 ab 2773.0 ± 66.6 bc 3012.1 ± 42.2 cd 3179 ± 39.1 de 3342.5 ± 63.0 e 3835.7 ± 87.7 f < 0.001 
n-3 FA: n -6 FA 1.3 ± 0.0 a 1.2 ± 0.0 ab 1.1 ± 0.0 bc 1.1 ± 0.0 c 1.0 ± 0.0 d 0.9 ± 0.0 de 0.9 ± 0.0 e 0.8 ± 0.0 f < 0.001 





Table 3.4: Fatty acid composition (mg 100 g-1 tissue) of white muscle of Yellowtail Kingfish (Seriola lalandi) from fish fed eight experimental 2007 
diets for 12 weeks (values presented as mean ± standard error, n = 3, different subscripts denote significant differences between treatments; P < 2008 
0.05). 2009 
Fatty acid DIET0.8 DIET1.0 DIET1.3 DIET1.6 DIET1.8 DIET2.1 DIET2.4 DIET3.0 P = 
t18:1n-9 (Palmitelaidic acid) 16.3 ± 0.4  16.8 ± 0.4  16.8 ± 0.5  15.9 ± 0.2  16.4 ± 0.3  15.8 ± 0.4  15.9 ± 0.3  15.7 ± 0.2  0.157 
t18:1n-7 (Elaidic acid) 23.0 ± 0.4  20.7 ± 0.7  23.1 ± 0.5  21.6 ± 0.5  22.1 ± 1.2  21.7 ± 2.5  22.1 ± 0.2  21.8 ± 0.6  0.837 
14:0 (Myristic acid) 123.1 ± 4.2 a 118.8 ± 4.0 a 126.8 ± 7.5 ab 139.1 ± 5.4 bc 142.3 ± 7.1 cd 148.2 ± 8.0 cd 156.0 ± 8.1 d 174.1 ± 7.5 e < 0.001 
15:0 (Pentadecanoic acid) 16.3 ± 0.4 ab 15.4 ± 0.4 a 16.2 ± 0.7 ab 16.9 ± 0.5 ab 17.2 ± 0.6 bc 17.7 ± 0.7 bc 18.5 ± 0.7 c 20.1 ± 0.6 d < 0.001 
16:0 (Palmitic acid) 1096.0 ± 9.8 a 1106.6 ± 11.9 ab 1108.0 ± 9.6 ab 1094.5 ± 6.3 a 1111.2 ± 5.1 ab 1119.3 ± 7.9 ab 1130.0 ± 5.0 b 1128.5 ± 8.1 b 0.004 
17:0 (Margaric acid) 25.0 ± 0.4 ab 24.3 ± 0.4 b 25.0 ± 0.5 ab 25.6 ± 0.5 ab 26.2 ± 0.7 bc 26.1 ± 0.5 bc 27.4 ± 0.5 cd 27.9 ± 0.5 d < 0.001 
18:0 (Stearic acid) 352.9 ± 4.7  361.3 ± 8.3  351.3 ± 3.9  348.5 ± 3.3  361.3 ± 3.9  355.3 ± 3.2  357.5 ± 5.0  348.5 ± 5.4  0.416 
20:0 (Arachidic acid) 9.5 ± 0.2 ab 9.1 ± 0.2 a 9.6 ± 0.3 ab 9.8 ± 0.3 abc 10.1 ± 0.3 bc 10.2 ± 0.4 bc 10.6 ± 0.3 c 11.5 ± 0.4 d < 0.001 
22:0 (Docosanoic acid) 4.1 ± 0.1 b 4.2 ± 0.1 bc 4.3 ± 0.2 bc 4.3 ± 0.1 abc 4.4 ± 0.1 bc 4.5 ± 4.7 bc 4.7 ± 0.1 cd 5.1 ± 0.2 d < 0.001 
24:0 (Tetracosanoic acid) 2.3 ± 0.1 b 2.5 ± 0.1 bc 2.4 ± 0.1 ab 2.3 ± 0.1 b 2.5 ± 0.1 bc 2.5 ± 0.1 bc 2.6 ± 0.0 bc 2.7 ± 0.1 c 0.003 
18:3n-3 (Alpha Linolenic acid- ALA) 109.0 ± 2.3 ab 110.5 ± 2.0 ab 111.3 ± 1.7 a 112.9 ± 1.6 a 108.9 ± 1.5 abc 106.7 ± 1.6 abc 103.7 ± 1.8 bc 102.1 ± 1.4 c < 0.001 
20:5n-3 (Eicosapentanaeoic acid- EPA) 164.8 ± 8.4 a 165.7 ± 7.6 a 176.8 ± 15.6 ab 196.5 ± 11.6 bc 216.3 ± 12.5 cd 227.4 ± 18.1 de 239.7 ± 16.5 e 288.0 ± 17.3 f < 0.001 
22:5n-3 (Docosapentaenoic acid- DPA)   64.1 ± 2.8 a 62.6 ± 1.8 a 62.8 ± 3.7 a 66.1 ± 2.9 ab 72.6 ± 2.2 bc 76.3 ± 3.5 c 77.6 ± 3.8 cd 85.0 ± 2.7 d < 0.001 
22:6n-3 (Docosahexaenoic acid- DHA) 366.1 ± 21.6 a 376.1 ± 29.0 a 356.4 ± 20.0 a 345.9 ± 12.1 a 395.9 ± 15.7 ab 421.7 ± 24.6 abc 453.9 ± 27.7 bc 486.2 ± 15.5 c < 0.001 
18:2n-6 (Linoleic acid- LOA) 753.4 ± 10.9 a 733.3 ± 8.9 ab 728.9 ± 15.0 b 720.1 ± 11.4 b 693.1 ± 11.7 c 681.2 ± 14.2 cd 663.9 ± 12.9 de 643.1 ± 16.4e < 0.001 
18:3n-6 (Gamma Linolenic acid) 9.3 ± 0.1  8.5 ± 1.3  8.5 ± 0.9  9.6 ± 0.3  9.5 ± 0.2  9.1 ± 0.2  10.8 ± 0.8  10.6 ± 0.5  0.101 
20:2n-6 (Eicosadienoic acid) 11.8 ± 0.2  11.8 ± 0.2  11.7 ± 0.2  11.7 ± 0.1  11.9 ± 0.2  11.8 ± 0.1  11.4 ± 0.1  11.7 ± 0.2  0.650 
20:3n-6 (Dihomo-gamma-linoleic acid) 9.5 ± 0.2 a 10.0 ± 0.1 ab 9.6 ± 0.2 a 9.7 ± 0.1 a 9.9 ± 0.2 ab 10.0 ± 0.1 ab 10.1 ± 0.1 ab 10.4 ± 0.2 b < 0.001 
20:4n-6 (Arachidonic acid) 49.6 ± 1.9 abc 50.4 ± 1.8 abc 47.4 ± 1.7 ab 45.7 ± 1.1 a 50.3 ± 1.2 abc 51.0 ± 1.7 abc 52.7 ± 2.0 bc 55.8 ± 0.9 c < 0.001 
22:4n-6 (Docosatetraenoic acid) 8.2 ± 0.3 ab 8.4 ± 0.2 ab 7.9 ± 0.2 ab 7.8 ± 0.2 a 8.4 ± 0.1 ab 8.3 ± 0.2 ab 8.4 ± 0.2 ab 8.7 ± 0.2 b 0.033 
16:1n-7 (Palmitoleic acid) 383.3 ± 5.7 ab 378.5 ± 6.5 a 388.6 ± 6.8 ab 403.9 ± 3.9 bc 396.2 ± 7.0 abc 400.5 ± 5.1 abc 401.7 ± 7.4 bc 416.8 ± 7.1 c < 0.001 
18:1n-7 (Octadecenoic acid) 184.7 ± 1.5 ab 183.7 ± 2.1 b 184.1 ± 2.1 ab 186.3 ± 1.9 ab 187.7 ± 1.8 ab 190.0 ± 1.1 ab 191.1 ± 2.0 a 190.6 ± 1.9 ab 0.003 
18:1n-9 (Oleic acid- OLA) 2504.2 ± 36.3 ab 2511.6 ± 39.0 a 2513.7 ± 39.3 ab 2496.1 ± 31.7 ab 2412.2 ± 26.2 bc 2369.1 ± 50.0 cd 2309.7 ± 48.7 d 2209.9 ± 36.4 e < 0.001 
20:1n-9 (Eicosenoic acid) 55.2 ± 1.0  52.6 ± 1.6  54.5 ± 1.4  55.0 ± 1.5  55.6 ± 1.5  56.3 ± 1.4  55.5 ± 1.3  59.0 ± 1.5  0.120 
22:1n-9 (Docosenoic acid) 6.2 ± 0.2 a 5.9 ± 0.2 a 6.1 ± 0.3 a 6.1 ± 0.3 a 6.5 ± 0.2 ab 6.4 ± 0.3 ab 6.7 ± 0.3 ab 7.5 ± 0.4 b 0.001 
24:1n-9 (Tetracosenoic acid) 10.0 ± 0.4 a 9.8 ± 0.4 a 10.0 ± 0.5 a 9.6 ± 0.5 a 10.4 ± 0.3 ab 10.5 ± 0.4 ab 11.1 ± 0.4 ab 11.9 ± 0.4 b < 0.001 
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Table 3.5: Fatty acid composition (mg 100 g-1 tissue) of red muscle of Yellowtail Kingfish (Seriola lalandi) from fish fed eight experimental diets 2011 
for 12 weeks (values presented as mean ± standard error, n = 3, different subscripts denote significant differences between treatments; P < 0.05). 2012 
Fatty acid DIET0.8 DIET1.0 DIET1.3 DIET1.6 DIET1.8 DIET2.1 DIET2.4 DIET3.0 P = 
t18:1n-9 (Palmitelaidic acid) 107.5 ± 6.4 a 100.4 ± 4.5 ab 97.8 ± 5.9 abc 95.8 ± 3.8 abc 89.1 ± 4.6 bc 79.8 ± 3.8 c 97.7 ± 6.0 abc 80.3 ± 4.9 c < 0.001 
t18:1n-7 (Elaidic acid) 110.8 ± 4.5 99.6 ±7.9  96.8 ± 5.7  101.4 ± 6.5  86.1 ± 4.5  86.4 ± 4.8  106.4 ± 6.8  98.1 ± 7.0  0.071 
14:0 (Myristic acid) 526.4 ± 12.4 a 540.7 ± 17.9 a 528.0 ± 23.4 a 566.5 ± 19.2 a 609.1 ± 19.4 b 612.8 ± 25.2 b 654.5 ± 26.0 c 709.4 ± 26.9 d < 0.001 
15:0 (Pentadecanoic acid) 73.6 ± 1.6 a 72.5 ± 1.4 a 72.8 ± 2.0 a 74.8 ± 1.9 ab 78.6 ± 1.8 bc 80.1 ± 2.4 cd 83.4 ± 2.4 d 88.7 ± 2.5 e < 0.001 
16:0 (Palmitic acid) 4844.1 ± 50.5 4862.7 ± 34.0  4912.1 ± 45.9  4856.4 ± 38.2  4933.6 ± 29.1  4947.2 ± 30.5  4953.5 ± 31.8  4970.2 ± 42.6  0.086 
17:0 (Margaric acid) 137.1 ± 8.8 140.9 ± 5.9  139.6 ± 6.7  130.0 ± 7.4  130.7 ± 7.1  138.8 ± 6.9  140.6 ± 5.1  137.8 ± 5.9  0.930 
18:0 (Stearic acid) 1596.0 ± 24.4 1601.0 ± 26.2  1620.7 ± 24.6  1622.1 ± 26.5  1632.8 ± 19.2  1647.1 ± 21.5  1616.3 ± 24.2  1605.0 ± 26.0  0.831 
20:0 (Arachidic acid) 68.5 ± 9.6 69.4 ± 7.4  51.9 ± 6.2  51.6 ± 8.6  55.3 ± 7.8  51.2 ± 6.9  65.0 ± 4.0  58.7 ± 4.3  0.377 
22:0 (Docosanoic acid) 23.5 ± 0.8 ab 23.0 ± 0.9 a 23.6 ± 0.8 ab 24.0 ± 0.9 ab 25.4 ± 0.6 abc 25.1 ± 0.8 abc 26.4 ± 0.8 bc 27.6 ± 1.0 c < 0.001 
24:0 (Tetracosanoic acid) 14.2 ± 0.6 a 14.5 ± 0.4 ab 15.4 ± 0.6 ab 15.6 ± 0.5 ab 15.4 ± 0.5 ab 16.2 ± 0.7 ab 16.2 ± 0.8 ab 17.5 ± 0.5 b 0.001 
18:3n-3 (Alpha Linolenic acid- ALA) 430.6 ± 16.5 ab 444.2 ± 7.4 a 424.0 ± 10.5 ab 413.2 ± 15.1 ab 407.4 ± 15.4 ab 399.5 ± 10.9 ab 405.7 ± 12.0 ab 382.3 ± 11.0 b 0.014 
20:5n-3 (Eicosapentanaeoic acid- EPA) 648.1 ± 34.4 a 678.9 ± 32.3 ab 701.0 ± 48.4 ab 747.9 ± 44.7 b 844.6 ± 44.9 c 882.5 ± 60.5 cd 945.1 ± 61.6 d 1085.8 ± 61.8 e < 0.001 
22:5n-3 (Docosapentaenoic acid- DPA) 343.1 ± 14.6 a 347.1 ± 14.4 a 358.9 ± 17.3 ab 362.0 ± 9.1 ab 391.3 ± 8.7 bc 410.0 ± 19.7 cd 419.9 ± 20.4 c 471.7 ± 19.0 d < 0.001 
22:6n-3 (Docosahexaenoic acid- DHA) 1474.0 ± 82.5 a 1521.5 ± 78.6 a 1653.0 ± 75.6 ab 1663.1 ± 39.1 ab 1776.1 ± 83.1 bc 1886.6 ± 122.4 c 1977.4 ± 136.3 c 2278.2 ± 109.8 d < 0.001 
18:2n-6 (Linoleic acid- LOA) 3198.8 ± 51.6 a 3110.1 ± 34.9 ab 3049.5 ± 74.8 b 3005.6 ± 43.7 bc 2908.8 ± 46.3 cd 2870.3 ± 58.4 d 2819.9 ± 58.6 de 2722.5 ± 71.5 e < 0.001 
18:3n-6 (Gamma Linolenic acid) 95.1 ± 10.2 94.3 ± 5.4  88.2 ± 8.8  79.3 ± 9.7  66.8 ± 9.4  77.8 ± 7.1  82.8 ± 8.9  73.8 ± 6.3  0.187 
20:2n-6 (Eicosadienoic acid) 57.3 ± 2.4  53.7 ± 0.8  54.2 ± 0.9  54.6 ± 0.9  56.1 ± 1.0  56.2 ± 1.7  53.9 ± 0.6  52.9 ± 1.3  0.242 
20:3n-6 (Dihomo-gamma-linoleic acid) 40.3 ± 0.6 a 41.0 ± 0.7 ab 40.3 ± 0.5 a 40.7 ± 0.4 a 42.4 ± 0.5 ab 42.3 ± 0.5 ab 41.8 ± 0.5 ab 43.1 ± 0.9 b 0.001 
20:4n-6 (Arachidonic acid) 194.0 ± 3.0 a 192.8 ± 4.5 a 198.2 ± 4.6 ab 194.4 ± 2.5 ab 201.8 ± 4.7 ab 204.6 ± 4.6 ab 208.8 ± 5.1 bc 222.3 ± 4.4 c < 0.001 
22:4n-6 (Docosatetraenoic acid) 38.8 ± 0.6  38.3 ± 0.7  39.2 ± 0.7  38.6 ± 0.5  39.4 ± 0.6 39.5 ± 0.9  38.7 ± 0.7  40.1 ± 0.7  0.620 
16:1n-7 (Palmitoleic acid) 1553.4 ± 12.1 ab 1579.3 ± 24.7 abc 1531.5 ± 21.4 a 1595.7 ± 27.4 abcd 1635.3 ± 27.4 bcd 1614.0 ± 24.2 abcd 1654.5 ± 25.3 cd 1685.0 ± 29.9 d < 0.001 
18:1n-7 (Octadecenoic acid) 850.6 ± 7.2 ab 851.5 ± 6.9 ab 848.4 ± 9.7 ab 840.8 ± 6.2 a 852.3 ± 6.5 ab 872.9 ± 11.3 ab 864.2 ± 7.1 ab 874.3 ± 8.9 b 0.014 
18:1n-9 (Oleic acid- OLA) 12071.7 ± 127.2 a 11949.9 ± 138.5 a 11882.0 ± 177.3 a 11885.9 ± 95.3 a 11583.4 ± 88.2 b 11434.3 ± 206.0 bc 11204.4 ± 183.7 c 10702.1 ± 193.4 d < 0.001 
20:1n-9 (Eicosenoic acid) 199.7 ± 6.3  268.2 ± 31.8  260.5 ± 37.8  263.5 ± 5.9  268.2 ± 32.1  220.2 ± 2.9  223.8 ± 3.5  274.4 ± 3.1  0.114 
22:1n-9 (Docosenoic acid) 30.9 ± 0.6 ab 31.0 ± 0.7 ab 30.2 ± 1.2 a 31.3 ± 1.2 ab 32.6 ± 0.7 ab 32.8 ± 0.8 ab 33.6 ± 1.0 bc 36.5 ± 1.1 c < 0.001 






Figure 3.1: Concentration (mg 100 g-1 tissue) of n-3 LC PUFA, total omega 6 (n-6) and total 2016 
omega 9 (n-9) fatty acids in white muscle of Yellowtail Kingfish (Seriola lalandi) compared 2017 
to feed concentration of n-3 LC PUFA (mg 100 g-1 feed) after 12 weeks of feeding (values 2018 
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Figure 3.2: Concentration (mg 100 g-1 tissue) of n-3 LC PUFA, total omega 6 (n-6) and total 2021 
omega 9 (n-9) fatty acids in red muscle of Yellowtail Kingfish (Seriola lalandi) compared to 2022 
feed concentration of n-3 LC PUFA (mg 100 g-1 feed) after 12 weeks of feeding (values 2023 
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Figure 3.3: White muscle concentration of docosahexaenoic acid (DHA) compared to white 2026 
muscle concentration of oleic acid (OLA) (mg 100 g-1 tissue) in Yellowtail Kingfish (Seriola 2027 
lalandi) after 12 weeks of feeding (values presented as mean ± standard error, n = 3). 2028 
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3.9. Statement to link Chapter 3 and Chapter 4  2030 
In Chapter 3 and in conjunction with the Stone et al., (2019) study, it became apparent 2031 
that YTK reared on diets with deficient dietary n-3 LC PUFA (high poultry oil/ low fish oil) 2032 
had slower growth and poorer feed conversion efficiency than YTK fed on the optimal 2.1 – 2033 
2.4 g n-3 LC PUFA 100 g-1 feed, and YTK fed dietary levels > 2.4 g n-3 LC PUFA (low poultry 2034 
oil/ high fish oil) did not achieve any further improvements to growth and feed conversion. The 2035 
fatty acid profile of the flesh was generally reflective of the respective dietary compositions 2036 
(with the exception of DHA and OLA in low n-3 LC PUFA diets), which suggested that lipids 2037 
from dietary fish oil and poultry oil were incorporated with equal efficiency. However, 2038 
assessing the digestibility of lipids from diets with different lipid compositions would provide 2039 
more clarity about lipid utilisation, this was addressed in Chapter 4.   2040 
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Abstract  2070 
Yellowtail Kingfish (Seriola lalandi) (YTK) require dietary omega 3 (n-3) long chain 2071 
polyunsaturated fatty acids (LC PUFA) for healthy development and growth. Dietary n-3 LC 2072 
PUFA are typically provided by incorporating fish oil (FO), however FO is routinely partially 2073 
replaced with poultry oil (PO) in aquafeeds. Replacing too much FO with PO has been shown 2074 
to reduce the n-3 LC PUFA content in flesh and negatively affect growth and performance of 2075 
YTK. The mechanism responsible has not been elucidated but likely results from either inferior 2076 
digestion or inferior utilisation of dietary fatty acids from PO compared to those from FO. 2077 
Three diets were formulated by incrementally replacing FO with PO: 0.8 (DIET0.8), 2.1 2078 
(DIET2.1) and 3.0 (DIET3.0) g n-3 LC PUFA 100 g-1 of feed and following an 84-day feed 2079 
trial these diets produced significantly different growth and performance results (reported by 2080 
Stone et al. (2019)). By measuring the lipid and fatty acid composition of the feeds and stripped 2081 
faecal material the apparent assimilation efficiency of these components was estimated. The 2082 
results indicated that the overall lipid component of the diets and the majority of fatty acids 2083 
were digested with high and equal efficiency. This suggested that digestibility of fatty acids 2084 
from PO was not the responsible for inferior growth and performance, so the cause is likely 2085 
further downstream – in the ability of the YTK to metabolise these lipids. While the results of 2086 
the current study do not resolve the question of the mechanism, another interesting trend was 2087 
observed in relation to the digestibility of saturated fatty acids by YTK. The percentage of 2088 
saturated fatty acids digested from YTK feeds decreased with increasing chain length. 2089 
Specifically, 89.1% of dietary 14:0 (myristic acid) was digested compared to only 74.5% of 2090 
dietary 22:0 (docosanoic acid). This suggested that replacing FO with alternative oils that have 2091 
a higher proportion of shorter chain saturated fatty acids, compared to longer chain saturated 2092 




Yellowtail Kingfish (Seriola lalandi); aquaculture; fish oil; poultry oil; fatty acid digestibility. 2095 
 2096 
Highlights 2097 
1. Yellowtail Kingfish appear to digest lipids and fatty acids from dietary poultry oil 2098 
and fish oil with equal efficiency.  2099 
2. Yellowtail Kingfish digest shorter chain saturated fatty acids with greater efficiency 2100 
than longer chain saturated fatty acids. 2101 
3. Replacement oils in aquafeeds for YTK should have a greater proportion of shorter 2102 
chain saturated fatty acids (<16:0) than longer chain saturated fatty acids (>17:0) to 2103 




4.1. Introduction 2106 
The composition of dietary lipids in aquafeeds for commercially reared finfish has 2107 
changed extensively over the last 20 years (Tocher, 2015). Increasing pressure to reduce the 2108 
quantity of fish oil (FO) used in commercial aquaculture has led to large proportions of lipids 2109 
now being supplied by poultry or beef tallow and/or vegetable oils, such as canola, sunflower 2110 
or palm oil (Gatlin et al., 2007, Tacon and Metian, 2008, Naylor et al., 2009, Turchini et al., 2111 
2009). The incremental replacement of dietary FO with alternative oils significantly increases 2112 
the proportions of omega 6 (n-6), omega 9 (n-9) and saturated fatty acids and reduces the 2113 
proportion of omega 3 (n-3) long chain (LC) polyunsaturated fatty acids (PUFA) (Turchini et 2114 
al., 2009). While in the majority of cases the alternative oils are able to fulfil the energy 2115 
requirements of the finfish, their interactions within their digestive system are different from 2116 
FO. As a consequence, dietary FO replacement has been shown to impact lipid digestibility, 2117 
growth, fat deposition, enzyme expression, feed conversion ratio (FCR) and product quality in 2118 
various marine fish (Menoyo et al., 2003, Seno-o et al., 2008, Thanuthong et al., 2011, Bowyer 2119 
et al., 2012a, Bowyer et al., 2012b, Yılmaz et al., 2016). 2120 
Menoyo et al., (2003) determined that the lipid metabolism of Atlantic Salmon (Salmo 2121 
salar) was affected by dietary fatty acids according to their degree of unsaturation and chain 2122 
length.  In both Atlantic Salmon and YTK saturated fatty acids were observed to be 2123 
preferentially utilised for energy via  oxidation (Menoyo et al., 2003, Bowyer et al., 2012b). 2124 
As such, the replacement of dietary FO with alternative oils in both species impacted lipid 2125 
metabolism and utilisation. Fish oil replacement was also shown to affect fatty acid 2126 
bioconversion in Rainbow Trout (Oncorhynchus mykiss) and European Sea Bass 2127 
(Dicentrarchus labrax) (Thanuthong et al., 2011, Yılmaz et al., 2016). In fish, reduced 2128 
bioconversion of dietary lipids due to changes in composition generally manifests as less 2129 
growth with the same quantity of feed, which can be problematic as it increases production 2130 
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costs. In YTK, FCR, growth and product quality have been shown to diminish with increasing 2131 
replacement of FO with alternative oils (Bowyer et al., 2012a, Stone et al., 2019). 2132 
For YTK a common dietary FO replacement that has been widely and successfully used 2133 
is poultry oil (PO) (Moran et al., 2009, Bowyer et al., 2012a, Bowyer et al., 2013, Collins et 2134 
al., 2014). In these studies, partial replacement of dietary FO with PO either has either had no 2135 
significant effect or indeed had a slight positive effect on growth but the fatty acid composition 2136 
of the muscle tissues has generally been reflective of the PO profile, which has implications 2137 
for YTK product quality. However, in a recent FO replacement trial conducted by Stone et al. 2138 
(2019), significant decreases in growth and diminished FCR were observed in YTK with 2139 
increasing replacement of FO with PO. The deposition of fatty acids in the flesh of YTK for 2140 
this study were also reported in Chapter 3, which showed that the dietary lipid profile was 2141 
reflected in the flesh fatty acid profile. Differences in the growth and FCR of YTK in Stone et 2142 
al., (2019) were speculated to be due to poorer digestibility and metabolism of PO by YTK, 2143 
however this was not quantified. In order to understand the reason for inferior growth and FCR 2144 
the current experiment was designed to determine whether dietary lipids from FO and PO were 2145 
digested with equal efficacy. Therefore, the aim of the current study was to quantify the 2146 
digestibility of lipids and fatty acids by YTK fed graded levels of FO and PO to determine 2147 
whether inferior growth was linked to reduced digestibility of PO as a dietary lipid source.   2148 
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4.2. Methods and Materials 2149 
4.2.1. Experimental location and animals 2150 
Animal ethics approval for this work was granted by the University of Adelaide animal 2151 
ethics committee (Approval number: S-2016-127). The experiment was conducted at the South 2152 
Australian Research and Development Institute (SARDI) South Australian Aquatic Science 2153 
Centre (SAASC) (West Beach, South Australia, Australia). Yellowtail Kingfish were supplied 2154 
by Clean Seas Seafood Ltd. (Port Lincoln, South Australia, Australia). Prior to the experiment, 2155 
fish were housed in 18 × 5000 L tanks supplied with partial flow-through/recirculating (100% 2156 
system water exchange day-1), sand filtered, UV treated, aerated sea water at ambient 2157 
temperature and held for ~3.5 months. During this period fish were fed a 9 mm commercial 2158 
diet (Ridley Pelagica diet; crude protein 46%; crude lipid 24%; gross energy 19.30 MJ kg-1; 2159 
Narangba, Queensland, Australia) to apparent satiation once daily. 2160 
4.2.2. Experimental diets 2161 
The diet kernels, FO and PO used in the experimental diets were supplied by Skretting 2162 
Australia. The diet formulations were based on Skretting Australia’s YTK diet (20% fish meal; 2163 
40% crude protein, 30% crude lipid and a gross energy level of approximately 21 MJ kg-1) 2164 
(Stone et al., 2019). The diet kernels contained a base level of 10% crude lipid and were then 2165 
top coated with an additional 17% lipid (graded blends of FO and PO; total crude lipid level 2166 
27%) at Aquafeeds Australia (Mount Barker, South Australia). The main effect of substituting 2167 
FO with PO was a decrease in n-3 LC PUFA with an increase in n-9 fatty acids (mostly oleic 2168 
acid, 18:1n-9, OLA). Three experimental diets were formulated with n-3 LC PUFA contents 2169 
of 0.8 (DIET0.8), 2.1 (DIET2.1) and 3.0 (DIET3.0) g 100 g-1 of feed (Table 4.1). 2170 
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4.2.3. Experimental housing and animal care 2171 
At the start of the feed trial, YTK were anaesthetised in 5000 L tanks (total water 2172 
volume 2500 L) using AQUI-S® (AQUI-S® New Zealand Ltd., Lower Hutt, New Zealand) at 2173 
a concentration of 14 mg L−1 of seawater. Fish were randomly distributed into 9 × 5000 L 2174 
recirculating aquaculture tanks (13 fish per tank) and randomly assigned one of the 3 2175 
experimental diets (3 replicate tanks diet-1). Fish were fed their experimental diet for 14 weeks, 2176 
with feeding once daily to apparent satiation and intake was recorded as grams consumed per 2177 
fish per day. Water quality parameters were measured daily and maintained within the accepted 2178 
optimal levels for YTK (Bowyer et al., 2014). Fish growth and FCR were determined after 12 2179 
weeks and faecal samples were collected at 13 and 14 weeks for digestibility analysis.  2180 
4.2.4. Faecal sample collection 2181 
In the 24 hours prior to sample collection fish were fed their respective experimental 2182 
diet to apparent satiation twice (0900 and 1600 h) to ensure that feed intake was not a limiting 2183 
factor affecting digestibility. Faecal samples were collected on 2 occasions (13 and 14 weeks) 2184 
to ensure that sufficient quantity of material could be obtained for analysis. To collect samples, 2185 
the fish were anaesthetised, removed from their tank and faecal material was manually stripped 2186 
from each fish following the procedure outlined by Stone et al. (2008). Faecal samples were 2187 
pooled by tank and immediately frozen by immersion in dry ice and thereafter stored at -20 ºC 2188 
prior to analysis. 2189 
4.2.5. Total lipid analysis 2190 
Total crude lipid (as a percentage of wet weight) was estimated for feed and faecal 2191 
samples utilizing the gravimetric approach (Folch et al., 1957). Briefly, weighed samples were 2192 
homogenised in 0.9% saline, thereafter lipids were extraction into a 4:1 chloroform: 2193 
isopropanol solution and the chloroform: isopropanol component was then transferred to a pre-2194 
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weighed glass scintillation vial and evaporated to dryness using nitrogen gas leaving only the 2195 
lipid component behind. The vial was re-weighed to get the weight of the extracted crude fat.  2196 
4.2.6. Fatty acid analysis 2197 
Fatty acid profiling was conducted for white and red muscle samples. The lipid 2198 
component (extracted during total lipid analysis) was transmethylated with 1% H2SO4 in 2199 
MeOH at 70 °C for 3 hours, then cooled to room temperature, after which fatty acid methyl 2200 
esters (FAME) were extracted into 2 mL of heptane. The heptane was transferred to a gas 2201 
chromatography (GC) vial with 30 mg of anhydrous sodium sulphate, sealed and stored at -20 2202 
°C until analysis by GC. Samples were processed on a Hewlett-Packard 6890 GC (Hewlett-2203 
Packard, CA, USA) with a flame ionization detector, a split injector and a BPX-70 capillary 2204 
column (50 m × 0.32 mm) with a 0.25 µm film thickness (SGE, Victoria, Australia). Gas 2205 
chromatography operating conditions were as described previously (Tu et al., 2010) and peaks 2206 
were identified with GLC 463 external standard (Nu-Chek Prep Inc., MN, USA). Data output 2207 
was processed with Agilent ChemStation (version Rev: B.01.03) (Agilent Technologies, CA, 2208 
USA). 2209 
4.2.7. Calculations 2210 
The total feed intake for each tank was recorded and feed consumption was assumed to 2211 
be equal between fish. Faecal output per tank was recorded as the quantity of faecal material 2212 
pooled from all fish per tank and it was assumed that excretion was equal among individual 2213 
fish. Thereafter the average faecal output was determined as a proportion of the assumed feed 2214 
intake for each fish. 2215 
Digested fatty acids were estimated both as apparent assimilation efficiency (%) and as 2216 
grams of fatty acids removed during digestion, both in relation to the quantity of lipids and 2217 
fatty acids in the feeds.  2218 
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- Apparent assimilation efficiency (%) = (mg of fatty acid present in faecal material / mg 2219 
of fatty acid consumed) × 100 2220 
- Mass of fatty acids removed during digestion = mg of fatty acid consumed – mg of fatty 2221 
acid present in faecal material  2222 
4.2.8. Statistics 2223 
Statistical analysis was performed using IBM SPSS (version 24). Homogeneity of 2224 
variance was assessed using Levene’s test, whilst normality was assessed with the 2225 
Kolmogorov-Smirnov test. Differences were analysed using a one-way ANOVA where diet 2226 
was a factor. Where significant differences were detected, post-hoc comparisons were made 2227 
via Tukey’s tests. An alpha level of 0.05 was used for all statistical tests. Results are presented 2228 
as means ± standard error (SE) of n= 3 tanks per treatment unless otherwise stated.   2229 
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4.3. Results 2230 
4.3.1. Feed trial performance 2231 
The mean water temperature during the experimental period was 19.7 ± 0.03 °C (range: 2232 
15.5 – 24.5 °C). Experimental diets were readily accepted by YTK with no rejection of feed 2233 
observed. Overall survival for the duration of the experiment was 98.5%. Fish behaviour and 2234 
gross pathology (data not shown) were typical of healthy fish suggesting there were no negative 2235 
impacts of dietary treatments. The mean final weights of YTK were significantly different 2236 
between groups, with DIET0.8 weighing significantly less than DIET2.1 or DIET3.0 fish,  for 2237 
DIET0.8, DIET2.1 and DIET3.0 fish weighed 3.61 ± 0.07, 3.79 ± 0.01 and 3.77 ± 0.04 kg (total 2238 
n = 117) respectively (See table 3.2 extracted from Stone et al. (2019)). The FCR achieved by 2239 
YTK improved from 2.43 to 2.11 as dietary n-3 LC PUFA levels increased from 0.8 to 3.0 g 2240 
100g-1 (DIET0.8 to DIET3.0) when dietary FO increased, and PO decreased (See table 3.2 2241 
extracted from Stone et al. (2019)). 2242 
4.3.2. Total lipid and fatty acid profiles 2243 
Mean lipid content of feed was 26.7 ± 0.27 g 100 g-1 feed (Table 4.1). Mean total lipid 2244 
content of the faeces was 2.4 ± 0.19 g 100 g-1 and was not significantly different between 2245 
treatments (one-factor ANOVA; P = 0.122; Table 4.1). The apparent assimilation efficiency of 2246 
total lipid during digestion was 91.1 ± 0.19 %, 89.1 ± 1.81 % and 92.6 ± 1.81 % for DIET0.8, 2247 
DIET2.1 and DIET3.0 respectively and was not significantly different between treatments 2248 
(one-factor ANOVA; P = 0.121; Table 4.1). 2249 
4.3.3. Fatty acid composition of feed and faeces 2250 
Fatty acid composition of the diets was reflective of the dietary lipid sources as FO was 2251 
incrementally replaced with PO (from DIET3.0 to DIET0.8); total n-6 and n-9 fatty acids 2252 
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increased, total n-3 fatty acids decreased, and total saturated fatty acid remained relatively 2253 
constant (Table 4.1).  2254 
Abundant dietary fatty acids including oleic acid, EPA, DPA and DHA that varied 2255 
among treatments were absorbed with equal efficiency. Specifically, the percentage of fatty 2256 
acids removed from feeds were not significantly different between treatments (Table 4.1). 2257 
Saturated fatty acids were the most abundant group present in the faecal material, accounting 2258 
for 62% of total fatty acids (Table 4.1). When quantified as mg 100 g-1 faeces, saturated fatty 2259 
acid content differed among treatment groups, with myristic acid (14:0), pentadecanoic acid 2260 
(15:0), margaric acid (17:0), arachidic acid (20:0) and docosanoic acid (22:0) all significantly 2261 
less abundant in DIET0.8 faeces than that of DIET2.1 or DIET3.0 (Table 4.1). However, when 2262 
the apparent assimilation efficiency was calculated, there were no significant differences in 2263 
14:0, 17:0, 20:0 and 22:0 between treatment groups (Table 4.1). On the other hand, there was 2264 
a significant difference in the apparent assimilation efficiency of 15:0 with a higher percentage 2265 
of 15:0 being extracted from DIET3.0 than DIET2.1 or DIET0.8.  2266 
When considering the apparent assimilation efficiency (pooled dietary treatments) it 2267 
was noted that longer chain saturated fatty acids were not digested with the same apparent 2268 
efficiency as shorter chain fatty acids (Figure 4.1). Specifically, 89.1% of dietary 14:0 (myristic 2269 
acid) was digested from YTK feeds which reduced to 74.5% of dietary 22:0 (docosanoic acid), 2270 
as chain length increased.  2271 
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4.4. Discussion 2272 
This study aimed to quantify the digestibility of lipids and fatty acids by YTK fed 2273 
graded levels of dietary FO incrementally replaced by PO and investigate whether 2274 
compromised growth was linked to reduced digestibility of PO as a dietary lipid source. The 2275 
results indicate that the overall lipid component of the diets and all the essential n-3 LC PUFA 2276 
were digested with equal efficiency. Thus, fish from each diet group extracted the same 2277 
quantity of energy from their dietary lipids, regardless of that fact that dietary lipid composition 2278 
was different. These lipids were then deposited in to the flesh with equal efficiency (Chapter 2279 
3) but yet there was still a reduction in growth and FCR (Stone et al., 2019). This strongly 2280 
suggests that while YTK are capable of digesting and depositing dietary fatty acids from PO, 2281 
they were not capable of utilising them with the same efficiency as those from FO, indicating 2282 
that they require the specific fatty acids supplied by dietary FO for optimal growth.  2283 
Given that the reduced growth and FCR observed in FO replacement trials could not be 2284 
explained by inferior digestibility of dietary lipids and fatty acids from PO as an alternative 2285 
lipid source, further investigation is recommended to elucidate the mechanisms responsible. 2286 
While decreasing digestibility of alternative dietary lipids would have been a reasonable 2287 
explanation for inferior growth and FCR, it appears that the cause is likely further downstream 2288 
in the ability of the YTK to metabolise these lipids.  2289 
Lipid metabolism, as a process, is facilitated by specific enzymes in fish. The 2290 
abundance of these enzymes (and expression levels of the genes that code for them) could be 2291 
affected by changes in dietary lipid sources and this could therefore have an impact on the 2292 
metabolic value to fish. In relation to enzyme activity, a previous study by Bowyer et al., 2293 
(2012b) showed that lipase activity was not affected by the inclusion of PO in small YTK diets, 2294 
indicating that it was not necessary for YTK to upregulate their enzyme activity to adequately 2295 
metabolise PO in the place of FO. It would be expected that if increased enzyme production 2296 
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and thus an increase in the energy required to metabolise lipids was causing reduced growth 2297 
and FCR that an increase in lipase activity would have been observed in that study. Therefore, 2298 
it is unlikely that the cause of reduced growth and FCR in YTK was increased energy required 2299 
to metabolise dietary lipids and that the cause it a decreased capacity to utilise the nutritional 2300 
products from PO as efficiently as those from FO.  2301 
Changes to the expression of genes associated with lipid metabolism has previously 2302 
been observed in Atlantic Salmon and Rainbow Trout that were fed diets with manipulated 2303 
lipids compositions (Panserat et al., 2008; Martinez-Rubio et al., 2013). Specifically, Panserat 2304 
et al., (2008) reported a lower level of the expression of genes for energy metabolism in 2305 
Rainbow trout when dietary FO was replaced with alternative lipids. While Martinez et al., 2306 
(2013) showed that decreasing dietary lipid content lead to the upregulation of biosynthetic 2307 
pathways and altered the expression of key genes associated with lipid and fatty acids 2308 
metabolism in Atlantic Salmon. It is possible that decreased gene expression in YTK when 2309 
reared on dietary PO could be responsible for the decreased growth and FCR observed in FO 2310 
replacement studies with YTK. Indeed, a recent review by Jobling (2016) discusses the role of 2311 
fatty acids in regulating lipid metabolism and modulating gene expression, with individual fatty 2312 
acids having differing effects. Therefore, the increased quantity of dietary n-6 and n-9 fatty 2313 
acids and decrease quantity of dietary n-3 LC PUFA could lead to differences in the efficiency 2314 
of fatty acid metabolism/ beta oxidation to make energy. 2315 
An interesting result observed during the current study was the pattern of varied 2316 
digestibility of saturated fatty acids by YTK. Specifically, YTK were observed to digest shorter 2317 
chain saturated fatty acids (<16:0) with greater efficiency than longer chain saturated fatty acids 2318 
(>17:0). Digestibility of nutrients was previously estimated for YTK by Miegel et al. (2010), 2319 
however that study only reported total crude lipid of digesta and faecal material without 2320 
reporting on the fatty acid profile. Greater efficiency in the digestion of shorter chain saturated 2321 
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fatty acids, compared to longer chain (>17 carbon) saturated fatty acids, has been well 2322 
documented in a range of other species including; rats (Carroll, 1958), humans (Ramırez et al., 2323 
2001) and a number of aquacultured fish (Cravedi et al., 1987, Sigurgisladottir et al., 1992, 2324 
Olsen et al., 1998, Johnsen et al., 2000, Menoyo et al., 2003, Francis et al., 2007). Fatty acids 2325 
each have their own chemical and physical properties which impact their interaction with the 2326 
gastrointestinal system. Fatty acid digestion and absorption in fish is known to be affected by 2327 
the chain length, its degree of unsaturation and its melting point of the lipid (Turchini et al., 2328 
2009). Importantly, there is increased digestibility of short and medium chain saturated fatty 2329 
acids as they are hydrophilic and as such can be absorbed with greater ease than longer chain 2330 
saturated fatty acids. These data demonstrate how considerations of the fatty acid content of 2331 
dietary lipids can be utilized to manipulate fatty acid digestion by cultured YTK and thus 2332 
improve the utilization of diets, potentially improve FCR and reduce the cost of YTK 2333 
production. Specifically, for YTK, given their ability to absorb 14 – 16 carbon length saturated 2334 
fatty acids with the greatest efficiency, dietary lipids that have a greater proportion of these 2335 
fatty acids and less 20 and 22 carbon length saturated fatty acids are recommended for 2336 
investigation for use in YTK feeds. Moreover, saturated fatty acids are readily utilized for 2337 
energy in YTK (Bowyer et al., 2012b) and as such replacing FO with alternative oils high in 2338 
short chain saturated fatty acids, should provide a digestible lipid that is an efficient source of 2339 
energy for YTK.   2340 
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4.5. Conclusions 2341 
Differences in the digestibility of dietary lipids and fatty acids did not explain the 2342 
differences in growth and FCR observed in FO replacement trials in large sub-adult YTK. 2343 
While decreasing digestibility of alternative dietary lipids would have been a reasonable 2344 
explanation for inferior growth and FCR, it appears that the cause is likely further downstream 2345 
in the ability of the YTK to metabolise these dietary lipids. 2346 
The finding of decreased digestibility of saturated fatty acids with increasing chain 2347 
length in YTK does not address the initial aim of this study, however, it does provide interesting 2348 
new knowledge for this species. This knowledge could assist YTK feed producers in selecting 2349 
advantageous alternative oils to replace dietary FO while mitigating negative impacts for 2350 
productivity and product quality for YTK.   2351 
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4.8. Tables and figures 2460 
Table 4.1: Total dietary lipid content (%) and fatty acid composition (mg 100 g-1) feed and faeces and percentage of lipid and fatty acids absorbed 2461 
from feed (%) of three experimental diets (Data presented as mean  SE; n = 3). 2462 
 Feed composition Faecal composition Percentage of lipid and fatty acid removed from feed 
  DIET0.8% DIET2.1% DIET3.0% DIET0.8% DIET2.1% DIET3.0% P = DIET0.8% DIET2.1% DIET3.0% P = 
Lipid content (%) 26.2 26.9 27.1 2.3 ± 0.1 2.9 ± 0.5 2.0 ± 0.1 0.122 91.1 ± 0.5 89.1 ± 1.8 89.1 ± 0.4 0.121 
Analysed fatty acids (mg 100 g-1)        
 
   
t18:1n-9 (Palmitelaidic acid) 83 73 72 2.8 ± 0.1 2.9 ± 0.1 3.0 ± 0.2 0.443 92.2 ± 0.6 88.2 ± 2.0 91.6 ±0.6 0.090 
t18:1n-7 (Elaidic acid) 140 119 108 7.8 ± 0.3 7.2 ± 0.5 7.4 ± 0.2 0.510 87.1 ± 0.8 83.2 ± 1.5 86.4 ± 0.7 0.051 
14:0 (Myristic acid) 420 730 900 20.4 ± 0.7a 31.0 ± 1.2b 41.7 ± 0.4c < 0.001 88.7 ± 0.7 88.0 ± 1.4 90.7 ± 0.4 0.141 
15:0 (Pentadecanoic acid) 53 77 89 4.1 ± 0.1a 4.8 ± 0.3a 6.0 ± 0.1b < 0.001 81.8 ± 1.2a 82.8 ± 1.4a 86.4 ± 0.7b 0.028 
16:0 (Palmitic acid) 5930 5760 5550 421 ± 16.8 374.2 ± 29.4 411.8 ± 6.8 0.245 83.5 ± 1.0 82.2 ± 1.2 85.1 ± 0.8 0.177 
17:0 (Margaric acid) 89 100 110 8.0 ± 0.4a 9.0 ± 0.7a 10.9 ± 0.2b 0.002 79.2 ± 1.3 75.5 ± 1.7 80.0 ± 1.3 0.096 
18:0 (Stearic acid) 1870 1770 1670 167.7 ± 6.4 151.3 ± 15.2 174.4 ± 3.1 0.256 79.2 ± 1.4 77.0 ± 1.1 79.0 ± 1.2 0.407 
20:0 (Arachidic acid) 36 51 53 4.0 ± 0.2a 4.6 ± 0.5a 6.2 ± 0.2b < 0.001 74.4 ± 1.6 75.6 ± 1.1 76.3 ± 1.3 0.600 
22:0 (Docosanoic acid) 25 30 31 2.5 ± 0.1a 3.0 ± 0.3a 4.1 ± 0.1b 0.001 76.6 ± 1.9 73.1 ± 1.1 73.6 ± 1.6 0.251 
24:0 (Tetracosanoic acid) 13 16 18 1.2 ± 0.1a 1.3 ± 0.1ab 1.7 ± 0.1b 0.021 78.2 ± 3.3 77.2 ± 1.4 80.4 ± 1.8 0.604 
18:3n-3 (Alpha Linolenic acid- ALA) 550 490 430 7.2 ± 0.7 8.7 ± 1.5 6.2 ± 0.2 0.213 96.9 ± 0.4 94.1 ± 2.1 97.1 ± 0.2 0.184 
20:5n-3 (Eicosapentanaeoic acid- EPA) 270 930 1350 3.4 ± 0.3a 13.3 ± 2.9b 11.9 ± 0.9b 0.002 97.0 ± 0.4 95.1 ± 2.0 98.2 ± 0.2 0.192 
22:5n-3 (Docosapentaenoic acid- DPA) 63 130 160 1.9 ± 0.3a 3.2 ± 0.4b 3.1 ± 0.2b 0.010 92.9 ± 1.4 92.2 ± 2.3 96.1 ± 0.3 0.212 
22:6n-3 (Docosahexaenoic acid- DHA) 420 1080 1440 13.1 ± 1.9a 26.2 ± 2.9b 27.6 ± 1.6b < 0.001 92.6 ± 1.3 92.3 ± 2.2 96.2 ± 0.3 0.160 
18:2n-6 (Linoleic acid- LOA) 3150 2650 2300 52.0 ± 4.5 57.8 ± 7.6 42.7 ± 1.9 0.154 96.1 ± 0.5 92.9 ± 2.2 96.3 ± 0.2 0.162 
18:3n-6 (Gamma Linolenic acid) 31 41 43 2.4 ± 0.3 2.5 ± 0.2 3.4 ± 0.3 0.062 82.1 ± 2.3 83.4 ± 1.6 84.6 ± 1.2 0.619 
20:2n-6 (Eicosadienoic acid) 28 32 36 0.8 ± 0.1 1.0 ± 0.1 0.9 ± 0.0 0.173 93.2 ± 0.6 90.9 ± 2.2 94.8 ± 0.2 0.137 
20:3n-6 (Dihomo-gamma-linoleic acid) 24 35 33 2.2 ± 0.2 2.0 ± 0.2 2.6 ± 0.1 0.111 78.8 ± 3.0 83.8 ± 2.0 84.3 ± 0.6 0.157 
20:4n-6 (Arachidonic acid) 110 50 170 2.6 ± 0.4 3.6 ± 0.3 3.0 ± 0.2 0.086 94.4 ± 0.9a 77.3 ± 6.2b 96.4 ± 0.3a 0.004 
22:4n-6 (Docosatetraenoic acid) 16 20 23 0.8 ± 0.1 0.7 ± 0.0 0.7 ± 0.1 0.956 88.7 ± 2.5 89.3 ± 2.0 93.4 ± 0.7 0.191 
16:1n-7 (Palmitoleic acid) 1450 1560 1610 22.5 ± 1.5 30.8 ± 4.6 25.6 ± 0.7 0.148 96.4 ± 0.4 93.6 ± 2.1 96.8 ± 0.2 0.167 
18:1n-7 (Octadecenoic acid) 640 660 670 16.1 ± 0.8 19.9 ± 1.7 18.4 ± 0.4 0.089 94.1 ± 0.5 90.6 ± 2.5 94.5 ± 0.3 0.146 
18:1n-9 (Oleic acid) 11050 9290 8020 227.4 ± 15.3 230.0 ± 26.7 173.8 ± 4.6 0.074 95.2 ± 0.5 92.1 ± 2.3 95.7 ± 0.2 0.172 
20:1n-9 (Eicosenoic acid) 130 150 160 3.9 ± 0.2a 5.2 ± 0.4b 5.3 ± 0.2b 0.004 93.0 ± 0.5 89.3 ± 2.6 93.4 ± 0.3 0.166 
22:1n-9 (Docosenoic acid) 11 20 26 0.7 ± 0.1a 0.8 ± 0.0ab 1.1 ± 0.1b 0.029 83.4 ± 3.0a 88.5 ± 1.5a 91.8 ± 0.4b 0.025 
24:1n-9 (Tetracosenoic acid) 20 41 48 1.3 ± 0.1a 2.1 ± 0.1b 2.9 ± 0.1c < 0.001 85.0 ± 0.6 85.7 ± 1.6 87.8 ± 0.6 0.198 
Total trans 223 192 180 10.6 ± 0.4 10.1 ± 0.5 10.4 ± 0.3 0.729 89.0 ± 0.7 85.1 ± 1.7 88.4 ± 0.6 0.050 
Total saturated  8436 8534 8421 629.0 ± 24.2  579.3 ± 47.7 656.9 ± 9.7 0.241 82.7 ± 1.1 81.5 ± 1.2 84.3 ± 0.8 0.192 
Total Omega 3 1303 2630 3380 25.6 ± 2.9a 51.4 ± 7.5b 48.8 ± 2.7b 0.004 95.4 ± 0.7 93.6 ± 2.1 97.1 ± 0.2 0.190 
Total Omega 6 3359 2829 2605 60.7 ± 5.1 67.6 ± 7.8 53.4 ± 2.2 0.224 95.7 ± 0.5 92.4 ± 2.3 95.9 ± 0.2 0.144 
Total Omega 7 2090 2220 2280 38.6 ± 2.4 50.7 ± 6.3 44.0 ± 1.1 0.130 95.7 ± 0.4 92.7 ± 2.2 96.1 ± 0.2 0.160 
Total Omega 9 11211 9501 8254 233.4 ±15.4  238.1 ± 27.0 183.2 ± 4.8 0.092 95.1 ± 0.5 92.0 ± 2.3 95.6 ± 0.2 0.172 




Figure 4.1: Percentage of saturated fatty acids absorbed from feed by Yellowtail Kingfish 2465 
(Seriola lalandi) (Data presented as mean ± SE; n = 3, subscripts denote significant differences, 2466 
one-way ANOVA; P < 0.001) 2467 








































4.9. Statement to link Chapter 3 and Chapter 5 2469 
In Chapter 3 and in conjunction with the Stone et al. (2019) study, it became apparent 2470 
that YTK could be reared on diets deficient in n-3 LC PUFA without a detrimental impact on 2471 
survival. Growth, feed conversion efficiency and flesh fatty acid composition were affected by 2472 
dietary n-3 LC PUFA concentration, but these losses could potentially be counteracted if the 2473 
financial cost of lost growth and feed conversion efficiency was outweighed by the cost savings 2474 
in aquafeed production due to reduced inclusion of expensive fish oil. If this approach was 2475 
financially viable it would be necessary to understand the rate at which the flesh fatty acid 2476 
profile could be restored prior to harvesting YTK. With this in mind, the rate at which YTK 2477 
could accumulate n-3 LC PUFA in the flesh following a change in diet was investigated. As an 2478 
additional investigation, the rate at which n-3 LC PUFA was diluted in YTK flesh following a 2479 
reduction in diet FO was assessed as a means of further understanding the time course for 2480 
changes in flesh n-3 LC PUFA.  2481 
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Abstract  2512 
Finishing diets have been extensively researched and utilised in the aquaculture 2513 
industry to improve the nutritional quality of commercially farmed fish for human consumers. 2514 
Marked changes to omega 3 long-chain polyunsaturated fatty acid (n-3 LC PUFA; including 2515 
eicosapentaenoic acid- EPA; docosapentaenoic acid - DPA and docosahexaenoic acid- DHA) 2516 
concentrations in the edible portion of the Yellowtail Kingfish (Seriola lalandi) (YTK) were 2517 
observed as a result of changes to dietary fish oil (FO) intake were investigated at warm water 2518 
temperatures (>20 C). The aim of the study was to better understand how quickly such changes 2519 
could happen and to make recommendations to industry about the length of time required to 2520 
obtain significant increases in white muscle n-3 LC PUFA by feeding a high n-3 LC PUFA 2521 
diet. In parallel, the rate at which n-3 LC PUFA diminished in YTK white muscle was also 2522 
investigated, with the aim of understand the rate at which the feeding diets deficient in n-3 LC 2523 
PUFA can negatively impact white muscle fatty acid profiles. Four diets were formulated: two 2524 
preconditioning diets which were either moderate or high in dietary FO (at 1.42 and 3.34 g n-2525 
3 LC PUFA 100 g-1 feed, respectively) and 2 finishing diets that were high and low in dietary 2526 
FO (at 2.85 and 0.71 g n-3 LC PUFA100 g-1 feed, respectively). These diets were fed in 2527 
succession to investigate the effects of the finishing diets relative to their starting points, 2528 
forming two treatment groups (MOD/HIGH and HIGH/LOW) to address the two aims. 2529 
Preconditioning diets were fed for 84 days, after which the fatty acid profile of the white muscle 2530 
of the two treatment groups was measured before finishing diets were fed for an additional 33 2531 
days, with the fatty acid profile measured again after 19 and 33 days of feeding of finishing 2532 
diets. With 33 days of feed of finishing diets, white muscle n-3 LC PUFA increased by 48 mg 2533 
100 g-1 (17% increase) and decreased by 51 mg 100 g-1 (14% decrease) with HIGH and LOW 2534 
finishing diets, respectively. Apparent feed conversion ratio (FCR) was impacted by dietary 2535 
treatment, with a superior FCR of 1.71 achieved by the MOD/HIGH group compared to 1.85 2536 
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by the HIGH/LOW group. A minimum 33 day finishing period was recommended for 2537 
commercial YTK producers to ensure a significant increase in white muscle n-3 LC PUFA 2538 
content. It was also recommended that the dietary n-3 LC PUFA content of YTK feeds should 2539 
be closely monitored with strict lower limits set with feed producers to ensure no diminishment 2540 
to product quality of feed conversion efficiency in commercially farmed YTK.   2541 
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 2545 
Highlights 2546 
1. The n-3 LC PUFA concentration of YTK white muscle was increased by 48 mg 100 2547 
g-1 (17% increase) by increasing the dietary concentration of n-3 LC PUFA by 1.42 g 2548 
100 g-1 feed in a finishing period of 33 days.  2549 
2. Conversely, the n-3 LC PUFA concentration of YTK white muscle was decreased by 2550 
51 mg 100 g-1 (14% decrease) by decreasing the dietary concentration of n-3 LC 2551 
PUFA by 2.63 g 100 g-1 feed in a period of 33 days. 2552 
3. The rate at which individual n-3 LC PUFA assimilate in YTK was not equal, EPA 2553 
was observed to be more readily altered in the white muscle than DHA. 2554 
4. Apparent FCR was influenced by a change in dietary n-3 LC PUFA concentration 2555 
over the 33-day finishing period, specifically a superior FCR of 1.71 was achieved by 2556 
the MOD/HIGH group compared to 1.85 by the HIGH/LOW group. 2557 
2558 
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5.1. Introduction 2559 
Finishing or washout diets have been extensively researched and utilised in the 2560 
aquaculture industry in the past 20 years (Bell and Sargent, 2003, Bell et al., 2003, Ng et al., 2561 
2004, Mourente and Bell, 2006, Naylor et al., 2009, Turchini et al., 2009, Tocher, 2015). The 2562 
basic premise of the finishing diet is that fish can be reared through the grow-out period on one 2563 
diet (either a less expensive or more sustainable formulation) and then given a second diet (e.g. 2564 
with flesh pigmenting additives or high in dietary lipid) prior to harvest. In some instances, the 2565 
grow-out diet is high in less expensive terrestrial plant or animal-based ingredients and the 2566 
finishing diet replaces those with fish meal and fish oil (FO). This change in composition 2567 
results in increased flesh content of omega 3 (n-3) long chain polyunsaturated fatty acids (LC 2568 
PUFA) including eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and 2569 
docosahexaenoic acid (DHA) (Naylor et al., 2009). The target for n-3 LC PUFA concentration 2570 
at harvest varies, but has been benchmarked to many different levels including: a comparable 2571 
level to wild fish, fish which have been reared on high FO diets throughout grow-out, parity 2572 
with what is achieved by other aquaculture species or to meet recommended dietary intake 2573 
levels for the human consumer (Einen et al., 1999). Regardless of the reason, the finishing diet 2574 
strategy has the potential to provide benefits for the producer in terms of reduced cost of 2575 
production.  2576 
Reducing consumption of FO is global priority for the aquaculture industry. A review 2577 
of feed demands for aquaculture by Tocher (2015) estimated that global aquaculture production 2578 
of marine fish would increase to 3.675 million tonnes per year by 2020 and this would be 2579 
responsible for consuming 4.998 million tonnes of feed per year. If the aquaculture industry is 2580 
going to continue to grow and supply the expanding human population with nutritious seafood 2581 
the careful management of finite FO supplies is imperative (Naylor et al., 2009). The optimal 2582 
inclusion of n-3 LC PUFA (determined by maximal growth rate and lowest food conversion 2583 
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ratio, FCR) for Yellowtail Kingfish (Seriola lalandi) (YTK) during grow-out is approximately 2584 
2.1 – 2.6 g n-3 LC PUFA 100 g-1 feed (Stone et al., 2019). At an average FCR of 1.6 this 2585 
equates to a consumption of 102.4 – 124.8 g of FO to produce every kilogram of YTK (based 2586 
on FO with 33% n-3 LC PUFA). Any decrease that can been made in dietary n-3 LC PUFA 2587 
inclusion for YTK from FO without compromising consumer nutrition will be beneficial for 2588 
the environment and specifically the diminishing supply of FO. 2589 
In the human diet, n-3 LC PUFA are nutritionally important, having anti-inflammatory 2590 
and cardio-protective effects as well as being highly important in infant development (Wood 2591 
et al., 2015). The international society for the study of fatty acids and lipids (ISSFAL) 2592 
recommends a daily intake of 500 mg of n-3 LC PUFA per day (ISSFAL, 2004). In YTK 2593 
dietary n-3 LC PUFA content is reflected in the flesh, and the recently determined optimal 2594 
dietary content of 2.1 g n-3 LC PUFA 100 g-1 feed (Stone et al, 2019) results in 725  16 mg 2595 
of n-3 LC PUFA 100 g-1 white muscle (Chapter 3). The daily recommended intake of n-3 LC 2596 
PUFA is achievable with a 69 g portion of white muscle, however any further increases to YTK 2597 
flesh n-3 LC PUFA could still benefit the human consumer, as a smaller portion or less frequent 2598 
consumption of fish would be required. Another possibility is for YTK to be reared on diets 2599 
with less than 2.1 g n-3 LC PUFA 100 g-1 feed, and then finished on diets with greater than 2.1 2600 
g n-3 LC PUFA 100 g-1 feed to restore the fatty acid profile of the flesh. This strategy would, 2601 
however, impact growth and FCR and detailed cost benefit analysis would be required before 2602 
implementing such strategies.  2603 
Since finishing diets have potential benefits for YTK producers, consumers and the 2604 
environment the aim of the current study was to investigate how quickly n-3 LC PUFA could 2605 
change in the muscle tissue of large YTK following either an increase or decrease in dietary 2606 
FO level.   2607 
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5.2. Methods and Materials  2608 
5.2.1. Experimental location and animals  2609 
Animal ethics approval for this work was granted by the University of Adelaide animal 2610 
ethics committee (Approval number: S-2017-103). The experiment was conducted at the South 2611 
Australian Research and Development Institute (SARDI) South Australian Aquatic Science 2612 
Centre (SAASC) (West Beach, South Australia, Australia). Yellowtail Kingfish were supplied 2613 
by Clean Seas Seafood Ltd. (Port Lincoln, South Australia, Australia). Prior to the experiment, 2614 
fish were housed in 18 × 5000 L tanks supplied with partial flow-through/recirculating (100% 2615 
system water exchange d-1), sand filtered, UV treated, aerated sea water at ambient temperature 2616 
and held for ~3.5 months. During this period fish were fed a 9 mm commercial diet (Ridley 2617 
Pelagica diet; crude protein 44%; crude lipid 24%; gross energy 19.30 MJ kg-1; Narangba, 2618 
Queensland, Australia) to apparent satiation once daily.  2619 
5.2.2. Experimental diets 2620 
The diet kernels, fish oil and poultry oil used in the experimental feed were supplied by 2621 
Ridley (Narangba, Queensland, Australia). The formulations were based on Ridley’s 2622 
Yellowtail Kingfish diet (30% fish meal; 44% crude protein, 25% crude lipid and a gross 2623 
energy level of approximately 21 MJ kg-1). Experimental diets were produced with a diet kernel 2624 
which contained a base level of 8% crude lipid, the kernels were top coated with an additional 2625 
14 - 17% lipid (graded blends of fish oil and poultry oil to give varying levels of n-3 LC-PUFA, 2626 
reaching a target 22 - 25% dietary lipid inclusion level).  2627 
5.2.3. Experimental design 2628 
The experimental fish used in this study were fed with a diet that was either moderate 2629 
(MOD) or high (HIGH) in n-3 LC PUFA for 84 days (the preconditioning phase), they were 2630 
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then switched to a different diet for a further 33 days, giving us two treatment groups, a 2631 
MOD/HIGH group and a HIGH/LOW group. The MOD/HIGH group’s diet changed from 1.4 2632 
to 2.85 g n-3 LC PUFA 100 g-1 feed and the HIGH/LOW group’s diet switched from 3.3 to 0.7 2633 
g n-3 LC PUFA 100 g-1 feed. (Table 5.1).  2634 
5.2.4. Animal housing and care 2635 
At the conclusion of the 84-day preconditioning period, fish were anaesthetised in 5000 2636 
L tanks (total water volume 2500 L) using AQUI-S® (AQUI-S® New Zealand Ltd., Lower 2637 
Hutt, New Zealand) at a concentration of 14 mg L−1 of seawater. Fish were weighed, measured 2638 
(fork length) and returned to their 9 × 5000 L recirculating aquaculture tanks (13 fish per tank) 2639 
and switched to their secondary experimental diets (3 replicate tanks diet-1). Fish were fed their 2640 
experimental diet once daily to apparent satiation and intake was recorded as grams consumed 2641 
per tank per day. Water quality parameters were measured daily and maintained within the 2642 
accepted optimal levels for YTK (Bowyer et al., 2014). Water temperature (ºC) was measured 2643 
with a thermometer. Dissolved oxygen (mg/ L and percentage saturation) was measured using 2644 
a dissolved oxygen meter (OxyGuard International A/S, Birkerød, Denmark). The pH was 2645 
measured using a multi-parameter meter (Oakton pHtestr 20; Oakton Instruments, Vernon 2646 
Hills, IL, USA). Ammonia (ppm) was measured using an Aquarium Pharmaceuticals ammonia 2647 
test kit (Mars Fishcare, North America). Salinity (g L-1) was measured weekly using a portable 2648 
salinity refractometer (model RF20, Extech Instruments, Nashua, NH, USA). 2649 
5.2.5. Sample collection 2650 
Tissue samples were collected from 3 fish per tank at 0, 19 and 33 days after being 2651 
anesthetised as previously described. At each sample time all fish were anaesthetised, measured 2652 
and weighed. Three randomly selected fish from each tank were humanely euthanised by 2653 
percussive stunning, and a section of white muscle was collected from the dorsal fillet adjacent 2654 
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to the dorsal fin. Remaining fish were returned to their respective tanks. Muscle samples were 2655 
immediately frozen by immersion in dry ice and thereafter stored at -20 ºC prior to analysis. 2656 
5.2.6. Growth and feed efficacy  2657 
Growth and feed efficacy indices were calculated using the following equations: 2658 
• Weight gain (g fish-1) = (total tank final biomass – total tank initial biomass) / number 2659 
of fishes 2660 
• Condition factor = (fish weight (g) / fish fork length (cm)3) × 100 2661 
• Specific growth rate (SGR, % day-1) = ((ln final tank average fish weight − ln initial 2662 
tank average fish weight) / days) × 100 2663 
• Apparent feed conversion ratio (Apparent FCR) = weight of total tank feed consumed 2664 
(dry weight)/ total tank fish weight gain (wet weight) 2665 
5.2.7. Total lipid analysis 2666 
Tissue total crude lipid (as a percentage of wet weight) was estimated utilizing the 2667 
gravimetric approach (Folch et al., 1957). Briefly, weighed muscle samples were homogenised 2668 
in 0.9% saline, thereafter muscle lipids were extraction in to a 4:1 chloroform: isopropanol 2669 
solution and the chloroform: isopropanol component was then evaporated in a pre-weighed vial 2670 
using nitrogen gas leaving only the lipid component behind.  2671 
5.2.8. Fatty acid analysis 2672 
Fatty acid profiling was conducted for all samples. The lipid component (extracted 2673 
during total lipid analysis) was transmethylated with 1% H2SO4 in MeOH at 70 °C for 3 hours, 2674 
then cooled to room temperature, after which fatty acid methyl esters (FAMES) were extracted 2675 
in to 2 mL of heptane. The heptane was transferred to a gas chromatography (GC) vial with 30 2676 
mg of anhydrous sodium sulphate, sealed and stored at -20 °C until analysis by GC. Samples 2677 
were processed on a Hewlett-Packard 6890 GC (Hewlett-Packard, CA, USA) with a flame 2678 
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ionization detector, a split injector and a BPX-70 capillary column (internal diameter of 50 m 2679 
× 0.32 mm) with a 0.25 µm film thickness (SGE, Victoria, Australia). Gas chromatography 2680 
operating conditions were as described previously (Tu et al., 2010) and peaks were identified 2681 
with GLC 463 external standard (Nu-Chek Prep Inc., MN, USA). Data output was processed 2682 
with Agilent ChemStation (version Rev: B.01.03) (Agilent Technologies, CA, USA). 2683 
5.2.9. Statistics 2684 
Statistical analysis was performed using IBM SPSS (version 24). Homogeneity of 2685 
variance was assessed using Levene’s test, whilst normality was assessed with the 2686 
Kolmogorov-Smirnov test. Where data met prior requirements, differences were analysed 2687 
using a one-way ANOVA (across time) or t-tests (between treatments). Two lines of inquiry 2688 
were followed: firstly, data were separated by treatment group and differences were assessed 2689 
for significance across time, and secondly, data were separated by sampling episode and 2690 
differences between treatments at each time point were assessed for significance. Where 2691 
significant differences were detected, post-hoc comparisons were made via Tukey’s tests. An 2692 
alpha level of 0.05 was used for all statistical tests. Results are presented as means ± standard 2693 
error (SE).   2694 
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5.3. Results 2695 
5.3.1. General observations 2696 
The mean water temperature during the experimental period was 20.8 ± 0.2 °C (mean 2697 
± SE, range: 19.0 – 23.0 °C). Experimental diets were readily accepted by YTK with no 2698 
rejection of feed observed. Overall survival for the duration of the experiment was 100%. Fish 2699 
behaviour and gross pathology (data not shown) were typical of healthy fish suggesting there 2700 
were no negative impacts of dietary treatments over the 33-day study.  2701 
5.3.2. Growth and feed efficacy 2702 
Weight and length increased significantly over time for both treatments (one-factor 2703 
ANOVA; P < 0.001 for all; Table 5.2), while condition factor did not differ significantly for 2704 
either treatment (one-factor ANOVA; MOD/HIGH P = 0.927 and HIGH/LOW P = 0.437; 2705 
Table 5.2). Total weight gain was not significantly different between treatment groups; but 2706 
trends showed the MOD/HIGH treatment group gaining quantitatively more weight (one-factor 2707 
ANOVA; P = 0.244; Table 5.3). During the 33-day experimental period the MOD/HIGH 2708 
treatment group gained 615.8 ± 27.7 g and increased their initial body weight by 29.9%, while 2709 
the HIGH/LOW treatment group only gained 490.0 ± 71.9 g and increased their initial body 2710 
weight by 22.2% (Table 5.3). Specific growth rate was not significantly different between 2711 
treatment groups. Average SGR was 0.76 and 0.65 % day-1 for the MOD/HIGH and 2712 
HIGH/LOW treatment groups respectively (Table 5.3). Apparent FCR was significantly 2713 
different between treatment groups, average FCRs were 1.71 and 1.85 for the MOD/HIGH and 2714 
HIGH/LOW treatment groups respectively (one-factor ANOVA; P = 0.029; Table 5.3). While 2715 
FCR for the HIGH/LOW treatment group was relatively consistent between the separate time 2716 
periods (1.89 during days 0 – 19 and 1.93 during days 20 – 33), the same could not be said for 2717 
the MOD/HIGH treatment group. The FCR for the MOD/HIGH was 2.27 during days 0-19, 2718 
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then reduced to 1.21 during the subsequent time period, this trend was driven by less weight 2719 
gain in the first period.  2720 
5.3.3. Total lipid content white muscle 2721 
Total lipid content of the white muscle did not differ significantly across time for either 2722 
treatment (one-factor ANOVA; MOD/HIGH: P = 0.370 and HIGH/LOW: P = 0.746; Table 2723 
5.4 and Table 5.5 respectively). However, the HIGH/LOW treatment group did show a trend 2724 
for decreased total lipid content over time.  2725 
5.3.4. Fatty acid profile of the white muscle 2726 
5.3.4.1. MOD/HIGH treatment group 2727 
In the MOD/HIGH treatment group there was a significant increase in total omega 3 2728 
fatty acids (one-factor ANOVA; P = 0.020; Table 5.4), a significant decrease in total omega 6 2729 
fatty acids (one-factor ANOVA; P < 0.001; Table 5.4) and no significant change in total omega 2730 
9 fatty acids (one-factor ANOVA; P = 0.747; Table 5.4) over time.  2731 
Total n-3 LC PUFA remained consistent for the first 19 days, then by day 33 there was 2732 
an increase of 45 mg 100 g-1 white muscle (one-factor ANOVA; P = 0.012; Figure 5.1). When 2733 
considering the individual fatty acids, EPA increased significantly after 19 days (one-factor 2734 
ANOVA; P = 0.009; Table 5.4), however, DPA and DHA did not significantly increase until 2735 
day 33 (one-factor ANOVA; P = 0.006 and P = 0.017 respectively; Table 5.4).  2736 
5.3.4.2. HIGH/LOW treatment group 2737 
For the HIGH/LOW treatment group there was a significant decrease in total omega 3 2738 
fatty acids (one-factor ANOVA; P = 0.013; Table 5.5) and significant increases in total omega 2739 
6 fatty acids and total omega 9 fatty acids (one-factor ANOVA; P = 0.001 and P = 0.007 2740 
respectively; Table 5.5) over time.   2741 
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Total n-3 LC PUFA decreased by 51 mg 100 g-1 in white muscle during the 33 days 2742 
(one-factor ANOVA; P = 0.023; Figure 5.2). When considering the individual fatty acids, EPA 2743 
steadily significantly decreased over time (one-factor ANOVA; P < 0.001; Table 5.5) and DPA 2744 
decreased from 0 to 19 days (one-factor ANOVA; P < 0.001; Table 5.5), while DHA did not 2745 
differ significantly over time (one-factor ANOVA; P = 0.201; Table 5.5).   2746 
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5.4. Discussion 2747 
The data presented here demonstrate that substantial increases or decreases in dietary 2748 
n-3 LC PUFA can have significant impacts on feed conversion and the fatty acid profile of 2749 
white muscle in large YTK in a relatively short (33-day) period of time. In 33 days, white 2750 
muscle n-3 LC PUFA increased 48 mg 100 g-1 muscle (17% increase) and decreased 51 mg 2751 
100 g-1 muscle (14% decrease) with switches to HIGH and LOW experimental diets, 2752 
respectively. Apparent FCR was also impacted by dietary treatment, with a superior FCR of 2753 
1.71 achieved by the MOD/HIGH group compared to 1.85 by the HIGH/LOW group. These 2754 
results have implications for human consumers and commercial fish producers, with changes 2755 
to dietary n-3 LC PUFA having repercussions for product quality (varied nutrient content for 2756 
consumers), the sustainability and efficiency of production for commercial producers.  2757 
Finishing diets, high in n-3 LC PUFA have been trialled for a range of other 2758 
commercially farmed fish, most notably with Atlantic Salmon (Salmo salar). In Atlantic 2759 
salmon finishing diets have been trialled for various durations from 12 weeks up to 24 weeks 2760 
(Bell et al., 2003, Bell et al., 2004, Ng et al., 2004). Bell et al. (2004) fed a 100% fish oil 2761 
finishing diet for 24 weeks to fish which had previously been fed a 100% linseed oil diet and 2762 
was able to restore muscle n-3 LC PUFA concentrations to 80% of those that were present in 2763 
fish fed a 100% FO diet throughout the whole growth period. A relative increase in muscle n-2764 
3 LC PUFA concentration of 453 mg 100 g-1 muscle was achieved in 24 weeks. Data presented 2765 
by Bell et al. (2003) showed similar results, with preconditioning linseed and rapeseed oil trials 2766 
followed by a 100% FO diet over a 20-week finishing period. The magnitude of the increase 2767 
of muscle n-3 LC PUFA achieved in those salmon was substantially greater than in YTK. This 2768 
can be attributed to a combination of factors. Firstly, initial linseed and rapeseed oil diets were 2769 
lower in n-3 LC PUFA thus the salmon muscle n-3 LC PUFA concentration began at a lower 2770 
starting point than YTK. Secondly, the high fat content in the muscle of salmon compared to 2771 
 140 
YTK (9.6% in salmon compared to 1.9% in YTK) would allow the finishing strategy to be 2772 
more efficient in salmon, as with a higher fat content there is a greater potential for quantitative 2773 
increases in n-3 LC PUFA. Lastly, the duration of the finishing period was 4 times longer in 2774 
salmon compared to YTK. Currently minimal data exists for the accumulation of n-3 LC PUFA 2775 
in YTK muscle as finishing diets have not been widely researched for this species. The current 2776 
and previous studies for other commercially farmed fish demonstrate that finishing diets can 2777 
be an efficient means of improving the fatty acid profile of aquacultured fish. However, by 2778 
comparing the quantitative increases in flesh n-3 LC PUFA between YTK and Atlantic salmon, 2779 
it was evident that the duration of the finishing period, the composition of preconditioning and 2780 
finishing diets, and biological differences between species influence the effectiveness of the 2781 
finishing diet.  2782 
Similarly, a number of studies have investigated the impact of feeding low n-3 LC 2783 
PUFA diets on flesh fatty acid composition, growth and feed conversion efficiency. Diets low 2784 
in n-3 LC PUFA have been trialled for Japanese Yellowtail (Seriola quinqueradiata), a species 2785 
that is closely related to YTK (Seno-o et al., 2008). While the primary aim of that study was to 2786 
investigate the effect of replacing dietary FO with olive oil on the product quality and shelf 2787 
stability of filleted products, it does provide a comparison group for the HIGH/LOW treatment 2788 
group in the current study. After 40 days a decreased dietary n-3 LC PUFA level of 1.94 g n-3 2789 
LC PUFA 100 g-1 feed had no effect on growth or the proximate composition of Japanese 2790 
Yellowtail. Similar to the current study, white muscle fatty acid composition was reflective of 2791 
dietary fatty acid composition (low in n-3 LC PUFA and high in omega 9 fatty acids from olive 2792 
oil) and feed conversion efficiency decreased with decreasing dietary n-3 LC PUFA. 2793 
Specifically, a decrease in dietary n-3 LC PUFA of 1.94 g n-3 PUFA 100 g-1 feed (from 3.33 2794 
g to 1.39 g) resulted in a decrease of 53 mg n-3 LC PUFA 100 g-1 in white muscle. This was 2795 
comparable the current study where a decrease of 51 mg n-3 PUFA 100 g-1 in white muscle 2796 
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was observed after 33 days. These two closely related species have similarities in dietary fatty 2797 
acid requirements (Deshimaru et al., 1982, Stone et al., 2019) and fatty acid utilisation patterns 2798 
(Masumoto, 2002, Hilton et al., 2008, Booth et al., 2010, Chapter 3) so this similarity was 2799 
expected. 2800 
Changes to dietary n-3 LC PUFA were observed to have an effect on feed conversion 2801 
efficacy in YTK and could have implications for commercial YTK farmers. In the 33-day 2802 
experimental period a significant difference in apparent FCR was observed, with the fish in the 2803 
MOD/HIGH group having a superior FCR compared to those in the HIGH/LOW group. 2804 
Similar finishing diet studies have reported no differences in growth between treatments and 2805 
have not reported apparent FCR (Bell et al., 2003, Bell et al., 2004, Ng et al., 2004).  In the 2806 
current study, growth was not different between treatment groups, but feed conversion was 2807 
significantly different, demonstrating the need to report both values. The pattern for inferior 2808 
FCR in the HIGH/LOW group was expected, given that the dietary n-3 LC PUFA concentration 2809 
in the finishing diet for this group was substantially lower than the recommended dietary 2810 
concentration (2.1g n-3 LC PUFA 100 g-1 feed) for YTK of this size (Stone et al., 2019). 2811 
Interestingly, a study utilizing juvenile YTK (approximately 100 g), carried out under similar 2812 
conditions (water temperature >20 C), which reared fish on diets that were low or high in n-3 2813 
LC PUFA (0.57 g and 2.02 g n-3 LC PUFA 100 g-1 respectively) for 5 weeks, recorded no 2814 
significant differences in apparent FCR between groups (Bowyer et al., 2012a). There are 2815 
however a number of challenges when comparing these 2 size classes of YTK. Juvenile YTK 2816 
are known to have superior FCR compared to adult YTK (Pirozzi and Booth, 2009), diet 2817 
composition and nutrient requirements differ over the size classes and could impact FCR, and 2818 
the quality of the feeds utilised in the two studies could have also impacted FCR. While n-3 2819 
LC PUFA dilution is not consistent over the lifecycle of YTK, the diminishment of white 2820 
muscle n-3 LC PUFA in large YTK fed diets low in n-3 LC PUFA has substantial implications 2821 
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for commercial producers. The results of the current study indicate that with a short period of 2822 
feeding of inadequate dietary n-3 LC PUFA, a reduced FCR can be observed for large YTK 2823 
during the grow-out period with feed not being converted to growth with the same efficiency 2824 
as when adequate dietary n-3 LC PUFA is supplied. This information will be valuable for 2825 
commercial YTK producers as reduced feed conversion efficiency will decrease the 2826 
profitability of production. These data demonstrate the necessity of setting minimum inclusion 2827 
levels for dietary n-3 LC PUFA and closely monitoring their content in feeds to ensure that 2828 
specifications are being met. 2829 
An additional finding of the current study was that the rate of change of the individual 2830 
n-3 LC PUFAs over time was not equal. Specifically, concerning the MOD/HIGH treatment 2831 
group, white muscle EPA was observed to increase in the first 19 days, while DPA and DHA 2832 
did not significantly increase until 33 days. Interestingly it appears that DHA takes longer to 2833 
accumulate in YTK white muscle. In the MOD/HIGH treatment group DHA increased by 41 2834 
mg 100 g-1 white muscle between day 19 and 33, indicating this fatty acid was slower to 2835 
respond, while EPA levels changed faster. By comparison, in the HIGH/LOW treatment group 2836 
white muscle EPA continually decreased from 0 to 33 days, DPA decreased in the first 19 days 2837 
and DHA did not differ significantly over time. Previous studies have suggested that DHA is 2838 
preferentially conserved (Bowyer et al., 2012b, Chapter 3) and the results of the current study 2839 
support this hypothesis. Changes in the flesh fatty acid profile of fish are known to be affected 2840 
by the growth achieved over the experimental period and the rate of turnover of stored fatty 2841 
acids, specifically in the forms of triglycerides (slow exchange rate) and phospholipids (more 2842 
readily exchangeable). While the relative changes to individual n-3 LC PUFA provide insight 2843 
into the capacity of YTK to preserve and utilise specific fatty acids, for producers it’s more 2844 
important to note that no increase in muscle n-3 LC PUFA was observed until after 19 days of 2845 
feeding of high n-3 LC PUFA diet. This indicates that the minimum finishing period, under 2846 
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these conditions (warm water >20 C), required to achieve a significant increase in muscle n-2847 
3 LC PUFA is somewhere between 20 and 33 days for YTK. Therefore, a minimum finishing 2848 
period of 33 days prior to harvest is recommended to commercial YTK producers, without 2849 
further research to refine the required duration. It would also be worthwhile considering the 2850 
capacity for further increases to muscle n-3 LC PUFA with higher water temperature, as growth 2851 
rates would be higher and thus a faster and/or greater increase could be achieved. 2852 
The current study differed from the majority of other finishing diet studies, with the 2853 
primary aim focusing on short term changes to n-3 LC PUFA concentrations in the edible 2854 
portion of the fish, rather than full restoration of a ‘normal’ fatty acid profile achieved with 2855 
100% FO diets. The International Society for the Study of Fatty Acids and Lipids (ISSFAL) 2856 
recommends a daily intake of 500 mg per day of n-3 LC PUFA for humans (ISSFAL, 2004) 2857 
and any improvement to the YTK muscle content of n-3 LC PUFA would make this target 2858 
more achievable for consumers. Increasing dietary content of n-3 LC PUFA in the current study 2859 
for 33 days resulted in an increase of 48 mg n-3 LC PUFA 100 g-1 white muscle (17% increase), 2860 
which would be significant for consumers. Further research is warranted to investigate the time 2861 
required for to reach full restoration of n-3 LC PUFA tissue levels.   2862 
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5.5. Conclusions 2863 
This study has demonstrated that the n-3 LC PUFA concentration of the white muscle 2864 
of YTK can be significantly increased in a 33-day finishing period. An additional 48 mg n-3 2865 
LC PUFA 100 g-1 white muscle was deposited when dietary n-3 LC PUFA was increased by 2866 
1.92 g 100 g-1 feed and so this would be made available to the human consumer. While 2867 
significant gains were achieved with the 33-day finishing period, further research was 2868 
recommended for commercial YTK producers to define appropriate finishing period under a 2869 
range of conditions.  2870 
Given that decreasing dietary n-3 LC PUFA concentration had significant negative 2871 
impacts for white muscle n-3 LC PUFA concentration and feed conversion it was also 2872 
recommended that YTK producers set strict minimum specifications for dietary n-3 LC PUFA 2873 
with feed manufacturers and closely monitor dietary n-3 LC PUFA content in their feed 2874 
products to ensure maximum profitability in production.   2875 
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5.8. Tables and figures 2968 
Table 5.1: Total dietary lipid (%) and n-3 LC-PUFA concentration (mg 100 g-1 feed) for 2969 
preconditioning and finishing diets.  2970 
 Preconditioning diets Finishing diets 
Item (as fed) MOD HIGH HIGH LOW 
Lipid content (%) 24.9 25.3 22.03 21.97 
Analysed fatty acids (mg 100 g-1) 
  
  
t18:1n-9 (Palmitelaidic acid) 0.06 0.07 0.06 0.07 
t18:1n-7 (Elaidic acid) 0.11 0.10 0.07 0.06 
14:0 (Myristic acid) 0.41 0.67 0.66 0.37 
15:0 (Pentadecanoic acid) 0.07 0.11 0.10 0.05 
16:0 (Palmitic acid) 6.21 5.70 4.44 4.95 
17:0 (Margaric acid) 0.12 0.12 0.10 0.09 
18:0 (Stearic acid) 1.88 1.55 1.16 1.51 
20:0 (Arachidic acid) 0.05 0.07 0.03 0.04 
22:0 (Docosanoic acid) 0.02 0.03 0.05 0.03 
24:0 (Tetracosanoic acid) 0.05 0.08 0.07 0.04 
18:3n-3 (Alpha Linolenic acid- ALA) 0.61 0.46 0.35 0.51 
20:5n-3 (Eicosapentanaeoic acid- EPA) 0.39 0.96 0.91 0.27 
22:5n-3 (Docosapentaenoic acid- DPA) 0.11 0.31 0.28 0.06 
22:6n-3 (Docosahexaenoic acid- DHA) 0.92 2.07 1.66 0.39 
18:2n-6 (Linoleic acid- LOA) 3.55 2.56 1.74 2.79 
18:3n-6 (Gamma Linolenic acid) 0.05 0.07 0.06 0.04 
20:2n-6 (Eicosadienoic acid) 0.04 0.07 0.06 0.03 
20:3n-6 (Dihomo-gamma-linoleic acid) 0.03 0.05 0.04 0.03 
20:4n-6 (Arachidonic acid) 0.14 0.20 0.16 0.10 
22:4n-6 (Docosatetraenoic acid) 0.02 0.04 0.04 0.02 
16:1n-7 (Palmitoleic acid) 1.44 1.42 1.15 1.16 
18:1n-7 (Octadecenoic acid) 0.64 0.77 0.74 0.59 
18:1n-9 (Oleic acid) 7.71 6.41 6.73 8.55 
20:1n-9 (Eicosenoic acid) 0.22 1.00 1.03 0.15 
22:1n-9 (Docosenoic acid) 0.02 0.16 0.18 0.02 
24:1n-9 (Tetracosenoic acid) 0.03 0.16 0.16 0.02 
Total trans 0.16 0.17 0.13 0.13 
Total saturated  8.85 8.41 6.60 7.08 
Total Omega 3 2.02 3.79 3.20 1.22 
Total Omega 6 3.83 2.99 2.09 3.01 
Total Omega 7 2.07 2.19 1.89 1.75 
Total Omega 9 7.95 7.56 8.09 8.74 
Total n-3 LC PUFA 1.42 3.34 2.85 0.71 
n-3 FA: n-6 FA 0.53 0.79 0.65 2.47 
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Table 5.2: Weight (kg), fork length (m) and condition factor of Yellowtail Kingfish (Seriola 2972 
lalandi) following a change in dietary n-3 LC PUFA level (MOD/HIGH and HIGH/LOW) for 2973 
33 days (Mean ± standard error; subscripts denote significant difference across time; statistical 2974 
test: One-way ANOVA; n = 3). 2975 
 2976 
 Day 0 Day 19 Day 33 P= 
Weight (kg)     
MOD/HIGH 2.07 ± 0.08 a 2.48 ± 0.07 b 2.68 ± 0.05 b < 0.001 
HIGH/LOW 2.21 ± 0.03 a 2.35 ± 0.08 a 2.69 ± 0.10 b < 0.001 
Length (m)     
MOD/HIGH 0.50 ± 0.00 a 0.53 ± 0.01 b 0.54 ± 0.00 b < 0.001 
HIGH/LOW 0.51 ± 0.00 a 0.52 ± 0.01 ab 0.54 ± 0.01 b < 0.001 
Condition factor     
MOD/HIGH 1.68 ± 0.02 1.69 ± 0.03 1.70 ± 0.03 0.927 
HIGH/LOW 1.66 ± 0.02 1.64 ± 0.05 1.71 ± 0.04 0.437 
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Table 5.3: Initial weight (g), final weight (g), total weight gain (g), percentage body weight 2978 
increase (%), specific growth rate and apparent feed conversion ratio of Yellowtail Kingfish 2979 
(Seriola lalandi) following a change in diet (MOD/HIGH and HIGH/LOW n-3 LC PUFA) for 2980 
33 days (Mean ± standard error; statistical test: One-way ANOVA; n = 3). 2981 
 2982 
 MOD/HIGH HIGH/LOW P = 
Initial weight (kg) 2068.7 ± 79.8 2201.9 ± 27.3 0.255 
Final weight (g) 2684.4 ± 52.1 2691.9 ± 99.3 0.952 
Weight gain (g) 615.8 ± 27.7 490.0 ± 71.9 0.244 
Percentage body weight increase (%) 29.9 ± 2.5 22.2 ± 3.0 0.187 
Specific growth rate (% day-1) 0.79 ± 0.06 0.61 ± 0.07 0.194 
Apparent feed conversion ratio 1.71 ± 0.02 1.85 ± 0.00 0.032 
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Table 5.4: Total lipid content (%) and fatty acid composition (mg 100 g-1) of white muscle 2984 
from Yellowtail Kingfish (Seriola lalandi) which were subjected to the MOD/HIGH dietary 2985 
change treatment for 33 days (Mean ± standard error, n = 3). 2986 
 2987 
  Day 0 Day 19 Day 33 P = 
Lipid content (%) 2.0 ± 0.3 2.4 ± 0.2 2.0 ± 0.2 0.370 
Analysed fatty acids (mg 100 g-1)      
t18:1n-9 (Palmitelaidic acid) 3.3 ± 0.1 ab 3.0 ± 0.2 a 3.6 ± 0.0 b 0.005 
t18:1n-7 (Elaidic acid) 0.0 ± 0.0 a 3.3 ± 0.2 b 0.7 ± 0.3 a < 0.001 
14:0 (Myristic acid) 33.1 ± 1.4 a 37.5 ± 1.0 b 31.5 ± 1.1 a 0.005 
15:0 (Pentadecanoic acid) 4.9 ± 0.1 a 5.5 ± 0.1 b 5.0 ± 0.1 a 0.001 
16:0 (Palmitic acid) 335.9 ± 2.3 a 353.1 ± 2.5 b 346.5 ± 2.2 b < 0.001 
17:0 (Margaric acid) 5.0 ± 0.5 a 5.5 ± 0.1 a 6.8 ± 0.0 b < 0.001 
18:0 (Stearic acid) 112.3 ± 3.3 ab 105.4 ± 2.0 a 114.8 ± 2.5 b 0.049 
20:0 (Arachidic acid) 3.7 ± 0.1 a 3.6 ± 0.1 a 2.3 ± 0.0 b < 0.001 
22:0 (Docosanoic acid) 1.0 ± 0.1 a 0.0 ± 0.0 b 1.2 ± 0.1 a < 0.001 
24:0 (Tetracosanoic acid) 7.5 ± 0.4 a 0.0 ± 0.0 b 0.7 ± 0.0 b < 0.001 
18:3n-3 (Alpha Linolenic acid- ALA) 35.6 ± 1.2 a 36.0 ± 0.7 a 29.2 ± 0.9 b < 0.001 
20:5n-3 (Eicosapentanaeoic acid- EPA) 50.7 ± 0.8 a 54.6 ± 0.9 b 55.2 ± 1.2 b 0.009 
22:5n-3 (Docosapentaenoic acid- DPA) 26.9 ± 0.9 a 26.8 ± 0.5 a 30.2 ± 0.9 b 0.006 
22:6n-3 (Docosahexaenoic acid- DHA) 202.4 ± 12.9 a 201.8 ± 5.8 a 242.8 ± 12.2 b 0.017 
18:2n-6 (Linoleic acid- LOA) 241.6 ± 3.8 a 233.5 ± 2.2 a 204.9 ± 3.7 b < 0.001 
18:3n-6 (Gamma Linolenic acid) 3.1 ± 0.1 a 3.8 ± 0.2 b 2.9 ± 0.0 a < 0.001 
20:2n-6 (Eicosadienoic acid) 4.1 ± 0.1 a 4.4 ± 0.1 a 4.8 ± 0.1 b < 0.001 
20:3n-6 (Dihomo-gamma-linoleic acid) 3.1 ± 0.0 3.0 ± 0.0 3.1 ± 0.0 0.383 
20:4n-6 (Arachidonic acid) 21.8 ± 1.2 20.8 ± 0.4 22.7 ± 1.0 0.361 
22:4n-6 (Docosatetraenoic acid) 3.1 ± 0.1 a 3.1 ± 0.1 a 3.5 ± 0.1 b 0.006 
16:1n-7 (Palmitoleic acid) 102.0 ± 3.5 a 106.8 ± 2.1 a 88.4 ± 2.5 b < 0.001 
18:1n-7 (Octadecenoic acid) 54.5 ± 0.7 a 58.3 ± 0.5 b 60.0 ± 0.5 b < 0.001 
18:1n-9 (Oleic acid) 643.4 ± 12.5 617.5 ± 6.3 620.8 ± 11.4 0.195 
20:1n-9 (Eicosenoic acid) 17.5 ± 3.3 a 35.2 ± 0.9 b 41.4 ± 1.7 b < 0.001 
22:1n-9 (Docosenoic acid) 7.2 ± 0.4 6.9 ± 1.3 5.1 ± 0.3 0.162 
24:1n-9 (Tetracosenoic acid) 2.6 ± 0.2 a 2.6 ± 0.3 a 4.6 ± 0.2 b < 0.001 
Total Trans 3.3 ± 0.1 ab 6.3 ± 0.3 c 4.3 ± 0.3 b < 0.001 
Total Saturates 506.3 ± 4.2 511.4 ± 3.7 509.3 ± 3.5 0.644 
Total Omega 3 315.6 ± 12.8 a 319.2 ± 5.7 ab 357.4 ± 12.5 b 0.020 
Total Omega 6 276.9 ± 3.4 a 268.7 ± 1.9 a 241.8 ± 3.1 b < 0.001 
Total Omega 7 156.5 ± 4.0 ab 165.2 ± 2.3 a 148.4 ± 3.0 b 0.004 
Total Omega 9 670.6 ± 11.0 662.1 ± 5.3 671.9 ± 11.2 0.747 
Total n-3 LC PUFA 280.0 ± 13.9 a 283.2 ± 6.3 a 328.2 ± 13.3 b 0.012 
n-3 FA: n-6 FA 890.2 ± 40.7 a 844.5 ± 21.0 a 684.9 ± 28.2 b < 0.001 




Table 5.5: Total lipid content (%) and fatty acid composition (mg 100 g-1) of white muscle 2990 
from Yellowtail Kingfish (Seriola lalandi) which were subjected to the HIGH/LOW dietary 2991 
change treatment for 33 days (Mean ± standard error; n = 3). 2992 
 2993 
 Day 0 Day 19 Day 33 P = 
Lipid content (%) 1.9 ± 0.3 1.7 ± 0.2 1.6 ± 0.3 0.746 
Analysed fatty acids (mg 100 g-1)      
t18:1n-9 (Palmitelaidic acid) 3.4 ± 0.1 a 3.0 ± 0.1 b 3.4 ± 0.1 a 0.002 
t18:1n-7 (Elaidic acid) 0.0 ± 0.0 a 3.1 ± 0.2 b 0.2 ± 0.2 a < 0.001 
14:0 (Myristic acid) 35.9 ± 1.7 a 35.5 ± 1.2 a 28.4 ± 1.3 b 0.001 
15:0 (Pentadecanoic acid) 5.7 ± 0.2 a 5.6 ± 0.2 a 4.6 ± 0.2 b < 0.001 
16:0 (Palmitic acid) 349.9 ± 5.0 a 365.0 ± 2.4 b 354.6 ± 3.4 ab 0.028 
17:0 (Margaric acid) 4.4 ± 0.9 a 5.8 ± 0.1 ab 6.6 ± 0.1 b 0.011 
18:0 (Stearic acid) 112.3 ± 3.8 111.3 ± 3.0 122.2 ± 3.9 0.076 
20:0 (Arachidic acid) 3.5 ± 0.1 b 3.8 ± 0.1 a 2.3 ± 0.1 c < 0.001 
22:0 (Docosanoic acid) 1.1 ± 0.1 a 0.0 ± 0.0 b 1.2 ± 0.0 a < 0.001 
24:0 (Tetracosanoic acid) 8.5 ± 0.3 a 0.0 ± 0.0 c 0.7 ± 0.0 b < 0.001 
18:3n-3 (Alpha Linolenic acid- ALA) 30.1 ± 1.3 31.2 ± 1.1 30.0 ± 1.1 0.744 
20:5n-3 (Eicosapentanaeoic acid- EPA) 64.9 ± 1.5 a 53.7 ± 1.1 b 46.9 ± 1.4 c < 0.001 
22:5n-3 (Docosapentaenoic acid- DPA) 33.9 ± 0.8 a 30.4 ± 0.7 b 28.4 ± 0.8 b < 0.001 
22:6n-3 (Docosahexaenoic acid- DHA) 259.9 ± 12.2 230.4 ± 9.7 232.3 ± 14.4 0.201 
18:2n-6 (Linoleic acid- LOA) 203.8 ± 4.0 a 214.5 ± 2.4 ab 219.2 ± 2.6 b 0.005 
18:3n-6 (Gamma Linolenic acid) 3.2 ± 0.1 3.6 ± 0.2 3.2 ± 0.1 0.105 
20:2n-6 (Eicosadienoic acid) 4.3 ± 0.0 a 4.6 ± 0.1 b 4.9 ± 0.1 c < 0.001 
20:3n-6 (Dihomo-gamma-linoleic acid) 3.1 ± 0.0 3.0 ± 0.1 3.1 ± 0.1 0.642 
20:4n-6 (Arachidonic acid) 24.5 ± 0.9 22.0 ± 0.9 22.6 ± 1.5 0.321 
22:4n-6 (Docosatetraenoic acid) 3.5 ± 0.1 3.3 ± 0.1 3.4 ± 0.1 0.500 
16:1n-7 (Palmitoleic acid) 96.2 ± 4.1 97.8 ± 3.1 86.9 ± 3.6 0.089 
18:1n-7 (Octadecenoic acid) 57.4 ± 0.8 58.3 ± 0.6 57.5 ± 0.6 0.558 
18:1n-9 (Oleic acid) 582.9 ± 11.6 a 595.9 ± 7.4 ab 629.9 ± 13.5 b 0.019 
20:1n-9 (Eicosenoic acid) 16.4 ± 5.3 a 39.9 ± 0.8 b 32.3 ± 0.9 b < 0.001 
22:1n-9 (Docosenoic acid) 10.8 ± 0.3 a 7.2 ± 1.8 ab 4.0 ± 0.1 b < 0.001 
24:1n-9 (Tetracosenoic acid) 3.3 ± 0.4 3.4 ± 0.5 4.0 ± 0.1 0.353 
Total Trans 3.4 ± 0.1 a 6.1 ± 0.3 b 3.6 ± 0.2 c < 0.001 
Total Saturates 525.9 ± 6.8 527.7 ± 3.9 521.0 ± 5.7 0.678 
Total Omega 3 388.8 ± 11.6 a 345.7 ± 8.9 b 337.6 ± 14.3 b 0.013 
Total Omega 6 242.5 ± 3.4 a 251.0 ± 1.6 b 256.3 ± 1.2 b 0.001 
Total Omega 7 153.6 ± 4.8 156.1 ± 3.6 144.5 ± 4.2 0.138 
Total Omega 9 613.5 ± 10.4 a 646.4 ± 8.0 ab 670.2 ± 14.4 b 0.007 
Total n-3 LC PUFA 358.7 ± 12.8 a 314.5 ± 9.9 ab 307.6 ± 15.4 b 0.023 
n-3 FA: n-6 FA 629.6 ± 25.3 a 730.6 ± 21.6 ab 772.7 ± 36.0 b 0.006 
n-3 FA: n-9 FA 1594.6 ± 71.1 a 1883.8 ± 67.7 ab 2033.8 ± 129.3 b 0.012 
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 2995 
Figure 5.1: Quantity (g 100 g-1 of tissue) of long-chain omega 3 polyunsaturated fatty acids 2996 
(n-3 LC PUFA; EPA + DPA + DHA) in the white muscle of Yellowtail Kingfish (Seriola 2997 
lalandi) which were subjected to the MOD/HIGH dietary change treatment for 33 days (Mean 2998 
± standard error, subscripts denote significant difference; One-way ANOVA; P = 0.016; n = 2999 
3) 3000 


































Figure 5.2: Quantity (g 100 g-1 of tissue) of long-chain omega 3 polyunsaturated fatty acids 3003 
(n-3 LC PUFA; EPA + DPA + DHA) in the white muscle of Yellowtail Kingfish (Seriola 3004 
lalandi) which were subjected to the HIGH/LOW dietary change treatment for 33 days (Mean 3005 
± standard error, subscripts denote significant difference; One-way ANOVA; P = 0.021; n = 3006 
3) 3007 

































5.9. Statement to link Chapters 2 – 5 to Chapter 6 3009 
Throughout this body of work (Chapters 2 – 5) the effects of dietary fatty acid 3010 
composition, particularly the effects of dietary n-3 LC PUFA and n-6 fatty acids, on product 3011 
quality, metabolism, growth and feed conversion efficiency have been addressed. In Chapter 3012 
6, the aim was to expand further on the role of these fatty acids within the biological systems 3013 
of YTK. Specifically, the aim was to study the effects of the bioactive components of these 3014 
fatty acids and their downstream products once they are circulating in the blood of YTK. These 3015 
include free fatty acids and oxylipins and in Chapter 6 a method to quantify these free fatty 3016 
acids was validated and used to quantify them among different dietary treatments in the hours 3017 
following a feeding episode. 3018 
  3019 
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Abstract  3048 
Yellowtail Kingfish (Seriola lalandi) (YTK) require dietary omega 3 (n-3) long chain 3049 
polyunsaturated fatty acids (LC PUFA) for healthy development and growth. However, the 3050 
fatty acid profile of the aquafeeds for many commercially cultured fish has changed extensively 3051 
over time as dietary fish oil (FO) is replaced with alternative oils. A variety of methods have 3052 
been utilised to assess the effects of replacing dietary FO in aquafeeds for a number of species, 3053 
mostly consisting of routine growth and feed conversion efficiency parameters. Despite 3054 
intensive research, the exact mechanisms by which fatty acids influence the growth and 3055 
development of fish (and many other organisms) are largely unknown. The current study aimed 3056 
to validate recently developed liquid chromatography and tandem mass spectroscopy (LC-3057 
MSMS) methods for the detection and quantification of free fatty acids and oxylipins in human 3058 
blood samples for use with YTK blood plasma. The study then further aimed to use the 3059 
technique to measure the effects of an acute feeding response following consumption of 3060 
deficient, target or excessive quantities of dietary n-3 LC PUFA on the composition of free 3061 
fatty acids (FFA) and oxylipins in the blood plasma of YTK. The results indicated that the LC-3062 
MSMS methods could be adapted for use with YTK blood plasma and that n-3 and omega 6 3063 
free fatty acids (FFA) and their oxylipin derivatives were able to be detected and quantified. 3064 
Thereafter it was shown that differences in FFA and oxylipin profiles were detected in fish on 3065 
3 types of diet, with increased dietary concentrations of n-3 LC PUFA being reflected in 3066 
significantly increased concentrations of n-3 FFA in YTK blood plasma. Similarly, increased 3067 
dietary concentrations of n-6 linoleic acid (18:2n-6) (LOA) translated into significantly 3068 
increased concentrations of free LOA in YTK blood plasma. Interestingly, plasma levels of n-3069 
3 FFA peaked at 3 hours post feed whilst n-6 LOA did not peak until 9 hours post feed. Omega 3070 
6 derived oxylipin abundance in YTK blood plasma also followed the same trend of the parent 3071 
dietary fatty acids concentration, however, levels of the n-3 derived oxylipin 4HDHA were not 3072 
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affected by variable dietary levels of n-3 LC PUFA. The methods used to measure FFA and 3073 
oxylipins in the current study had only previously been utilised for human biological samples 3074 
and this study demonstrates for the first time that these methods can be applied to acquire 3075 
similar information from YTK blood plasma samples. Further expansion of this technique to 3076 
include measuring omega 9 and saturated FFA and their downstream oxylipins would be highly 3077 
beneficial and future research should aim to address these knowledge gaps.  3078 
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Keywords 3079 
Yellowtail Kingfish; omega 3 (n-3) long chain (LC) polyunsaturated fatty acids (PUFA); free 3080 
fatty acids (FFA); oxylipins; aquaculture.  3081 
 3082 
Highlights 3083 
1. A new high throughput, highly sensitive and robust method for measuring FFA and 3084 
oxylipins in human blood utilising LC-MSMS was adapted and validated for use with 3085 
YTK blood plasma. 3086 
2. Changes were observed in the concentration of omega 3 and omega 6 FFA present in 3087 
YTK blood plasma concurrent with alterations in dietary n-3 LC PUFA concentrations.  3088 
3. Omega 3 and omega 6 FFA were observed to peak in blood plasma at different times 3089 
after a feeding episode, free DHA and EPA peaked at 3 hours post feed while free LOA 3090 
did not peak until 9 hours post feed. 3091 
4. Omega 6 derived oxylipin abundance reflected the relative abundances of the parent 3092 
FFA in the blood plasma. 3093 
5. Abundance of the DHA-derived oxylipin 4HDHA was not reflective of the relative 3094 
abundances on free DHA in YTK blood plasma, suggesting that at this inclusion level, 3095 
variation in the dietary quantity of this key fatty acid does not influence the abundance 3096 
of its downstream oxylipin. 3097 
3098 
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6.1. Introduction 3099 
Yellowtail Kingfish (Seriola lalandi) (YTK) have a nutritional requirement for omega 3100 
3 (n-3) long chain polyunsaturated fatty acids (LC PUFA), specifically they achieve optimal 3101 
growth and feed conversion efficiency when supplied with 2.1 g of n-3 LC PUFA 100 g-1 3102 
aquafeed (Stone et al., 2019). These n-3 LC PUFA, including eicosapentaenoic acid (EPA), 3103 
docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA), are necessary for healthy 3104 
cellular metabolism and maintaining cell membrane structure and integrity in fish (Sargent et 3105 
al., 1999a, Miller et al., 2008) and also play a vital role in human nutrition (McCann and Ames, 3106 
2005, Eilander et al., 2007). In commercial aquaculture, dietary n-3 LC PUFA are primarily 3107 
supplied by dietary inclusions of fish oil (FO) (NRC, 2011). The fatty acid composition of 3108 
commercial aquafeeds has varied substantially over time as dietary fish oil (FO) has been 3109 
incrementally replaced with alternative oil, such as terrestrial plant oils (e.g. canola oil) or 3110 
animal by-product oils (e.g. poultry oil). As FO is incrementally replaced with alternative oils, 3111 
the quantity of omega 6 (n-6), omega 9 (n-9) and saturated fatty acids in aquafeeds have 3112 
increased (Turchini et al., 2009), which is likely to have an extensive effect on the biological 3113 
functioning of YTK and other farmed fish. 3114 
Despite intensive research, the exact mechanism by which fatty acids work to influence 3115 
the growth and development of fish and many other organisms is largely unknown, although 3116 
various hypotheses have been put forward (Caldwell, 2009, Bruins et al., 2013, Hewawasam 3117 
et al., 2017, Hewawasam et al., 2018). One mechanism that has received traction in animal and 3118 
human studies is that dietary fats can be stored/incorporated in tissues, largely as phospholipids 3119 
and triglycerides, and as required for basic physiological needs or in response to trauma can be 3120 
liberated as free fatty acids (FFA). These in turn can be oxidised to form highly reactive 3121 
compounds such as prostaglandins, leukotrienes, resolvins, protectins and maresins known 3122 
collectively as oxylipins (Samuelsson et al., 1987, Buckley et al., 2014). 3123 
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Oxylipins have a range of known activities spanning from pro- to anti-inflammatory 3124 
actions (Jira et al., 1997, Jira et al., 1998, Duffield et al., 2006, Aoki et al., 2008), however, 3125 
very little is known about the role that oxylipins play in the normal physiology of fish. Recently 3126 
a method has been developed that is capable of preserving the integrity of fatty acids in dried 3127 
blood spots (DBS) which provides an ideal collection device for monitoring the fatty acid status 3128 
of fish in the field and in feed trials (Liu et al., 2014). More recently, Hewawasam et al. (2017) 3129 
and Hewawasam et al. (2018) have reported that the DBS system could be utilised to measure 3130 
both the FFA and the oxylipins present in human blood. Given these recent developments and 3131 
the lack of understanding of the presence, abundance and role of FFA and oxylipins in fish, 3132 
this method presents an interesting opportunity to better understand the mechanisms by which 3133 
dietary fatty acids might affect growth and development in fish.  3134 
Therefore, the aim of the current study was to validate the methods described by 3135 
Hewawasam et al. (2017) and Hewawasam et al. (2018) for use with YTK blood plasma and 3136 
then to measure the effects of feeding deficient, target or excessive dietary quantities of n-3 LC 3137 
PUFA on the composition of free fatty acids and oxylipins in the blood plasma of YTK.  3138 
  3139 
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6.2. Methods and Materials  3140 
6.2.1. Feeding trial and sample collection 3141 
6.2.1.1. Experimental location and animals  3142 
Animal ethics approvals for this work was granted by the University of Adelaide 3143 
(Approval number: S-2016-127) animal ethics committee. The experiment was conducted at 3144 
the South Australian Research and Development Institute (SARDI) aquatic sciences pool farm, 3145 
West Beach, South Australia. Yellowtail Kingfish were supplied by Clean Seas Seafood Ltd. 3146 
in Port Lincoln, South Australia. Prior to being subjected to experimental protocol fish were 3147 
housed in 9 × 5000 L recirculating seawater tanks and fed a 9 mm commercial diet (Pelagica 3148 
formulation) made by Skretting Australia (Cambridge, TAS, Australia) to apparent satiation 3149 
once per day for a 4-week acclimation period. Fish were exposed to a natural photoperiod and 3150 
ambient seawater temperatures throughout.  3151 
6.2.1.2. Experimental diets 3152 
The diet kernels, FO and PO used in the experimental diets were supplied by Skretting 3153 
Australia. The diet formulations were based on Skretting Australia’s YTK diet (20% fish meal; 3154 
40% crude protein, 30% crude lipid and a gross energy level of approximately 21 MJ kg-1) 3155 
(Stone et al., 2019). The diet kernel contained a base level of 10% crude lipid and it was then 3156 
top coated with an additional 17% lipid (graded blends of FO and PO to give varying levels of 3157 
n-3 LC PUFA and n-9 fatty acids; total crude lipid level 27%) at Aquafeeds Australia (Mount 3158 
Barker, SA). Three experimental diets were formulated with n-3 LC PUFA contents of 0.8 3159 
(DIET0.8), 2.1 (DIET2.1) and 3.0 (DIET3.0) g 100 g-1 of feed (Table 6.1). 3160 
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6.2.1.3. Animal housing and care 3161 
At the start of the feed trial, YTK were anaesthetised in 5000 L tanks (total water 3162 
volume 2500 L) using AQUI-S® (AQUI-S® New Zealand Ltd., Lower Hutt, New Zealand) at 3163 
a concentration of 14 mg L−1 of seawater. Fish were randomly distributed into 9 × 5000 L 3164 
recirculating aquaculture tanks (13 fish per tank) and randomly assigned one of the 3 3165 
experimental diets (3 replicate tanks diet-1). Fish were fed their experimental diet for 12 weeks, 3166 
with feeding once daily to apparent satiation and intake was recorded as grams consumed per 3167 
tank per day. Water quality parameters were measured daily and maintained within the 3168 
accepted optimal levels for YTK (Bowyer et al., 2014).  3169 
6.2.1.4. Sample collection 3170 
At the conclusion at the experiment, fish were fed their experimental diets once more 3171 
to satiation after which blood samples were collected at 0, 3 and 9 hours post feed (HPF). In 3172 
order to collect blood samples fish were crowded and netted out of their tank one at a time (3 3173 
fish per tank per time point). Thereafter fish were secured by being wrapped in a damp towel, 3174 
and then a blood sample was drawn from the caudal vein using an 18-gauge 1.5-inch needle 3175 
and a 10 mL syringe. Importantly, all fish were sampled within 3 minutes from the initial 3176 
introduction of the sampling stress. Each blood sample was immediately deposited into a 6 mL 3177 
EDTA vacutainer and refrigerated until the sample could be separated. The vacutainers were 3178 
centrifuged at 4 C at 3000 rpm for 10 minutes and the plasma portion was separated, with 2 × 3179 
30 L samples of plasma deposited on to the PUFAcoat™ paper designed as part of the DBS 3180 
system (Liu et al., 2014) and the remainder of the plasma frozen at -80 C.  3181 
6.2.2. Laboratory methods 3182 
The methods used for analysis of free fatty acids and oxylipins are outlined in 3183 
Hewawasam et al. (2018) and are briefly described below.  3184 
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6.2.2.1. Standards and reagents 3185 
LC–MS grade methanol and acetonitrile were from Merck (VIC, Australia). America 3186 
Chemical Society grade formic acid and analytical standard grade 3,5–di–tert–4–3187 
butylhydroxytoluene (BHT) were sourced from Sigma–Aldrich (NSW, Australia). Analytical 3188 
standards (≥98% purity) for oxylipins, 4–hydroxydocosahexaenoic acid (4–HDHA), 13–3189 
hydroxyoctadecadienoic acid (13–HODE), 5–hydroxyicosatetraenoic acid (5–HETE), 8–3190 
hydroxyeicosatetraenoic acid (8–HETE), 9–hydroxyeicosatetraenoic acid (9–HETE), 11–3191 
hydroxyeicosatetraenoic acid (11–HETE), 12–hydroxyeicosatetraenoic acid (12–HETE), 15–3192 
8,9–epoxyeicosatrienoic acid (8(9)–EET), leukotriene B4 (LTB4) and free fatty acids 3193 
eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LOA) and 3194 
arachidonic acid (AA) were purchased from Cayman Chemical Company (Michigan, USA). 3195 
Deuterated internal standards (≥99% purity) d5–EPA, d5–DHA, d4–LA and d8–AA, d4–13–3196 
HODE, d4–LTB4 and d8–12–HETE, were purchased from Cayman Chemical Company 3197 
(Michigan, USA).  3198 
6.2.2.2. Sample extraction from PUFAcoat™ paper 3199 
Lipid extraction was preformed following a method described by Hewawasam et al. 3200 
(2017). Firstly, a 3mm disc was removed from each dried PUFAcoat plasma sample and placed 3201 
in a 96–well plate. Extraction solvent (150 μL of 80% methanol) containing deuterated internal 3202 
standard mix (stock was prepared in methanol at 0.01 ng μL-1 of d4–13–HODE, d4–LTB4 and 3203 
d8–12–HETE) was added to each well, and the plate was covered, then gently shaken on a 3204 
plate shaker for 30 min at room temperature. The extract from each well was transferred to a 3205 
second 96 well plate, sealed and analysed by UPLC–MS/MS. 3206 
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6.2.2.3. Instrument parameters 3207 
Instrument parameters for the mass spectrometer were set as outlined in Hewawasam 3208 
et al. (2017) and Hewawasam et al. (2018). Briefly, all analysis was conducted with an Agilent 3209 
1290 Infinity LC system (Agilent Technologies, VIC, Australia) fitted with a binary pump and 3210 
thermostated autosampler held at 4 °C, connected to a 5500 triple quadrupole mass 3211 
spectrometer (AB Sciex, VIC, Australia), using electrospray ionisation in negative mode. 3212 
6.2.2.4. Standard curve preparation 3213 
For data interpretation standard curves were prepared following the methods outlined 3214 
in Hewawasam et al. (2018), with the exception that human blood samples were substituted 3215 
with YTK blood plasma samples. 3216 
6.2.3. Statistics 3217 
Statistical analysis was performed using IBM SPSS (version 24). Homogeneity of 3218 
variance was assessed using Levene’s test, whilst normality was assessed with Kolmogorov-3219 
Smirnov test. Where data met prior requirements, differences were analysed using two-way 3220 
ANOVAs, where HPF and diet were factors. Where significant differences were detected, post-3221 
hoc comparisons were made via pairwise comparisons. An alpha level of 0.05 was used for all 3222 
statistical tests. Results are presented as means ± standard error (SE).   3223 
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6.3. Results 3224 
6.3.1. General observations 3225 
Experimental diets were readily accepted and palatable for YTK with no rejection of 3226 
feed observed. Blood samples were able to be collected within 3 minutes of sampling stress 3227 
being induced and fish which had not been sampled appeared to return to routine swimming 3228 
behaviour within 5 minutes of the end of each sampling episode.  3229 
6.3.2. Standard curves 3230 
Standard curves in YTK blood plasma were developed for free fatty acids including; 3231 
EPA, DPA, DHA, AA and LOA (R2 > 0.85 for all, Figure 6.1), and for oxylipins; 9-HODE, 3232 
13-HODE, 5-HETE, 8-HETE, 11-HETE, 12-HETE, 4-HDHA, 8(9)-EET and LTB4 (R2 > 0.98 3233 
for all, Figure 6.2).  3234 
6.3.3. Free fatty acids 3235 
For all free fatty acids measured there was no significant interaction between diet and 3236 
HPF (two-factor ANOVA; P > 0.050 for all; Figure 6.3), however significant differences were 3237 
observed among diets and HPF for each free fatty acid.  3238 
The concentration of EPA was observed to be significantly different across diets and 3239 
HPF (two-factor ANOVA; P = 0.001 and P < 0.001 respectively; Figure 6.3A). The mean 3240 
concentration of EPA in YTK blood plasma was significantly lower in fish fed DIET0.8 3241 
compared to DIET2.1 or DIET3.0 (two-factor ANOVA – pairwise comparisons; P = 0.019 and 3242 
P < 0.001, respectively). The mean concentration of EPA in YTK blood plasma was 3243 
significantly higher at 3 and 9 HPF compared to 0 HPF (two-factor ANOVA – pairwise 3244 
comparisons; P < 0.001 and P < 0.001 respectively; Figure 6.3A). 3245 
Docosahexaenoic acid concentrations were observed to be significantly different across 3246 
diets and HPF (two-factor ANOVA; P < 0.001 for both; Figure 6.3B). The mean concentration 3247 
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of DHA in YTK blood plasma was significantly lower in fish fed DIET0.8 compared to 3248 
DIET2.1 or DIET3.0 and for DIET2.1 compared to DIET3.0 (two-factor ANOVA – pairwise 3249 
comparisons; P = 0.002 P < 0.001 and P = 0.039 respectively). The mean concentration of 3250 
DHA in YTK blood plasma was significantly higher at 3 and 9 HPF compared to 0 HPF (two-3251 
factor ANOVA – pairwise comparisons; P < 0.001 and P < 0.001 respectively). 3252 
Arachidonic acid concentrations were observed to be significantly different only across 3253 
HPF (two-factor ANOVA; P < 0.001; Figure 6.3C). The mean concentration of AA in YTK 3254 
blood plasma was significantly higher at 3 and 9 HPF compared to 0 HPF (two-factor ANOVA 3255 
– pairwise comparisons; P < 0.001 for both). 3256 
The concentration of LOA was observed to be significantly different across diets and 3257 
HPF (two-factor ANOVA; P = 0.039 and P = 0.049 respectively; Figure 6.3D). The mean 3258 
concentration of LOA in YTK blood plasma was significantly lower in fish fed DIET3.0 3259 
compared to DIET0.8 (two-factor ANOVA – pairwise comparisons; P = 0.012). The mean 3260 
concentration of LOA in YTK blood plasma was significantly higher at 9 HPF compared to 0 3261 
HPF and 3 HPF (two-factor ANOVA – pairwise comparisons; P = 0.026 and P = 0.041 3262 
respectively). 3263 
6.3.4. Oxylipins 3264 
For all oxylipins measured there was no significant interaction between diet and HPF 3265 
(two-factor ANOVA; P > 0.050 for all; Figures 6.4 and 6.5), however significant differences 3266 
were observed among diets and HPF for each free fatty acid. 3267 
6.3.4.1. DHA derived oxylipins 3268 
The concentration of 4HDHA in YTK blood plasma was observed to vary significantly 3269 
across HPF but was not affected by diet (two-factor ANOVA; P < 0.001 and P = 0.966 3270 
respectively; Figure 6.4C). At 3 and 9 HPF mean 4HDHA concentration was significantly 3271 
 169 
higher in YTK blood plasma than at 0 HPF (two-factor ANOVA – pairwise comparisons; P < 3272 
0.001 and P = 0.002 respectively). 3273 
6.3.4.2. LOA derived oxylipins 3274 
The concentration of 9HODE in YTK blood plasma was observed to vary significantly 3275 
across diet and with HPF (two-factor ANOVA; P = 0.005 and P < 0.001 respectively; Figure 3276 
6.4A). The mean 9HODE concentration was significantly higher in YTK blood plasma at 3 3277 
and 9 HPF compared to 0 HPF, and at 3 HPF compared to 9 HPF (two-factor ANOVA – 3278 
pairwise comparisons; P < 0.001, P < 0.001 and P = 0.014 respectively). The mean 3279 
concentration of 9HODE was significantly higher in the blood plasma of fish fed DIET0.8 3280 
compared to DIET2.1 and DIET3.0 (two-factor ANOVA – pairwise comparisons; P = 0.010 3281 
and P = 0.002 respectively). 3282 
The concentration of 13HODE in YTK blood plasma was observed to vary significantly 3283 
across diet and with HPF (two-factor ANOVA; P = 0.034 and P < 0.001 respectively; Figure 3284 
6.4B). The mean 13HODE concentration was significantly higher in YTK blood plasma at 3 3285 
and 9 HPF compared to 0 HPF, and at 3 HPF compared to 9 HPF (two-factor ANOVA – 3286 
pairwise comparisons; P < 0.001, P < 0.001 and P = 0.008 respectively). The mean 3287 
concentration of 13HODE was significantly higher in the blood plasma of fish fed DIET0.8 3288 
compared to DIET2.1 and DIET3.0 (two-factor ANOVA – pairwise comparisons; P = 0.043 3289 
and P = 0.015 respectively). 3290 
6.3.4.3. AA derived oxylipins 3291 
The concentration of 5HETE in YTK blood plasma was observed to vary significantly 3292 
across diet and with HPF (two-factor ANOVA; P = 0.016 and P < 0.001 respectively; Figure 3293 
6.5A). At 3 and 9 HPF mean 5HETE concentration was significantly higher in YTK blood 3294 
plasma than at 0 HPF (two-factor ANOVA – pairwise comparisons; P < 0.001 for both). The 3295 
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mean concentration of 5HETE was significantly higher in the blood plasma of fish fed DIET0.8 3296 
compared to DIET3.0 (two-factor ANOVA – pairwise comparisons; P = 0.004). 3297 
The concentration of 8HETE in YTK blood plasma was observed to vary significantly 3298 
across diet and with HPF (two-factor ANOVA; P = 0.005 and P < 0.001 respectively; Figure 3299 
6.5B). The mean 8HETE concentration was significantly higher in YTK blood plasma at 3 and 3300 
9 HPF compared to 0 HPF, and at 3 HPF compared to 9 HPF (two-factor ANOVA – pairwise 3301 
comparisons; P < 0.001, P < 0.001 and P = 0.002 respectively). The mean concentration of 3302 
8HETE was significantly higher in the blood plasma of fish fed DIET0.8 compared to DIET2.1 3303 
and DIET3.0 (two-factor ANOVA – pairwise comparisons; P = 0.010 and P = 0.003 3304 
respectively). 3305 
The concentration of 11HETE in YTK blood plasma was observed to vary significantly 3306 
only across HPF and not with diet (two-factor ANOVA; P < 0.001 and P = 0.111 respectively; 3307 
Figure 6.5C). The mean 11HETE concentration was significantly higher in YTK blood plasma 3308 
at 3 and 9 HPF compared to 0 HPF, and at 3 HPF compared to 9 HPF (two-factor ANOVA – 3309 
pairwise comparisons; P < 0.001, P = 0.001 and P = 0.032 respectively). 3310 
The concentration of 12HETE in YTK blood plasma was observed to vary significantly 3311 
only across HPF and not with diet (two-factor ANOVA; P < 0.001 and P = 0.075 respectively; 3312 
Figure 6.5D). The mean 12HETE concentration was significantly higher in YTK blood plasma 3313 
at 3 and 9 HPF compared to 0 HPF, and at 3 HPF compared to 9 HPF (two-factor ANOVA – 3314 
pairwise comparisons; P < 0.001, P = 0.002 and P = 0.043 respectively). 3315 
The concentration of 8(9)EET in YTK blood plasma was observed to vary significantly 3316 
across diet and with HPF (two-factor ANOVA; P = 0.024 and P < 0.001 respectively; Figure 3317 
6.5E). The mean 8(9)EET concentration was significantly higher in YTK blood plasma at 3 3318 
and 9 HPF compared to 0 HPF (two-factor ANOVA – pairwise comparisons; P < 0.001 for 3319 
both). The mean concentration of 8(9)EET was significantly higher in the blood plasma of fish 3320 
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fed DIET0.8 compared to DIET2.1 and DIET3.0 (two-factor ANOVA – pairwise comparisons; 3321 
P = 0.035 and P = 0.010 respectively). 3322 
The concentration of LTB4 in YTK blood plasma was observed to vary significantly 3323 
only across HPF and not with diet (two-factor ANOVA; P < 0.001 and P = 0.056 respectively; 3324 
Figure 6.5F). The mean LTB4 concentration was significantly higher in YTK blood plasma at 3325 
3 and 9 HPF compared to 0 HPF (two-factor ANOVA – pairwise comparisons; P < 0.001 for 3326 
both). 3327 
  3328 
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6.4. Discussion 3329 
The methods used to measure free fatty acids and oxylipins in the current study have 3330 
only previously been utilised for human biological samples using dried blood spot technology 3331 
(Hewawasam et al., 2017, Hewawasam et al., 2018). The results presented here demonstrate 3332 
for the first time that these methods can be applied to acquire similar information from YTK 3333 
blood plasma samples, with detectable differences in free fatty acid and oxylipin concentrations 3334 
across dietary treatments and in the hours following a feeding episode. 3335 
The oxidation of dietary fatty acids mainly by the enzymatic or chemical formation 3336 
of fatty acid hydroperoxides drives many processes within the body. Importantly, oxylipins, 3337 
which are biologically important lipid mediators, are derived enzymatically from free fatty 3338 
acids and have a substantial role in regulating inflammatory processes (Samuelsson et al., 1987, 3339 
Buckley et al., 2014). In humans, n-3 LC PUFA and their downstream oxylipins have anti-3340 
inflammatory actions (Duffield et al., 2006, Aoki et al., 2008), while n-6 PUFA and their 3341 
downstream oxylipins generally have pro-inflammatory actions (Jira et al., 1997, Jira et al., 3342 
1998, Grapov et al., 2012, Zivkovic et al., 2012). Given that the quantity, ratio and types of n-3343 
3 LC PUFA and n-6 PUFA are readily manipulated in commercial aquaculture diets and differ 3344 
substantially from those in ‘natural’ fish diets, the investigation of the production of oxylipins 3345 
in aquacultured fish could provide a novel opportunity for better understanding and improving 3346 
fish nutrition. 3347 
In the current study, when free fatty acids and oxylipins were measured in fish plasma 3348 
after 24 hours fasting, significant differences were detectable in EPA and DHA between dietary 3349 
treatments. These n-3 LC PUFA were strategically altered in the diets of the treatment groups, 3350 
demonstrating that changes to dietary fatty acids do indeed affect the circulating free fatty acid 3351 
pool in YTK. As dietary n-3 LC PUFA decreased dietary LOA increased, but while plasma 3352 
free LOA was not significantly different between diet treatments after 24 hours fasting (0HPF), 3353 
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free LOA was significantly higher in DIET0.8 overall, specifically free LOA was higher in 3354 
DIET0.8 at 9 HPF, and free LOA derived oxylipins were also observed to peak in DIET0.8. 3355 
These findings support the hypothesis that increased dietary n-6 PUFA will drive increased n-3356 
6 free fatty acids and their derived oxylipins, which could be a mechanism by which growth 3357 
and feed efficacy in YTK fed excess potentially proinflammatory dietary n-6 PUFA is 3358 
mediated.  Arachidonic acid was only present in the diets in very small quantities and as such 3359 
diet had no effect on the level of free AA in YTK plasma. However, there was a significant 3360 
effect on the AA derived oxylipins such that the highest level of AA derived oxylipins was 3361 
seen in the DIET0.8 group, which also had the lowest dietary n-3 LC PUFA concentration. The 3362 
only n-3 LC PUFA derived oxylipin measured in the current study was 4HDHA and it was not 3363 
observed to be significantly different between treatment groups, however for all treatment 3364 
groups there was an increase in 4HDHA at 3 HPF. While low concentrations of dietary n-3 LC 3365 
PUFA are known to reduce growth and feed conversion efficiency in YTK (Stone et al., 2019), 3366 
it appears that even at these low dietary n-3 LC PUFA concentrations, YTK are still capable of 3367 
producing anti-inflammatory oxylipins. 3368 
The interpretation of the actions of n-3 LC PUFA and n-6 PUFA free fatty acids and 3369 
derived oxylipins are based on their known bioactive roles in humans and land animals but 3370 
their mode of action in fish is still to be confirmed. However, given the known effects of 3371 
reduced growth and feed efficacy in a range of commercially farmed fish due to low n-3 LC 3372 
PUFA/ high n-6 PUFA diets, it is likely that their role is similar. The current study was 3373 
exploratory in nature, and it is the first report of free fatty acids and oxylipins in the plasma of 3374 
YTK, although oxylipins have been reported in flesh of other fish species (Flaskerud et al., 3375 
2017). The actual role of oxylipins in fish physiology remains to be determined, but the finding 3376 
that we could not detect differences in n-3 LC PUFA derived oxylipins in YTK plasma despite 3377 
the highly variable levels of n-3 LC PUFA in the diets, is intriguing. Clearly further work 3378 
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remains to be done in this important arena, to understand the role and function of free fatty 3379 
acids and oxylipins in YTK and to better inform nutritional studies.   3380 
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6.5. Conclusions 3381 
This study was the first to utilise LC-MSMS technology to assess the free fatty acid and 3382 
oxylipin concentrations in YTK blood plasma, in the hours post feed and to detect differences 3383 
driven by changes to dietary fatty acid intake. Free fatty acids, including EPA, DHA and AA, 3384 
in YTK blood plasma was observed to peak within 3 hours of a feeding episode, while LOA 3385 
did not peak until 9 HPF.  Differences in the concentration of plasma free fatty acids followed 3386 
differences in dietary composition, which is similar to the pattern for utilisation of total dietary 3387 
fatty acids in YTK. Omega 6 derived oxylipin abundance in YTK blood plasma also followed 3388 
the same trend of the parent dietary fatty acids composition, however, n-3 derived 4HDHA was 3389 
not affected by highly variable dietary levels of n-3 LC PUFA. The role of oxylipins in the 3390 
physiology of fish remains unknown but there is ample opportunity for it to provide productive 3391 
avenues for aquaculture nutrition research.  3392 
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6.8. Tables and figures 3474 
Table 6.1: Total dietary lipid content (%) and fatty acid profile (mg 100 g-1 feed) of three 3475 
experimental diets used in the free fatty acid and oxylipin validation study. 3476 
Item (as fed) DIET0.8% DIET2.1% DIET3.0% 
Lipid content (%) 28.44 26.71 26.73 
Analysed fatty acids (mg 100 g-1)    
t18:1n-9 (Palmitelaidic acid) 83 73 72 
t18:1n-7 (Elaidic acid) 140 119 108 
14:0 (Myristic acid) 420 730 900 
15:0 (Pentadecanoic acid) 53 77 89 
16:0 (Palmitic acid) 5930 5760 5550 
17:0 (Margaric acid) 89 100 110 
18:0 (Stearic acid) 1870 1770 1670 
20:0 (Arachidic acid) 36 51 53 
22:0 (Docosanoic acid) 25 30 31 
24:0 (Tetracosanoic acid) 13 16 18 
18:3n-3 (Alpha Linolenic acid- ALA) 550 490 430 
20:5n-3 (Eicosapentanaeoic acid- EPA) 270 930 1350 
22:5n-3 (Docosapentaenoic acid- DPA) 63 130 160 
22:6n-3 (Docosahexaenoic acid- DHA) 420 1080 1440 
18:2n-6 (Linoleic acid- LOA) 3150 2650 2300 
18:3n-6 (Gamma Linolenic acid) 31 41 43 
20:2n-6 (Eicosadienoic acid) 28 32 36 
20:3n-6 (Dihomo-gamma-linoleic acid) 24 35 33 
20:4n-6 (Arachidonic acid) 110 50 170 
22:4n-6 (Docosatetraenoic acid) 16 20 23 
16:1n-7 (Palmitoleic acid) 1450 1560 1610 
18:1n-7 (Octadecenoic acid) 640 660 670 
18:1n-9 (Oleic acid) 11050 9290 8020 
20:1n-9 (Eicosenoic acid) 130 150 160 
22:1n-9 (Docosenoic acid) 11 20 26 
24:1n-9 (Tetracosenoic acid) 20 41 48 
Total trans 223 192 180 
Total saturated  8436 8534 8421 
Total Omega 3 1303 2630 3380 
Total Omega 6 3359 2829 2605 
Total Omega 7 2090 2220 2280 
Total Omega 9 11211 9501 8254 
Total n-3 LC PUFA 753 2140 2950 
n-3 FA: n-6 FA 2.58 1.08 0.77 
n-3 FA: n-9 FA 8.60 3.61 2.44 
 3477 
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Table 6.2: Concentration of fatty acids in Yellowtail Kingfish diets (mg 100 g-1), total fatty acids in white muscle tissue (mg 100 g-1), free fatty 3479 
acids in blood plasma (ng µL-1) and oxylipins in blood plasma (ng L-1), that were fed three experimental diets for 84 days, samples collected after 3480 
24 hours of fasting (Data is presented as mean ± SE; difference subscripts denote significant differences between treatment groups, P > 0.05, n = 3481 
3). 3482 
 Diet (mg 100 g
-1) Tissue - White muscle (mg 100 g-1)  FFA and oxylipins in plasma (ng L
-1)  
 DIET0.8 DIET2.1 DIET3.0 DIET0.8 DIET2.1 DIET3.0 P = DIET0.8 DIET2.1 DIET3.0 P = 
EPA 270 930 1350 164.8 ± 8.4 a 227.4 ± 18.1 b 288.0 ± 17.3 c < 0.001 4.34 ± 0.27 a 5.95 ± 0.34 b 6.45 ± 0.48 b 0.002 
DHA 420 1080 1440 366.1 ± 21.6 a 421.7 ± 24.6 b 486.2 ± 15.5 c < 0.001 10.45 ± 0.66 a 16.63 ± 1.56 b 18.56 ± 1.25 b < 0.001 
DHA derivative             
 - 4HDHA        0.147 ± 0.019 0.164 ± 0.026 0.163 ± 0.014 0.798 
AA 110 50 170 49.6 ± 1.9 a 51.0 ± 1.7 a 55.8 ± 0.9 b < 0.009 1.35 ± 0.08 1.66 ± 0.10 1.68 ± 0.13 0.103 
AA derivatives            
 - 5HETE        0.342 ± 0.046 0.267 ± 0.041 0.25 ± 0.022 0.212 
 - 8HETE        0.017 ± 0.003 0.013 ± 0.003 0.012 ± 0.001 0.373 
 - 11HETE        0.026 ± 0.006 0.022 ± 0.006 0.020 ± 0.003 0.703 
 - 12HETE        0.016 ± 0.003 0.013 ± 0.003 0.012 ± 0.002 0.677 
 - 8(9)EET        0.008 ± 0.001 0.006 ± 0.001 0.006 ± 0.001 0.340 
 - LTB4        0.024 ± 0.009 0.013 ± 0.005 0.015 ± 0.004 0.414 
LOA 3150 2650 2300 753.4 ± 10.9 a 681.2 ± 14.2 b 643.1 ± 16.4 c < 0.001 9.85 ± 0.53 9.82 ± 1.44 8.17 ± 0.82 0.399 
LOA derivatives            
 - 9HODE        0.139 ± 0.030 0.081 ± 0.021 0.076 ± 0.019 0.139 
 - 13HODE        0.144 ± 0.033 0.088 ± 0.024 0.082 ± 0.022 0.217 




Figure 6.1: Standard curves, concentration of free fatty acid (ng µL-1) verses peak area ratio, 3486 
for; A) EPA (R2= 0.8606 and y= 0.3089x), B) DHA (R2= 0.9572 and y= 0.0964x), C) AA (R2= 3487 
0.9800 and y= 0.1368x) and D) LOA (R2= 0.9819 and y= 0.0255x) in Yellowtail Kingfish 3488 
blood plasma. 3489 
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 3491 
Figure 6.2: Standard curves, concentration of oxylipins (ng µL-1) verses peak area ratio, for; 3492 
A) 9-HODE (R2= 0.9852 and y= 25.642x), B) 13-HODE (R2= 0.9903 and y= 5.7149x), C) 5-3493 
HETE (R2= 0.9983 and y= 11.108x), D) 8-HETE (R2= 0.9898 and y= 11.758x), E) 11-HETE 3494 
(R2= 0.9968 and y= 29.484x), F) 12-HETE (R2= 0.9927 and y= 24.432x), G) 4-HDHA (R2= 3495 
0.9950 and y= 19.372x), H) 8(9)-EET (R2= 0.9879 and y= 23.708x) and I) LTB4 (R2= 0.9935 3496 
and y= 2.7411x) in Yellowtail Kingfish blood plasma. 3497 
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Figure 6.3: Concentration of free fatty acids (ng µL-1) in blood plasma of Yellowtail Kingfish 3499 
(Seriola lalandi) fed three diets that contained different levels of fish oil resulting in n-3 LC 3500 
PUFA concentrations of 0.8 (DIET0.8), 2.1 (DIET2.1) and 3.0 (DIET3.0) g 100g-1 feed at time 3501 
0, 3 hr and 9 hr post feeding; A) EPA, B) DHA, C) AA and D) LOA. (Data is presented as 3502 
mean ± SE; n = 3) 3503 
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 3504 
Figure 6.4: Concentration of linoleic acid (LOA) and docosahexaenoic acid (DHA) derived 3505 
oxylipins (ng µL-1) in blood plasma of Yellowtail Kingfish (Seriola lalandi) fed three diets 3506 
that contained different levels of fish oil resulting in n-3 LC PUFA concentrations of 0.8 3507 
(DIET0.8), 2.1 (DIET2.1) and 3.0 (DIET3.0) g 100g-1 feed at time 0, 3 hr and 9 hr post 3508 





Figure 6.5: Concentration of arachidonic acid (AA) derived oxylipins (ng µL-1) in blood 3513 
plasma of Yellowtail Kingfish (Seriola lalandi) fed three diets that contained different levels 3514 
of fish oil resulting in n-3 LC PUFA concentrations of 0.8 (DIET0.8), 2.1 (DIET2.1) and 3.0 3515 
(DIET3.0) g 100g-1 feed at time 0, 3 hr and 9 hr post feeding; A) 5-HETE, B) 8-HETE, C) 3516 
11-HETE, D) 12-HETE E) 8(9)-EET and F) LTB4 (Data are presented as mean ± SE; n = 3). 3517 
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Chapter 7 – General discussion 3519 
7.1.  Purpose 3520 
During the course of this research program the primary focus was to increase our 3521 
understanding of Yellowtail Kingfish (Seriola lalandi) (YTK) utilisation of dietary lipids, with 3522 
a view to manipulating aquafeeds to improve the health, growth, feed conversion efficiency 3523 
and product quality of aquacultured YTK. Within the experimental chapters, results and 3524 
conclusions were considered in the context of benefits to the human consumer and also 3525 
commercial YTK farmers. In this general discussion the major findings and contribution to the 3526 
field of aquaculture nutrition, the limitations of the research and proposed future research will 3527 
be discussed.  3528 
7.2. Major findings and contribution to the field of aquaculture nutrition 3529 
In order to create a benchmark for the lipid and fatty acid tissue profile of commercially 3530 
cultured YTK, wild YTK from South Australia were captured and their tissue lipid and fatty 3531 
acid profile investigated. While this portion of the research was limited by a relatively small 3532 
number of wild fishes, it did provide initial data that was able to be used throughout the 3533 
remainder of this research. Key differences were identified between wild and aquacultured 3534 
YTK. Wild YTK were found to have significantly less total lipid in each of the tissue regions 3535 
measured. Wild YTK were found to have significantly less total omega 6, omega 7, omega 9, 3536 
saturated and trans fatty acids which are commonly associated with terrestrial protein sources, 3537 
when compared to aquacultured YTK, no doubt reflecting the diet of farmed fish. Conversely, 3538 
no significant difference in n-3 LC PUFA content in the white muscle was observed between 3539 
the wild and aquacultured YTK, and it was concluded that in regard to these vital fatty acids, 3540 
either source of YTK would be equally beneficial to human consumers. It is relevant that 3541 
similar conclusions were made in wild and aquacultured YTK from southern Africa (O’Neill 3542 
et al., 2015). Overall, these findings are positive for both YTK consumers and commercial 3543 
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producers: consumers can have increased confidence in the nutritional benefits of aquacultured 3544 
YTK and commercial producers can use these values to benchmark their products.  3545 
The next three chapters focused on increasing our understanding of the factors that 3546 
affect fatty acid digestion, assimilation and deposition in aquacultured YTK, with a specific 3547 
emphasis on n-3 LC PUFA, due to their necessity for YTK and human nutrition. Reducing 3548 
dietary n-3 LC PUFA in aquafeeds is a high global priority (Naylor et al., 2009), however in 3549 
order to achieve this we need to understand the effects that reduced dietary n-3 LC PUFA 3550 
content has on YTK growth, health and product quality. The study described in Chapter 3 3551 
identified a key relationship which affects n-3 LC PUFA deposition, with DHA being spared 3552 
at the expense of oleic acid in the white muscle (but not the red muscle) and recommended that 3553 
the level of oleic acid needs to be carefully considered in YTK diet formulations. This is 3554 
important because any natural mechanism that could assist in better utilisation of dietary n-3 3555 
LC PUFA would increase the economic and environmental sustainability of YTK production. 3556 
In Chapter 4 results indicated that YTK absorb n-3 LC PUFA and oleic acid with equal 3557 
efficiency even when dietary concentrations are changed. Furthermore, YTK do not absorb all 3558 
saturated fatty acids with equal efficiency, specifically shorter chain saturated fatty acids (< 3559 
16:0) were absorbed more efficiently than long chain saturated fatty acids (> 17:0). In the 3560 
context that saturated fatty acids are readily utilised for energy by YTK, this was an important 3561 
finding and could be used to inform commercial YTK diet formulations. By ensuring that the 3562 
majority of saturated fatty acids in YTK feeds is present in these more absorbable forms there 3563 
is potential to improve feed efficacy and decrease production costs. In the Chapter 5 study the 3564 
rate of n-3 LC PUFA assimilation by YTK was investigated, with an aim to better understand 3565 
the effects of dietary changes and make recommendations concerning the required duration of 3566 
finishing periods where YTK are fed diets rich in n-3 LC PUFA. Finding that an additional 3567 
17% n-3 LC PUFA could be deposited into the white muscle in less than 5 weeks of feeding 3568 
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of a diet rich in n-3 LC PUFA was again a positive for consumers and commercial producers. 3569 
Consumers could obtain an increased quantity of n-3 LC PUFA and commercial producers 3570 
could achieve increased product quality (in relation to muscle n-3 LC PUFA concentration) 3571 
with minimal expense. While each key finding from Chapters 3 – 5 only represents a small 3572 
opportunity to improve commercial YTK production, when implemented in combination their 3573 
impact could be meaningful. Furthermore, each finding assists researchers and producers in 3574 
understanding the complex nature of nutrient utilisation in YTK. 3575 
In Chapter 6 a method was presented which had previously not been utilised for 3576 
aquaculture nutrition investigations, indeed the method has only recently been optimised as a 3577 
tool for human nutrition studies. In this chapter a high throughput, high precision method for 3578 
quantifying free fatty acids and oxylipins in YTK blood plasma was validated. Importantly, 3579 
differences between dietary treatments and across time following a feeding event were 3580 
detectable. As these free fatty acids and oxylipins are the bioactive products of digested dietary 3581 
lipids, and have pro- and anti-inflammatory actions within the body, they will likely be a useful 3582 
tool to assess the impacts of dietary changes on the biological functioning of fish in future 3583 
nutrition studies.  3584 
7.3. Limitations 3585 
7.3.1. Wild YTK sampling 3586 
The sample of wild YTK collected during this research was limited to six individual 3587 
fish, collected from one geographical location, during a single sampling event. It is well known 3588 
that the lipid and fatty acid composition of YTK varies due to water temperature/ seasonality, 3589 
sex, sexual maturity and across geographical locations. During winter, when water temperature 3590 
decreases, the total lipid content of YTK reduces as they utilise their lipid stores for energy 3591 
(Bowyer et al., 2012a). When YTK mature and prepare to spawn their gonadal mass is known 3592 
to increase substantially in size, diminishing lipid reserves from other body compartments, and 3593 
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the timing of this process and the extent of its effect on lipid and fatty acid composition differs 3594 
between the sexes (Poortenaar et al., 2001). Geographical location is likely to affect lipid and 3595 
fatty acid composition of YTK, due to the availability and type of prey species, as well as the 3596 
temperature of the water (O'Neill et al., 2015).  3597 
With a sample size of only six fish, confidence in the data in Chapter 2 is limited, 3598 
however the variance in the data was minimal. Furthermore, gonads were visually scored 3599 
during sampling in order to limit the effect of this factor on the data set and no individual 3600 
appeared to be preparing for spawning or increasing their gonadal mass relative to the rest of 3601 
their body mass. Data were also separated by sex, in order to identify if this was influencing 3602 
the results and no differences were identified between the sexes (data not included in 3603 
manuscript). As such the effects of small sample size, sex and sexual maturity were able to be 3604 
mitigated however the effects of water temperature/ seasonality and geographical location were 3605 
unable to be overcome. Additional wild YTK samples were not obtained due to the costly 3606 
nature of sampling. Numerous other sampling strategies were considered to obtain additional 3607 
wild YTK samples, however, samples needed to be obtained from fish immediately after their 3608 
removal from the ocean to ensure that sample collection was consistent, and samples were not 3609 
degraded. This restricted samples to those collected first hand by researchers, eliminating the 3610 
possibility to engage recreational fishers. Additionally, the target size range for aquacultured 3611 
YTK (2 - 4 kg, 50 - 70cm) falls partially below the minimum size limit for recreational fishing 3612 
of YTK in South Australia (>60cm), however ministerial approval was required to catch and 3613 
keep a maximum of 10 wild YTK below the minimum recreational size limit. After a failed 3614 
attempt to capture any wild YTK on the first sampling occasion, a recreational fishing charter 3615 
boat was engaged to assist in obtaining wild YTK, while this strategy was effective it was 3616 
costly and as such could not be repeated to increase sample size or eliminate the effects of 3617 
water temperature/ seasonality and geographical location.  3618 
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7.3.2. Diet formulations 3619 
The experimental diets used in Chapters 3 – 5 were limited to formulations which could 3620 
be realistically utilised by commercial YTK producers. This research was conducted under 3621 
funding provided by the Kingfish for Profit project (RnD4Profit-14-01-027), with 50% of the 3622 
funding for the project provided by industry partners who were focused on manipulation of 3623 
diets within the limitation of the commercial environment. This affected the current study 3624 
primarily by restricting the upper and lower dietary n-3 LC PUFA limits. In Chapter 3, this 3625 
meant that the effects of low dietary n-3 LC PUFA on DHA sparing in YTK white muscle 3626 
could not be further explored. In Chapter 5, the rate at which n-3 LC PUFA was shown to 3627 
accumulate and dilute in YTK flesh could likely be increased with diets with n-3 LC PUFA 3628 
significantly higher or lower respectively in FO, but such diets could not be trialled. Restricting 3629 
the upper and lower limits of dietary n-3 LC PUFA inclusion rates has provided important 3630 
information for industry partners but constrained the scientific questions which might have 3631 
been addressed by these experiments. Future research should endeavour to understand the time 3632 
required for the full restoration of tissue n-3 LC PUFA during the washout period after feeding 3633 
diets low in FO.  3634 
 3635 
7.3.3. Feed trial duration 3636 
The trial schedule for the Kingfish for Profit project was designed to obtain the maximal 3637 
information during its 3-year duration. Previously, feed trials for YTK have demonstrated that 3638 
the effects of dietary changes can be observed within 12 weeks of feeding (Booth et al., 2011). 3639 
As such, the feeding trials were scheduled for 12-week durations, with adequate time between 3640 
trials for the tank system to be cleaned, and new fish to be transferred in and acclimated, with 3641 
few opportunities for modification to the schedule. While this strategy was effective for the 3642 
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majority of experiments, it did limit research presented in Chapter 3. While DHA sparing at 3643 
the expense of oleic acid in the white muscle was quantifiable within the 12-week feed trial, it 3644 
would have been beneficial to extend the feed trial to observe the capacity of YTK to continue 3645 
sparing DHA in the white muscle when dietary n-3 LC PUFA was lower than 1.6 g n-3 LC 3646 
PUFA 100 g-1 feed. It is likely that at some point the fish would reach a breakpoint where it 3647 
was no longer able to spare DHA and tissue levels would begin to deplete, which could have 3648 
negative flow on effects for fish health and growth. Future research should endeavour to 3649 
understand the rate at which this will occur, and the factors that might be influential.  3650 
7.4. Proposed future research 3651 
7.4.1. Collection of additional wild YTK samples  3652 
During this study, time and resources limited the number of wild YTK caught but it has 3653 
provided a starting point for future data to build on. It would be beneficial to have a thorough 3654 
understanding of the lipid and fatty acid profiles of wild YTK throughout the lifecycle and 3655 
during different environmental conditions. Currently our understanding of what is ‘normal’ for 3656 
YTK is limited and we proposed that future research should aim to address this by collecting 3657 
additional wild YTK samples.  3658 
7.4.2. DHA sparing in YTK white muscle 3659 
Further research is also required to investigate the capacity of YTK to spare DHA at 3660 
the expense of oleic acid in the white muscle when dietary n-3 LC PUFA is supplied at less 3661 
than 1.6 g 100 g-1 feed for extended periods of time. While this trade-off was observed during 3662 
an 84-day feed trial it is plausible that a more prolonged deficiency of dietary n-3 LC PUFA 3663 
could have more negative effects as YTK may not have the capacity to continue sparing DHA. 3664 
It is also possible that under the conditions described above, the utilisation of the DHA and 3665 
other n-3 LC PUFA in storage adipose may be observable.  3666 
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7.4.3. Oxylipins and free fatty acid measurements as a tool for nutrition research 3667 
The number of oxylipins and free fatty acids which could be quantified during this 3668 
research was limited due to the extensive work required to validate the method for use with 3669 
YTK blood plasma. We targeted specific n-3 LC PUFA and omega 6 fatty acids which were 3670 
likely to be important in YTK but being able to quantity the full range of free fatty acids and 3671 
their respective oxylipins will likely be important for aquaculture nutrition studies. Given the 3672 
abundance of saturated and omega 9 fatty acids in YTK feed it would be of great benefit to be 3673 
able to measure oxylipins produced from these parent fatty acids.  3674 
7.5. Relevant knowledge gaps that could not be addressed within the scope of 3675 
this research program 3676 
There are a number of important aspects that have a role in lipid metabolism in YTK 3677 
that were not able to be able to be assessed within research program but could provide various 3678 
means of improving lipid utilisation in aquacultured YTK.  There is an ongoing need to assess 3679 
new commercial dietary lipid/ n-3 LC PUFA sources as they become available. Whilst vast 3680 
strides have been made towards upscaling algal oil production for use in aquafeeds and 3681 
producing genetically modified terrestrial crops that are able to produce n-3 LC PUFA, there 3682 
is substantial requirement for ongoing research to assess their suitability to various 3683 
commercially cultured fish.  3684 
At the start of this project there was a plan to assess the effects of dietary emulsifiers 3685 
on lipid metabolism in YTK, however, as time went on this was not possible. The addition of 3686 
emulsifiers to aquafeeds may have the potential to improve lipid digestibility (Dickinson, 3687 
1993), thereby increasing the efficacy of feed conversion and reducing the cost of production. 3688 
In this PhD (Chapter 4), it was seen that a proportion of dietary lipid was not absorbed from 3689 
feeds. If this could be improved dietary lipid content could be reduced, creating meaningful 3690 
savings for producers.  3691 
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The effect of water temperature of dietary lipid metabolism was not investigated here 3692 
but there was an aim to assess the suitability of various alternative lipid sources, selected based 3693 
on their melting point, for use in winter YTK diets. Yellowtail Kingfish digestion, lipid 3694 
metabolism and growth are negatively affected by the reduced winter water temperatures 3695 
recorded in South Australia. One possible way to mitigate these negative effects is to increase 3696 
the digestibility of dietary lipids. This could potentially be achieved by replacing poultry oil 3697 
(which is solid at winter water temperatures) with alternative lipid sources that are liquid at 3698 
winter water temperatures. Little research has focused on understanding how the physical 3699 
properties of dietary lipids affect their biochemical interactions within the digestive system of 3700 
cultured fish. This remains an area that could be addressed in future studies.  3701 
Lastly, there is still a substantial amount of research required to fully understand the 3702 
role of enzymes and specific genes associated with lipid metabolism in YTK. For example, in 3703 
Atlantic Salmon dietary fatty acid composition has been suggested to be a driving factor for 3704 
the regulation of genes involved in lipid metabolism, specifically the ratio of dietary n-3 LC 3705 
PUFA and n-6 fatty acids, with lack of n-3 LC PUFA increasing gene expression (Martinez-3706 
Rubio et al., 2013). This upregulation of gene expression is likely to be metabolically costly to 3707 
the fish and as such an understanding of the full range of factors affecting such processes will 3708 
be beneficial. Similarly, in small YTK dietary FO replacement with canola oil has been shown 3709 
to downregulate lipase activity (Bowyer et al., 2012b). This reduced enzyme activity would 3710 
also be a driving factor for reduced lipid metabolism, but research has not yet fully investigated 3711 
whether large YTK have the capacity to regulate their digestive enzymes to sufficiently cope 3712 
with the pressure of challenging dietary lipid compositions. Understanding the full range of 3713 
factors influencing lipid utilisation in YTK will allow future diets to be formulated to positively 3714 
interact with all YTK biological systems and fully exploit all aquafeed ingredients.  3715 
  3716 
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